Organization of the Streptococcal ExPortal and its Interaction with Cationic Antimicrobial Peptides by Vega, Luis Alberto
Washington University in St. Louis
Washington University Open Scholarship
All Theses and Dissertations (ETDs)
9-4-2012
Organization of the Streptococcal ExPortal and its
Interaction with Cationic Antimicrobial Peptides
Luis Alberto Vega
Washington University in St. Louis
Follow this and additional works at: https://openscholarship.wustl.edu/etd
This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All
Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.
Recommended Citation
Vega, Luis Alberto, "Organization of the Streptococcal ExPortal and its Interaction with Cationic Antimicrobial Peptides" (2012). All
Theses and Dissertations (ETDs). 986.
https://openscholarship.wustl.edu/etd/986
WASHINGTON UNIVERSITY IN ST. LOUIS 
Division of Biology and Biomedical Sciences 
Molecular Microbiology and Microbial Pathogenesis 
 
 
Dissertation Examination Committee: 
Michael Caparon, Chair 
John Atkinson 
David Haslam 
David Hunstad 
Petra Levin 
Heather True-Krob 
 
 
 
 
 
Organization of the Streptococcal ExPortal and its Interaction with 
Cationic Antimicrobial Peptides 
 
 
 
By 
Luis Alberto Vega 
 
 
A dissertation presented to the 
Graduate School of Arts and Sciences 
of Washington University in 
partial fulfillment of the 
requirements for the degree 
of Doctor of Philosophy 
 
August 2012 
Saint Louis, Missouri 
  ii 
ABSTRACT OF THE DISSERTATION 
 
Organization of the Streptococcal ExPortal and its Interaction with Cationic  
Antimicrobial Peptides 
By 
Luis Alberto Vega 
Doctor of Philosophy in Molecular Microbiology and Microbial Pathogenesis 
Washington University in St. Louis, 2012 
Professor Michael G. Caparon, Chairperson 
 
Streptococcus pyogenes and other Gram-positive pathogens are highly dependent 
on secreted virulence proteins for their ability to colonize a host and evade the immune 
effectors that act on pathogens to prevent this. Unlike eukaryotes and Gram-negative 
bacteria, all Gram-positive pathogens lack a cellular compartment dedicated to folding 
and processing secreted proteins once they have been translocated across the cytoplasmic 
membrane. S. pyogenes and other Gram-positive organisms overcome this challenge by 
clustering the secretory translocons at a defined anionic lipid microdomain of the 
cytoplasmic membrane that is enriched for accessory factors needed for protein 
biogenesis, referred to as the ExPortal. The manner in which S. pyogenes achieves and 
maintains spatial coordination of the factors that constitute the ExPortal is not 
understood. Given the importance of secreted virulence proteins to streptococcal 
pathogenicity, the ExPortal is an attractive target for the development of therapeutics that 
can efficiently counter streptococcal infections. I investigated the interaction of cationic 
antimicrobial peptides with the streptococcal ExPortal to provide insights into how this 
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secretory organelle is organized and how it may be targeted by this mechanism of innate 
immunity. 
Cationinc antimicrobial peptides (CAPs) targeted the anionic lipid microdomain 
of the ExPortal. Traditionally regarded as membrane permeabilizing compounds, CAPs 
interacted with the streptococcal membrane at concentrations that did not porate the 
membrane. Rather, exposure of S. pyogenes to sub-lethal CAP concentrations resulted in 
concomitant redistribution of anionic lipids, translocons and accessory factors to 
peripheral regions of the membrane. In addition, CAPs inhibited secretion of important 
virulence proteins, including the pathogenically relevant SpeB protease and Streptolysin 
O (SLO) cytolysin. One of the CAPs investigated also targets the lipid II precursor of 
extracellular peptidoglycan, suggesting the influence of CAPs on ExPortal organization 
extended beyond their affinity for negatively charged membrane lipids and that the 
streptococcal cell wall is involved in organizing the ExPortal.  
Removal of extracellular peptidoglycan also resulted in redistribution of anionic 
lipids and ExPortal protein, indicating the cell wall is required for maintaining proper 
localization of both lipid and protein components of the ExPortal. Exposure of 
streptococci to lantibiotics that preferentially bind and sequester lipid II in the 
cytoplasmic membrane disrupted ExPortal organization and secretory function in a 
manner similar to CAP activity. Given that both CAPs and lantibiotics target lipid 
components of the cytoplasmic membrane, it appears that lipid segregation in the 
membrane is central to organization of the ExPortal. Establishment or maintenance of 
this lipid segregation could involve interaction with petidoglycan synthesis in the 
streptococcal membrane, as two membrane-localized synthetic enzymes, one integral 
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(MraY), the other membrane-associated (MurN), that are required for lipid II production 
are localized in the same anionic lipid microdomain to where secretory translocons of the 
ExPortal are targeted to. This provides a potential model for the mechanism(s) organizing 
the ExPortal. Cytoskeletal proteins and cell wall biogenesis components which are 
observed to interact with cytoplasmic membrane structures to organize membrane 
localized processes required for cell growth and division influence the segregation of 
anionic lipids in the membrane, and by extension, where and how the ExPortal is 
organized. 
Testing of this model by genetic and molecular approaches that target components 
of cell division and peptidoglycan will provide both further insights into how Gram-
positive bacteria coordinate protein biogenesis with secretion as well as reveal novel 
potential targets for the development of effective therapeutics against pathogens like S. 
pyogenes.  
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SCOPE OF THESIS 
Streptococcus pyogenes and other Gram-positive bacteria circumvent the lack of a 
specialized cellular compartment for folding secreted proteins following their 
translocation by clustering the Sec translocons at a defined microdomain of the 
cytoplasmic membrane that is also enriched in anionic lipids and accessory factors for 
protein biogenesis, referred to as the ExPortal. The function of this secretory organelle 
appears to be that of spatially coupling secretion with protein maturation, but the 
mechanisms organizing the ExPortal are still poorly understood. In order to further 
knowledge of how spatial coordination of protein secretion and processing is achieved 
and maintained in streptococci, examination of cationic antimicrobial peptide (CAP) 
interaction with the anionic lipid-enriched membrane microdomain of the ExPortal was 
undertaken. Two CAPs, the therapeutically important polymyxin B and physiologically 
relevant human neutrophil peptide 1 (HNP-1), preferentially targeted the ExPortal at sub-
lethal, non-porating concentrations. This non-permeabilizing interaction with the 
membrane resulted in disruption of ExPortal organization, as observed by the 
redistribution of ExPortal anionic lipids, the secretory translocon ATPase SecA and the 
chaperone protease HtrA into the peripheral membrane. Redistribution was associated 
with inhibition of secretion of certain toxins, including the SpeB cysteine protease and 
the Streptolysin O (SLO) cytolysin, but not SIC, a protein that protects S. pyogenes from 
CAPs. These data suggest a novel function for CAPs in targeting the ExPortal and 
interfering with secretion of factors required for infection and survival.  This report also 
contributed to literature indicating CAPs can kill their bacterial targets in the absence of 
pore formation, exerting their lethal effect by interfering with the dynamic function of 
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lipid-associated complexes, such as the ExPortal, by a so-called “sand in a gearbox” 
mechanism. 
Previous research showed that interaction of HNP-1 with the bacterial membrane 
is not limited to anionic lipids, since the peptide also binds the lipid II peptidoglycan 
precursor. As an emerging literature indicates that cell wall biogenesis components 
interact with cytoplasmic membrane structures to organize membrane-localized 
processes, involvement of the streptococcal cell wall in organizing and maintaining the 
ExPortal was investigated. Removal of extracellular peptidoglycan by the action of a 
streptococcal phage lysin resulted in redistribution of both lipid and aforementioned 
protein components of the ExPortal, suggesting the cell wall is required for maintaining 
proper localization of the secretory organelle. Exposure to a lipid II-targeting lantibiotic 
also concomitantly disrupted localization of anionic lipids and ExPortal proteins, as well 
as secretion of the streptococcal virulence factors observed to be affected by CAPs. These 
results support the hypothesis that lipid localization in the membrane is central to 
organization and maintenance of the ExPortal. Given that lantibiotic activity disrupts cell 
wall synthesis by binding lipid II and sequestering it away from the sites of peptidoglycan 
biogenesis, it was of interest to determine whether lipid II production and ExPortal 
secretion are spatially coordinated processes. Fluorescent tagging of MraY and MurN, 
two proteins involved in the membrane-associated steps of lipid II synthesis, revealed 
these to localize at foci in the streptococcal membrane that coincide with the anionic lipid 
microdomain and secretory translocons of the ExPortal. These results suggest a model for 
ExPortal organization in which peptidoglycan synthesis co-localizes with the ExPortal, 
influences its establishment and is required for its maintenance. 
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INTRODUCTION 
Streptococcus pyogenes Pathogenesis 
S. pyogenes is a gram-positive pathogen that can cause numerous diseases in 
humans that range from superficial infection of the skin and mucous membranes 
(impetigo, pharyngitis), to highly invasive and life-threatening diseases (necrotizing 
fasciitis), as well as serious post-infection sequelae (rheumatic fever, glomerulonephritis, 
reviewed in [1]). Annually, Group A streptococcus (GAS) infections account for an 
estimated 700 million cases of mild, non-invasive infections worldwide, of which 
approximately 650,000 progress to severe, invasive (at a sterile site) infections with an 
associated mortality of approximately 25% [2].  
This ability to cause disease is dependent on the secretion of an extensive network of 
virulence proteins (Figure 1) [1, 3]. Among these are the proteases ScpC (SpyCEP), 
ScpA, EndoS and SpeB; surface-bound Protein F (SfbI) and M protein adhesins or 
polymeric structures such as pili; host-targeted cytotoxins such as Streptolysin O (SLO), 
streptococcal NAD glycohydrolase (SPN) and Streptolysin S (SLS); polypeptides like 
streptococcal inhibitor of complement (SIC) and extracellular DNAses that directly 
inhibit immune effectors [3, 4]. Extracellular DNAses degrade chromatin and break down 
the neutrophil extracellular traps (NETs) extruded by neutrophils to trap pathogens and 
subject them to microbicidal effectors, thus helping streptococci evade neutrophil killing 
[5, 6]. SIC is one of multiple defenses streptococci have developed against such 
microbicidal effectors. As its name indicates, SIC was first identified as a secreted 
polypeptide that can inhibit membrane attack complex of complement by preventing 
uptake of C5b67 complement complexes on bacterial membranes [7, 8]. SIC however, 
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also interacts with and inhibits multiple host microbicidal proteins, including lysozyme, 
cathelicidin LL-37, human neutrophil peptide-1 (HNP-1) and human beta-defensins 
(hßD1, -2, -3) [9-11]. Proteins bound to the streptococcal surface also play a major role in 
the evasion of phagoyctic cells and their effectors [3]. Specifically, M protein inhibits 
opsonophagocytosis of streptococci by binding multiple host proteins [12-14] and 
promotes colonization alongside SfbI by interacting with extracellular matrix components 
and adhering to host epithelial cells [15-17]. Additionally, similar to other pathogenic 
bacteria, S. pyogenes assembles multimeric proteinaceous fibres on its surface known as 
pili, which are involved in the adhesion of the bacterium to host epithelia [18]. 
Like all Gram positive bacteria, Group A streptococci lack the specialized secretory 
systems and the accompanying host cell cytosol-targeted effectors that are necessary for 
virulence in some gram-negative pathogens (e.g. Type III secretion of Salmonella 
enterica [19]). However, the cytolysin SLO and NAD glycohydrolase SPN constitute a 
unique mechanism for specifically translocating the latter into the host cell via so-called 
cytolysin mediated translocation (CMT) [20]. The cholesterol-dependent cytolysin SLO 
oligomerizes to form large pores in host cell membranes and can thus acts on its own to 
induce cell death [21].   However, this pore-forming capacity is not required for the 
translocation of SPN by CMT [22] and mutations to SLO that do not interfere with pore-
forming activity, or modifications to SPN that do not affect NAD-glycohydrolase activity 
render these proteins incompetent for CMT [23, 24].  The precise mechanism by which 
CMT of SPN occurs then is an area of active research, but it is clear that CMT is 
important for pathogenesis [20, 25], and that the process involves interaction of 
streptococci with the host cell surface as well as between SPN and SLO. Another 
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secreted toxin of streptococci, SLS, is cytolytic to erythrocytes, leukocytes and 
subcellular organelles [26-28], promotes evasion of phagocytic killing via its cytolytic 
activity on neutrophils [29] and inhibits neutrophil recruitment during the early stages of 
streptococcal infection [30]. 
 
 
Figure 1. Virulence factors secreted by Streptococcus pyogenes. These factors include 
proteases (ScpA, ScpC, EndoS, SpeB, Mac1/IdsE), surface-bound adhesins (SfbI, M protein, 
Protein H) host-targeted cytotoxins (SLO, SLS), extracellular DNAses (Sda1) immunity effector-
targeted polypeptides (SIC). A majority of these virulence factors are involved in the evasion of 
phagocytic killing [3]. 
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The secreted proteases of Group A streptococci (GAS) serve to inactivate all kinds 
of proteins involved in host immunity. ScpC cleaves and inactivates interleukin-8 (IL-8) 
[31] and ScpA acts as an endopeptidase to cleave the C5a polypeptide fragment of the 
complement cascade [32]. EndoS hydrolyzes the chitobiose core of the asparagine-linked 
glycan on Immunoglobulin G (IgG) to prevent recognition of IgG by phagocyte Fc 
receptors, while SpeB cleaves IgA, IgM, IgD and IgE antibodies as well [33]. In fact, 
SpeB degrades a myriad of host proteins, including extracellular matrix components, 
cytokine precursors and antimicrobial peptides [34, 35]. The protease activity of SpeB 
extends to extracellular and surface-associated streptococcal proteins, including M 
protein [36], various superantigens [37], streptokinase  [38], SLO [39] and SIC [40]. 
Given such a variety of virulence-associated targets, the precise role of SpeB in 
streptococcal pathogenesis is still unclear and an area of active investigation. 
The SpeB cysteine protease is one of the most intensively researched virulence factors of 
GAS, and these efforts have revealed that production of enzymatically active SpeB is a 
complex process involving a variety of regulatory controls and multiple accessory factors 
post-translation (reviewed in [41]). Expression of SpeB is growth phase dependent and 
influenced by environmental factors including pH [42], NaCl concentration [43] and 
nutrient availability [44]. Peptide transport also affects SpeB expression as was 
determined by the mutational inactivation of the oligopeptide permease (Opp) and 
dipeptide permease (Dpp) systems responsible for peptide acquisition [45, 46].  Multiple 
regulatory proteins influence speB expression by either directly activating (RopB, CcpA 
[47-49]) or indirectly inducing (Mga, CodY, SagP, LuxS [50-52]) or repressing 
(CovR/CovS, Srv, LacD.1, Nra, Vfr [53-58]) transcription; something that reflects the 
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variety of inputs that affect SpeB production and suggests that timely and appropriate 
synthesis of this protease is of great importance to streptococcal pathogenesis. The speB 
transcript is translated into a 40kDa zymogen, that through either inter- or intramolecular 
autocatalytic processing at nine reported cleavage sites is proteolytically processed into a 
28kDa active enzyme [59-61]. Prior to this processing however, the SpeB zymogen is 
modified by the peptidyl-prolyl cis-trans isomerases (PPIase) RopA and PrsA [47, 62]. 
The PPIases isomerize one or more of the 13 proline residues in the SpeB zymogen and 
this activity is required for proteolytic processing of the polypeptide. Dysregulation of 
PrsA adversely affects both SpeB activity and pathogenicity of GAS [63]. Interestingly, 
the PPIase activity of RopA is dispensable for secretion of the SpeB zymogen, but loss of 
RopA expression inhibits secretion of SpeB [47], suggesting that aside from its 
processing role RopA is an accessory factor for secretion of the protease. Another 
accessory factor of SpeB secretion and processing is the serine protease HtrA. This 
extracellular membrane-anchored protease is involved in the folding and maturation of 
secreted proteins as well as the degradation of proteins misfolded during secretion in 
Lactococcus lactis [64]. In GAS functional HtrA is required for the efficient conversion 
of secreted SpeB zymogen into its active form [65], although HtrA does not directly 
process SpeB in vitro [66]. Additionally, mis-localization of HtrA out of the cytoplasmic 
membrane results in altered maturation kinetics of SpeB [67]. Given the multitude of 
stretptococcal and host proteins SpeB acts on, it is not surprising that its biogenesis is a 
highly regulated process involving many factors. It is possible though that other secreted 
virulence proteins of streptococci that have not been as well characterized as SpeB also 
require the interaction of multiple accessory factors for their production. Most 
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importantly, existing research has demonstrated that loss or inhibition of these secreted 
proteins’ activity results in reduced virulence [5, 68-71], highlighting the importance of 
understanding the mechanism(s) by which these proteins are secreted and processed into 
their active forms. 
 
 
Figure 2. Secretion systems of Gram-positive bacteria. In gram-positive bacteria (Monoderm, 
as the figure states), secreted proteins can be (i) anchored to the CM (i.e. lipoproteins); (ii) 
attached to the CW either covalently (i.e. LPXTG proteins) or non-covalently (i.e. by LysM, GW, 
CWBD1, CWBD2, SLHD or WXL motifs); (iii) part of cell-surface appendages, such as pili 
(whose subunits are secreted via Sec), competence pseudo-pili (assembled via FPE) or flagella 
(assembled via FEA); (iv) released into the extracellular milieu via Sec, Tat, holin or Wss; or (v) 
translocated into a host cell after secretion via Sec of a cholesterol-dependent cytolysin, which 
integrates into the membrane of a host cell to permit transport of secreted effectors via cytolysin-
mediated translocation (CMT). Black arrows show routes of proteins targeted to CM exhibiting 
an N-terminal signal peptide, blue arrows routes used by proteins lacking a signal peptide. Red 
arrows relate to secretion, and violet arrows refer to integration of membrane proteins (IMP). 
Secreted proteins are blue. Abbreviations: Cyto, cytoplasm; CM, cytoplasmic membrane; CW, 
cell wall; Ext, extracellular milieu; FPE, fimbrilin-protein exporter; FEA, flagella export 
apparatus [72]. S. pyogenes possesses only the Sec secretory pathway. 
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Secreted protein biogenesis and the ExPortal of GAS 
In bacteria, the most conserved route of protein translocation across the 
cytoplasmic membrane is the general secretory (Sec) pathway (for a detailed review see 
[73]). The membrane-embedded enzyme complex that constitutes the translocase is 
composed of a molecular motor, the peripheral adenosine triphosphatase (ATPase) SecA 
[74] and a trimeric protein complex that acts as the conducting channel. This channel is 
formed by the SecY [75], SecE [76] proteins that together associate with the integral 
membrane subunit SecG [77], or with another heterotrimeric complex composed of the 
SecD, SecF and YajC proteins encoded in the secD operon [78, 79]. S. pyogenes however 
expresses the SecYEG complex, SecA and YajC proteins, but its genome does not 
encode genes for SecDF  [80]. Studies in Escherichia coli and Bacillus subtilis reveal that 
YajC is a membrane protein with a single transmembrane segment and a large cytosolic 
domain that, except for the observation that it associates with SecDF, is not needed for 
protein translocation or viability [81, 82]. Therefore, given that streptococci lack SecDF, 
the precise function of YajC in GAS remains unknown.  
Proteins destined for secretion via the Sec pathway are synthesized as preproteins 
that are targeted to the Sec translocons by an 18 to 30 amino acid N-terminal signal 
sequence containing a positively charged N-terminal domain, a hydrophobic core and a 
more polar C-terminal domain [83]. This signal is cleaved off by a signal peptidase, a 
membrane bound protease that acts on the cleavage site in the C-domain of the signal 
peptide during the translocation reaction. Proteins thus produced can either be post-
translationally or co-translationally translocated, and the mechanism in GAS for directing 
the latter process is the signal recognition particle (SRP) pathway. In bacteria the SRP is 
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a complex composed of a 4.5S RNA and the GTPase Ffh [84] that interacts with the 
signal sequence of nascent preproteins as they emerge from the ribosome [85]. This so-
called ribosome nascent chain (RNC) complex bound to SRP in a GTP-dependent 
manner interacts with a membrane bound receptor, FtsY [86]. It is this complex that, 
upon GTP hydrolysis by both FtsY and SRP, transfers the RNC to the translocase to 
initiate export of the polypeptide [87]. For many bacteria the SRP pathway is essential to 
survival, but, as described in the Appendix, in GAS it was found to be dispensable for 
growth under in vitro conditions, yet necessary for virulence and the production of certain 
secreted virulence factors, including SLO, SPN and SpeB, the latter in a nutrient-
dependent manner. [88]. 
The secreted proteins of streptococci that remain surface-bound are anchored to 
either the outer leaflet of the cytoplasmic membrane or to the streptococcal cell wall via 
sortases. These enzymes function to covalently join secreted surface factors to cell wall 
peptidoglycan or to polymerize the proteins that constitute multimeric structures like pili 
into their functional fibrous form (for a detailed review see [89]). Though not virulence 
effectors themselves, the role sortases play in targeting surface factors required for 
virulence like those previously described means sortases are crucial for pathogenesis. The 
known sortases that act on cell wall-anchored substrates all function as cysteine 
transpeptidases, joining proteins containing a cell wall sorting signal to an acceptor 
amino group on the outer cell surface [90]. The sorting signal consists of an LPXTG 
motif (X standing for any amino acid), followed by a segment of hydrophobic amino 
acids and a tail of predominantly positively charged residues. The enzymatic reaction 
carried out by these sortases consists of breaking the threonine and glycine peptide bond 
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in the LPXTG motif to form a substrate-sortase complex in order to transfer the surface 
protein to the peptidoglycan precursor lipid II, thus generating an isopeptide linked 
protein-lipid II product [91]. The transglycosylation and transpeptidation reactions that 
synthesize the cell wall then incorporate the lipid-II bound surface protein into the 
peptidoglycan polymer. The gram-positive sortases characterized to date are categorized 
into six different classes based on sequence homology and functionality [89]. Two of 
these classes are represented in S. pyogenes. One is the class commonly referred to as the 
‘housekeeping’ Class A sortases, whose enzymatic activity anchors a diverse array of 
surface proteins to the cell wall, including M protein, SfbI and ScpA [92]. The other is 
the Class B sortases exemplified by Sortase C, which is involved in the assembly of the 
adhesive pili required for streptococcal biofilm formation and adhesion to host epithelia 
[93]. 
S. pyogenes lack all of the other known secretion systems of Gram-positive bacteria, 
diagrammed in Figure 2 [72, 80]; thus all secreted virulence proteins of GAS are 
exported via the Sec pathway. Sreptococci however, like all Gram-positive bacteria, lack 
a specialized cellular compartment for folding secreted proteins following their 
translocation across the membrane by the Sec system.  This problem is circumvented in 
S. pyogenes and several other species of Gram-positive cocci by clustering the Sec 
translocons and secretory accessory factors at a defined microdomain of the cytoplasmic 
membrane that has been termed the ExPortal [67, 94-97]. In S. pyogenes, secretion of the 
SpeB protease occurs at a unique site on the streptococcal surface, as does secretion of a 
non-native Sec pathway substrate (PhoZ) expressed from a plasmid [94]. This site of 
SpeB secretion coincides with the membrane localization of the SecA ATPase and of the 
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HtrA serine protease [67, 94]. Likewise SrtC, the sortase required for the polymerizatioin 
of pili in Enterococcus faecalis, co-localizes with SecA in the enterococcal membrane, 
and loss of SrtC expression resulted in accumulation of pilus subunits (EbpA, EbpC) at 
unique foci on the bacterial surface [95]. Other examples of this coordination of Sec 
translocons and accessory proteins include the co-localization of SecA and the cell wall 
protein–anchoring Sortase A at unique foci in the membrane of Streptococcus mutans 
[97], whereas in replicating Streptococccus pneumoniae cells HtrA and SecA were 
observed to oscillate between septal and polar membrane microdomains [98]. The 
membrane microdomain to which SpeB secretion localizes to in S. pyogenes is also 
enriched in anionic lipids [99], while in S. pneumoniae, cells devoid of the cardiolipin 
synthase encoding gene cls failed to localize SecA to septal membrane microdomains 
[98]. A similar mutation in GAS did not affect secretion of SpeB, suggesting that in S. 
pyogenes it is the more abundant phosphatidylglycerol that localizes to the ExPortal [99]. 
Moreover, additional evidence from both enterococci and GAS indicates that sorting of 
cell wall-anchored virulence factors occurs in the immediate vicinity of their site of 
secretion and coincides with the site of de-novo peptidoglycan synthesis [95, 97, 100, 
101]. Altogether, this suggests that a function of the ExPortal is to spatially couple 
secretion with protein maturation, and that this coordination could involve membrane 
lipid organization and cell wall synthesis as well. 
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Bacterial lipid membrane microdomains 
As mentioned, the ExPortal of S. pyogenes has been shown to have an asymmetric 
lipid content enriched in anionic phospholipids [99] that may contribute to the 
preferential retention of certain proteins at the ExPortal vs. the peripheral membrane [95]. 
Other bacterial membranes have been known to contain localized microdomains enriched 
for specific phospholipds, as was shown in the case of cardiolipin and 
phophatidylethanolamine-rich septal membrane domains of B. subtilis [102, 103]. These 
domains were absent in mutants disrupted in the cardiolipin synthase-encoding gene clsA 
[102] and in the genes encoding phosphatidlyserine carboxylase (psd) and 
phophatidylserine synthase (pssA) [103]. Interestingly, the majority of the lipid synthases 
localize to the septal membrane region at which cardiolipin and 
phosphatidylethanolamine are retained [103]. Membrane lipid spirals detected along the 
long axis of cells in B. subtilis co-localized with GFP protein fusions of MinD, thus 
hinting at possible involvement of lipid membrane microdomains in cell division [104]. 
Anionic lipids also play a multitude of roles in organizing the protein components 
of the bacterial membrane, including targeting secretory proteins by their signal 
sequence, directing membrane proteins via the SRP pathway, facilitating the interfacial 
insertion of peripherally attached protein domains, influencing or even determining the 
correct topology of transmembrane segments, and promoting efficient formation of 
protein complexes in the membrane (reviewed in [105]). Particularly with respect to 
protein secretion, phosphatidylglycerol is involved in optimal protein translocation via 
the Sec pathway by influencing interaction of the SecA ATPase with the SecYEG 
translocon [106-108], as well as interacting with pre-protein signal sequences during 
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protein translocation [109], and with the FtsY component of the SRP pathway, enhancing 
its GTPase activity [110]. Thus, bacterial membrane lipids play a vital role in the 
organization and functionality of the bacterial cell’s secretory processes. However, in 
gram-positive bacteria secretion is one of several important cellular processes occurring 
at the surface for which lipid organization appears to be of particular importance. Another 
such process, as described below, is cell wall synthesis.  
 
Figure 3. Gram-positive cell wall biogenesis.  The enzymatic steps of cell wall synthesis in 
Staphylococcus aureus, a representative gram-positive pathogen, are shown. The cytoplasmic 
conversion of UDP-GlcNAc to the soluble precursor UDP-MurNAc-pentapeptide is carried out 
by sequential action of the MurA to MurF enzymes. The membrane-associated synthesis of lipid 
II by MraY and MurG involves conjugation of MurNAc-pentapeptide to undecaprenyl-phosphate 
(C55-P) and addition of GlcNAc. Addition of the interpeptide crosslinker (5 x Gly) is catalyzed by 
the FemXAB transferases just prior to translocation of the lipid II precursor across the 
cytoplasmic membrane. Extracellular transglycosylation (TG) and transpeptidation (TP) reactions 
carried out by penicillin binding proteins (PBPs) assemble lipid II precursors into the cell wall 
peptidoglycan polymer [111]. 
 16 
Gram-positive cell wall synthesis 
The cell wall of Gram-positive pathogens is an extracellular organelle that plays a 
multitude of roles essential to both survival and virulence (for a review see [112]). A 
rigid peptidoglycan exoskeleton made up of polymers of alternating N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic acid (MurNAc) glycan units cross-linked via peptide 
bridges, its main purpose is to preserve cellular integrity against osmotic forces from 
without and within the bacterial cell [113]. The structural rigidity required for this is 
balanced by the flexibility necessary to allow for changes in cell shape during growth and 
division. This plasticity results from the combined activities of penicillin binding proteins 
(PBPs) and cell wall hydrolases. PBPs are the enzymes that carry out the 
transglycosylation reactions involved in the polymerization of disaccharide units to 
produce the individual strands of peptidoglycan, as well as the transpeptidation reactions 
that crosslink these strands via peptide bridges [114]. Their name stems from the fact that 
they are the targets of the ß-lactam class of antibiotics to which penicillin belongs to. 
PBPs are classified as high molecular weight (HMW) Class A PBPs, which are 
bifunctional proteins with both glycosyltransferase and transpeptidase activity, HMW 
Class B PBPs with transpeptidase activity and low molecular weight PBPs with 
carboxypeptidase or endopeptidase activity [115]. Along with enterococci and other 
streptococci, GAS morphologically fit into the class of so-called ovococci, referring to 
gram-positive bacteria that are not true cocci due to their ellipsoid shape and divide in the 
same single plane perpendicular to the long axis of the cell, thus forming chains of cells 
[114]. To accomplish this most ovococci utilize a common set of PBPs: three class A 
PBPs (PBP1a, 1b and PBP2a), two class B PBPs (PBP2b and 2x) and a LMW PBP 
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(PBP3); GAS encodes all of the above with the exception of PBP2b. The hydrolases 
involved in modifying peptidoglycan during cell wall synthesis include N-
acetylmuramidases and N-acetylglucosaminidases that digest the glycan backbone, 
amidases that cleave the peptide cross-links, and lytic transglycosylases [116]. In S. 
pyogenes these enzymes have remained largely uncharacterized; however a secreted 
protein containing a cysteine and histidine-dependent aminohydrolase/peptidase (CHAP) 
domain [117] common to N-acetylmuramidases was recently identified as a functionally 
active peptidoglycan hydrolase required for virulence [118]. Disrupting expression of this 
protein, termed CdhA (CHAP-domain containing and chain forming cell wall hydrolase), 
resulted in severe growth defects, including the inability to form chains, suggesting a role 
in coordinating cell division plane recognition and cell wall synthesis in streptococci. It is 
known that ovococci synthesize the cell wall mostly at the division site mid-cell, the new 
hemispheres of the daughter cells being synthesized between the parting parent 
hemispheres [119, 120]. The precise coordination of PBPs and other cell wall synthesis 
factors (i.e. hydrolases and cell division proteins) in order to achieve this is an area of 
active investigation and the organization of cell wall biogenesis appears to result largely 
from underlying cytoplasmic membrane organization and the positioning of cell division 
machinery [104, 121-123]. 
 Synthesis of the cell wall by PBPs requires the production and translocation 
across the cytoplasmic membrane of peptidoglycan subunits in the form of undecaprenyl-
pyrophosphoryl-MurNAc-(petapeptide)-GlcNAc (lipid II). The final steps of lipid II 
biogenesis occur at the inner leaflet of the cytoplasmic membrane (Figure 3) and involve 
membrane-associated (MraY, MurG) as well as cytosolic proteins (FemABX; for a 
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review see [124]). MraY is an integral membrane protein that carries out the first 
membrane-associated step in the synthesis of lipid II by catalyzing the transfer of the 
phospho-MurNAc-pentapeptide from the soluble cytoplasmic UDP-MurNAc-
pentapeptide substrate to the membrane embedded undecaprenyl-phosphate (C55-P) 
acceptor [125, 126], thus producing undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide 
(lipid I), the immediate precursor of lipid II. The subsequent step involves the extrinsic 
membrane transferase MurG, which catalyzes the transfer of the GlcNAc moiety from 
UDP-GlcNAc to lipid I in order to produce lipid II [127]. The peptidoglycan structure of 
many gram-positive bacteria contains an additional peptide cross-link between the 
pentapeptide chain and the cross-linked strand, something that requires the addition of 
interchain residues to the pentapeptide of the lipid II intermediate [128]. Cytosolic non-
ribosomal peptidyltransferases carry out this reaction in Staphylococcus aureus 
(FemABX [129, 130]), E. faecalis, S. pneumoniae and S. pyogenes (MurMN [131, 132]) 
on the inner leaflet of the cytoplasmic membrane prior to translocation of lipid II across 
the membrane [124]. In S. aureus synthesis of these peptide bridges is required for the 
sortase-mediated attachment of surface virulence factors to the cell wall [133] and their 
loss results in reduced virulence [134].  
The dynamic quality of the cell wall is also important for its function as an 
attachment site for extracellular factors that interact with the host environment, which 
aside from surface virulence proteins also includes lipoteichoic and teichoic acids. Given 
the role of sortases in processing the former, most research into the interaction of gram-
positive secretion with cell wall biogenesis to date, particularly in the case of 
streptococci, has focused on the characterization of sortase function [89], rather than the 
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the coordination  between secretion  and cell wall synthesis, an area that holds great 
potential for important discoveries. The cellular processes described thus far (i.e. proteins 
secretion, membrane lipid segregation and cell wall synthesis) are clearly linked to one 
another in a variety of ways; whether it is that molecular substrates of one process (e.g. 
secreted surface factors) are inputs for another (cell wall assembly), or the organization of 
one (membrane lipid segregation) appears to inform the functionality of another (protein 
secretion). It follows then that certain disruptive influences on any one of these processes 
could have deleterious consequences on the others and, by extension, the most effective 
antimicrobials will be those that can influence any one of these processes in such a way 
as to affect the others as well. Such antimicrobial compounds exist in nature, are the 
subject of active investigation and a summary of their known properties and activities is 
given below. 
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Cationic antimicrobial peptides 
Cationic antimicrobial peptides (CAPs) are gene-encoded peptides produced by 
nearly all known life-forms as part of an ancient nonspecific innate immune system that 
is the main defense mechanism during the initial stages of infection against many 
organisms (for a review see [135]). They display a broad range of activity across a range 
of pathogens, including bacteria, fungi, metazoans, parasites and viruses [136], and some 
are even active against cancerous cells [137]. Some are systemically expressed while 
others are localized to specific cells or tissue types most susceptible to infection by 
pathogens (e.g. histatins in human saliva [138]). In mammalian hosts, their contribution 
to overall immunity varies between different tissue sites (skin, oral, gastrointestinal and 
respiratory epithelia) within a host and from one organism to another [139].  
Though they display a broad range of activity, have limited sequence homology and 
a wide range of secondary structures, the great majority of CAPs share similar physical 
properties. In general, they derive from larger precursors by proteolytic processing, are 
12 to 50 amino acids in size, carry a net cationic charge (+2 to +11), possess a nearly 
50% hydrophobic residue composition and are able to adopt an amphipathic structure in 
contact with lipid membranes [140]. Structurally, the majority of CAPs fall into either of 
two categories: amphipathic α- helices, and amphipathic β-sheets. The former group is 
made up of the majority of CAPs known so far, which are short linear cationic α-helical 
peptides (e.g. magainins, cathelicidins, cecropins [141-143]). The amphipathic β-sheets 
on the other hand present a defined number of β-strands organized in a common 
amphipathic manner, with relatively few or no helical domains, and constrained either by 
disulfide bonds (e.g. defensins, protegrins) or by cyclization of the peptide backbone 
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(gramicidin S or polymyxin B). The defensins make up most of the cysteine-containing 
peptides and are frequently formed by several antiparallel β-strands stabilized by a series 
of up to six disulfide bonds [144]. They are expressed by neutrophils and epithelial cells 
of humans and other mammals, functioning both as broad-spectrum microbicides and as 
modulators of the immune response by influencing epithelial cell proliferation, enhancing 
wound healing, regulating production of pro-inflammatory cytokines, and directing 
chemotaxis of several types of leukocytes [139, 145]. 
As described previously, the conjugation of lipids with proteins in supramolecular 
complexes is central to multiple biological processes. Thus, it is not surprising that the 
lipid membrane of pathogens is the principal target of CAP activity. It is generally 
accepted that the primary mechanism of antibacterial activity of CAPs involves 
interactions of their charged and hydrophobic residues with the hydrophilic charged head 
groups and the fatty acyl chains of phospholipids in the bacterial membrane. The 
consequences of this interaction include the dissipation of the electrochemical potential 
and lipid asymmetry, loss of important metabolites and cellular components due to the 
destruction of membrane permeability and eventual bacterial cell death [146-148]. The 
membrane-CAP interaction typically involves initial adsorption and binding of peptides 
to the membrane, followed by the accumulation of bound peptides that upon reaching a 
threshold level results in conformational transitions that permit peptide insertion into the 
membrane in order to exert their membranolytic activity [135]. Given their variety in size 
and structure, there is no unique mode by which all CAPs permeabilize bacterial 
membrane, rather a variety of mechanisms shared amongst different CAPs, as illustrated 
in Figure 4. 
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Figure 4. CAP membranolytic mechanisms. The principal models proposed for the pore-
forming activity of CAPs are shown. Following binding to the outer surface of the cytoplasmic 
membrane (top-left), peptides can oligomerize and form pores according to the barrel-stave 
model (A), aggregate on the membrane surface in a detergent-like manner as in the carpet model 
(B) or distort the membrane to form lipid/peptide-lined pores as in the toroidal pore model (C). In 
the molecular electroporation model (D), lipid-bound CAPs promote an electrical potential 
difference across the membrane that induces transient poration. The sinking raft mechanism (E) 
proposes that peptide aggregation on the outer leaflet causes a mass imbalance between the two 
leaflets. The ensuing curvature gradient causes peptides to ‘sink’ into the membrane and form 
transient pores that permeabilize the cell and promote translocation of CAPs to the inner leaflet 
[135]. 
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The membranolytic mechanisms of CAP activity include the formation of stable 
pores (barrel-stave and toroidal pore models), membrane thinning (via molecular 
electroporation or the sinking raft model) and micellization of membranes in a detergent-
like manner (carpet model). In the barrel stave model (Figure 4A), peptide helices form a 
bundle in the membrane with a central lumen that constitutes the pore, a mechanism 
observed for alamethicin and zervamicin peptides [149, 150]. It is interesting to note that 
the formation of cytolytic pores by SLO and other cholesterol-dependent cytolysins like it 
involves a similar mechanism of oligomerization and protein conformational changes of 
the cytolytic polypeptide [151]. The toroidal pore model (Figure 4C) involves similar 
partitioning of peptides into the membrane, with the additional effect of inducing bending 
of the membrane leaflets such that the resulting pore is lined by both the inserted peptides 
and lipid head groups [148]. The molecular electroporation model (Figure 4D) describes 
the pore-forming activity of annexin V and consists of the aggregation of CAPs at the 
membrane surface with sufficient charge density to generate an electrical field that 
induces the formation of pores similar in size to those of polymyxin B and melitin 
peptides in the absence of overall membrane disruption [152, 153]. Another membrane 
thinning mechanism, the sinking raft model (Figure 4E), was described only recently for 
an α-helical peptide and involves an imbalance in mass ratio of the membrane due to 
binding of a particular lipid microdomain [154, 155]. This results in the formation of 
transient pores following translocation of the peptide and dissipation of the peptide 
induced membrane leaflet mass imbalance. The carpet model (Figure 4B), as its name 
implies, consists of adsorption of CAPs to the membrane such that the bilayer surface is 
‘carpeted’ by the peptides. At the critical threshold concentration, peptides that act via 
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this mechanism (e.g. ovispirin, dermaseptin, magainins [156, 157]) will form toroidal 
pores lined by the peptide, allowing further access to the inner leaflet of the membrane by 
the CAP, and resulting in membrane disintegration through the formation of micelles in a 
detergent-like manner.  
Recent studies however, suggest that many CAPs have multiple targets and/or much 
more complicated mechanisms of action than membrane poration alone (reviewed by 
[158]).  In particular, some peptides can produce significant membrane perturbation by 
forming lipid-peptide domains, lateral phase segregation of zwitterionic lipids from 
anionic lipids and even inducing non-lamellar phases under physiologically relevant 
conditions [135]. A more in depth discussion of such CAP activity on bacterial 
membranes can be found in Chapter IV, especially as it relates to the effect of CAPs on 
ExPortal organization. Peptide-induced lipid segregation of anionic components has 
mainly been observed in gram-positive model membranes that are enriched in 
phosphatidylglycerol [159-162], the principal anionic lipid of S. pyogenes and other 
gram-positive pathogens [99, 163]. Another aspect of the peptide-pathogen interaction 
that was not often examined but is now of increasing interest is the effect CAPs have on 
their bacterial targets at levels below their minimum inhibitory concentrations. One 
studied effect is the induction of regulatory responses involved in resistance to CAPs. 
Bacteria have developed multiple factors to resist killing by CAPs, and expression of 
these factors is activated by regulatory mechanism responsive to sub-lethal amounts of 
CAPs. Researchers have exploited this to uncover previously unknown resistance 
mechanisms, by treating bacteria with sub-lethal peptide amounts and performing 
transcriptional analyses of the ensuing responses. Examples of this include studies on 
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Bacilllus cereus resistance to enterocin [164], Aspergillus niger responses to caspofungin 
and fenpropimorph [165], and characterization of SigB-mediated antibiotic resistance in 
Listeria monocytogenes [166], to name a few. In the case of GAS responses to CAPs, 
sub-inhibitory concentrations of cathelicidin LL-37 stimulate expression of the S. 
pyogenes hyaluronic acid capsule synthesis operon (hasABC), which results in a more 
invasive phenotype [167]. This is a regulatory effect apparently exclusive to LL-37 
among all the CAPs tested and involves direct sensing of the extra-cellular concentration 
of the LL-37 peptide by the CsrRS (CovRS) two-component regulatory system [167, 
168]. Replacement of three acidic amino acids with uncharged residues in the 
extracellular domain of the CsrS (CovS) sensor-kinase abrogated induction of the 
hasABC operon by LL-37 [168], providing strong evidence of a close relationship 
between CAPs and streptococcal virulence. Mutagenic approaches combined with 
exposure to CAPs have conversely uncovered the regulatory networks controlling CAP 
resistance, as was the case in S. aureus with the identification of a two component 
regulatory system (GraRS) as the controller of key determinants of staphylococcal 
surface charge (mprF and dlt) required for resistance to multiple CAPs (HNP-1, 
polymyxin B) [169]. Another actively investigated effect of sub-lethal exposure to CAPs 
is the inhibition of antibiotic resistance factors produced by pathogens. For example, sub-
lethal amounts of designer analogs of the CAP pyrrhocoricin inhibited the activity of the 
TEM-1 ß-lactamase by targeting the heat-shock protein DnaK, thus restoring amoxicillin-
sensitivity to ß-lactam resistant strains of E. coli [170]. Also at sub-lethal levels, the 
enterocin peptide modifies the ion permeability of bacteria, dissipating the membrane 
proton motive force; this impairs the activity of multidrug efflux systems in Listeria 
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innocua, rendering it susceptible to traditional antibiotics [171], a potentially useful 
therapeutic tool given the troubling rise in multidrug resistance amongst pathogens. 
Certain CAPs have additionally been demonstrated to act on intracellular targets 
or by non-permeabilizing mechanisms [172]. Examples include, activation of bacterial 
proteases by indolicidin [173], inhibition of DNA replication by PR-39 or microcin B17 
[174, 175], or protein synthesis inhibition by pleurocidin [176]. However, the best 
characterized and most effective CAPs with additional non-permeabilizing activity are a 
class of lipid II-targeting bacterial defense peptides commonly referred to as lantibiotics 
(for a review, see [177]). The term lantibiotic designates gene-encoded peptides that 
contain the thioether amino acids lanthionine or methyllanthionine, which are formed by 
post-translational modifications that introduce intramolecular cyclic structures. The most 
representative lantibiotic, nisin, specifically binds lipid II in a defined stoichiometry in 
order to form pores that efficiently permeabilize bacterial membranes [178, 179]. More 
importantly however, non-porating variants of nisin have been shown to efficiently kill 
bacteria using an alternative mechanism by which lipid II is clustered into patches in the 
cytoplasmic membrane away from the regions where cell wall peptidoglycan synthesis 
occurs [180]. Other lantibiotics such as gallidermin, epidermin and mutacin have been 
observed to act via this alternative mechanism [180-182], thus inhibiting cell wall 
synthesis and causing bacterial cell death without permeabilizing the cytoplasmic 
membrane. 
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Characterizing ExPortal organization and its interaction with CAPs 
Recent studies have shown that multiple human CAPs are lethal to GAS in vitro 
[183, 184], and that the CAP cathelicicin LL-37 is highly expressed in severe soft tissue 
infection in humans at sites coinciding with high tissue burdens of S. pyogenes [185].  
Several studies have highlighted the important role of CAPs in innate immune defenses 
against S. pyogenes.  These include the observation that soft tissue infection by S. 
pyogenes in mice deficient in a major CAP of the cathelicidin family (CRAMP) was 
significantly exacerbated [186] and that overexpression of a cathelicidin in murine skin 
provides enhanced protection [187]. It is not surprising then, that much recent research 
has been directed at identifying streptococcal factors that subvert the lethal effects of 
CAP activity [10, 167, 188].   
The signature ability of CAPs to bind to the cytoplasmic membrane, offers 
numerous targets whose functions could be affected at sub-inhibitory concentrations.  
The cytoplasmic membrane is of particular importance to S. pyogenes since, as described 
previously, its pathogenicity relies on an extensive network of virulence proteins.  Due to 
their cationic nature, CAPs predominantly bind to anionic phospholipids in bacterial 
membranes [147].  The ExPortal of S. pyogenes has been shown to have an asymmetric 
lipid content enriched in anionic phospholipids [99] that may contribute to the 
preferential retention of certain proteins at the ExPortal vs. the peripheral membrane [95].  
These observations suggest that the ExPortal may thus be uniquely sensitive to the action 
of CAPs.  
This presented the unique opportunity to expand understanding of the interaction of 
a strictly human pathogen like S. pyogenes with an important component of the innate 
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immune response, such as CAPs are, and of the mechanisms underlying the coordination 
of protein secretion and processing by the ExPortal in an organism as dependent as GAS 
are on secreted virulence factors. Thus, I investigated the interaction of CAPs at sub-
lethal concentrations with S. pyogenes and the effects of said interaction on ExPortal 
organization and function. Given that lipid II-targeting CAPs can disrupt cell wall 
synthesis absent effects on membrane permeability and the potential for the ExPortal as a 
target for CAPs, this work was also designed to determine whether a link exists between 
cell wall biogenesis and organization of the secretory organelle that is the ExPortal. 
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ABSTRACT 
Although they possess a well-characterized ability to porate the bacterial 
membrane, emerging research suggests that cationic antimicrobial peptides (CAPs) can 
influence pathogen behavior at levels that are sub-lethal. In this study, we investigated 
the interaction of polymyxin B and human neutrophil peptide (HNP-1) with the human 
pathogen Streptococcus pyogenes. At sub-lethal concentrations, these CAPs 
preferentially targeted the ExPortal, a unique microdomain of the S. pyogenes membrane, 
specialized for protein secretion and processing. A consequence of this interaction was 
the disruption of ExPortal organization and a redistribution of ExPortal components into 
the peripheral membrane.  Redistribution was associated with inhibition of secretion of 
certain toxins, including the SpeB cysteine protease and the Streptolysin O (SLO) 
cytolysin, but not SIC, a protein that protects S. pyogenes from CAPs. These data suggest 
a novel function for CAPs in targeting the ExPortal and interfering with secretion of 
factors required for infection and survival.  This mechanism may prove valuable for the 
design of new types of antimicrobial agents to combat the emergence of antibiotic-
resistant pathogens. 
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INTRODUCTION 
 
Cationic antimicrobial peptides (CAPs) are gene-encoded antibacterial peptides 
produced by nearly all known life-forms. A group of these, the defensins, are expressed 
by neutrophils and epithelial cells of humans and other mammals, functioning both as 
broad-spectrum microbicides and as modulators of the immune response [1]. It is 
generally accepted that the antibacterial activity of CAPs involves interactions of their 
charged and hydrophobic residues with the hydrophilic charged head groups and the fatty 
acyl chains of phospholipids in the bacterial membrane.  The consequence of this 
interaction is the destruction of membrane permeability and bacterial cell death [2, 3].  
However, more recent studies have suggested that many of these peptides may have 
multiple targets and/or much more complicated mechanisms of action (reviewed by [4]).  
In particular, one aspect of the peptide-pathogen interaction that is not often examined is 
the manner in which CAPs act on their bacterial targets at levels below their minimum 
inhibitory concentrations.  
Interaction with CAPs plays an important role in host-pathogen interactions for 
infections caused by Streptococcus pyogenes (group A streptococcus).  This Gram-
positive pathogen can cause numerous diseases in humans that range from largely 
superficial infection of the skin and mucous membranes (impetigo, pharyngitis), to highly 
invasive and life-threatening diseases (necrotizing fasciitis), as well as, serious post-
infection sequelae (rheumatic fever, glomerulonephritis, reviewed in [5]).  Recent studies 
have shown that multiple human CAPs are lethal to S. pyogenes in vitro [6, 7], and that 
the CAP cathelicicin LL-37 is highly expressed in severe soft tissue infection in humans 
at sites coinciding with high tissue burdens of S. pyogenes [8].  Several studies have 
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highlighted the important role of CAPs in innate immune defenses against S. pyogenes.  
These include the observation that soft tissue infection by S. pyogenes in mice deficient 
in a major CAP of the cathelicidin family (CRAMP) was significantly exacerbated [9] 
and that overexpression of a cathelicidin in murine skin provides enhanced protection 
[10].  It is not surprising then, that much recent research has been directed at identifying 
streptococcal factors that subvert the lethal effects of CAP activity [11-13].   
The signature ability of CAPs to bind to the cytoplasmic membrane, offers 
numerous targets whose functions could be affected at sub-inhibitory concentrations.  
The cytoplasmic membrane is of particular importance to S. pyogenes, as its ability to 
cause disease is dependent on the secretion of an extensive network of virulence proteins 
[14]. Lacking other known secretion systems, these virulence proteins are exported by the 
general secretory [15] pathway, which is highly conserved between Gram-positive and –
negative bacteria and eukaryotes (for a review see [16]).  However, unlike these latter 
two classes, Gram-positive bacteria lack a specialized cellular compartment for folding 
proteins following their translocation across the membrane by the Sec system.  A solution 
to this problem used by S. pyogenes and several other species of Gram-positive cocci, is 
to cluster the Sec translocons at a defined microdomain of the cytoplasmic membrane 
that has been termed the ExPortal [17-21].  The ExPortal is also highly enriched with 
accessory factors for protein biogenesis, including sortases, and HtrA. The former are 
involved in the covalent attachment of proteins to the cell wall, while the latter is a multi-
function protease and chaperone that is required for the biogenesis of the active form of 
the SpeB protease.  These data suggest that one function of the ExPortal is to spatially 
couple secretion with protein maturation [17-19, 22, 23].  This is supported by the 
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observation that mutations causing the mis-localization of HtrA or sortase C outside of 
the ExPortal microdomain result in a highly reduced efficiency for maturation of secreted 
proteases and pili, in S. pyogenes and Enterococcus faecalis, respectively [18, 19].   
Due to their cationic nature, CAPs predominantly bind to anionic phospholipids in 
bacterial membranes [3].  Of interest, the ExPortal of S. pyogenes has been shown to have 
an asymmetric lipid content enriched in anionic phospholipids [22] that may contribute to 
the preferential retention of certain proteins at the ExPortal vs. the peripheral membrane 
[19].  These observations suggest that the ExPortal may be uniquely sensitive to the 
action of CAPs.  In the present study, we examined the interaction between several CAPs 
and S. pyogenes and report that CAPs preferentially interact with the ExPortal when 
examined at sub-lethal concentrations and that this results in a re-distribution of ExPortal 
components into the peripheral membrane.  Furthermore, this disruption is associated 
with an inhibition of secretion of the SpeB cysteine protease and the Streptolysin O 
(SLO) cytolysin.   
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RESULTS   
Polymyxin B binds to a single, unique site on the S. pyogenes membrane.  To test the 
hypothesis that CAPs may interact with the ExPortal, we examined how the CAP 
polymyxin B interacts with the S. pyogenes membrane at sub-lethal concentrations. 
Readily available and well-characterized in its ability to bind anionic lipids [24], 
polymyxin B is a cyclic CAP antibiotic that is highly active against Gram-negative, but 
not most Gram-positive bacteria [25].  However, S. pyogenes is an exception and is 
highly susceptible to polymyxin B (see below), which likely reflects that unlike many 
other Gram-positive species its genome does not contain mprF [26], which encodes an 
enzyme that modifies the negative charge of phosphatidyl glycerol via lysinylation to 
reduce its affinity for binding CAPs [27, 28].  The interaction of polymyxin B with S. 
pyogenes was therefore examined using a biotin-labeled derivative of polymyxin B to 
treat cultures of the M1 serotype S. pyogenes strain SF370 in a “challenge assay.” In this 
assay (see “Experimental Procedures”), polymyxin B was added to cultures in the late 
logarithmic phase of growth (time = 0 h) and samples harvested for analysis after cultures 
had entered stationary phase (Fig. S3).  The concentrations of polymyxin B used had no 
effect on viability in this assay and did not result in significant poration of membranes 
(see “Experimental Procedures” and Fig. S1).  Bound polymyxin B was detected using a 
streptavidin-gold conjugate and examined by electron microscopy.  This analysis 
revealed that rather than a uniform pattern of circumferential staining, cells consistently 
exhibited a single intense focus of gold particles at a discrete location adjacent to the 
membrane (Fig. 1A).  An identical pattern was observed following treatment of the M14 
serotype S. pyogenes strain HSC5 (data not shown) and minimal staining with the 
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streptavidin conjugate was observed in the absence of treatment with biotin-labeled 
polymyxin B (data not shown).   
 
Polymyxin B targets the ExPortal. The pattern of polymyxin B binding was then  
examined following treatment with a fluorescent derivative of polymyxin B (dansyl-
polymyxin B) at sub-inhibitory concentrations. Treatment with <60 µM polymyxin B 
under our challenge assay conditions (see “Experimental Procedures”) did not alter the 
viability of cultures at the end of the period of incubation as determined by enumeration 
of colony forming units (Fig. S1A).  Examination of cultures treated with a fluorescent 
probe that is excluded by intact membranes (Live/Dead®) confirmed the viability of 
polymyxin B treated cultures and demonstrated that most cells had membranes that were 
not porated (Fig. S1B). Examination by fluorescent microscopy revealed that when 
treated at concentrations <15 µM the fluorescent CAP typically localized to a single 
discrete site of the membrane (Fig. 1B, C, D, E). Some cells with staining at multiple foci 
or with a more diffuse distribution around the circumference of the cell were also 
observed (data not shown).  However, when examined quantitatively, the number of cells 
with single foci exceeded 60% and was significantly higher than that observed for any 
other staining pattern (P<0.0001, Fig. 1F).  To assess whether polymyxin B was targeting 
the ExPortal, co-staining was conducted to determine if these foci corresponded to the 
site of secretion of the SpeB cysteine protease, a signature feature of the ExPortal [17, 
18].  This was conducted using an assay that employs a protease substrate that is 
intramolecularly quenched but becomes active when cleaved to visualize the site of 
secretion of active SpeB protease in cells that have been embedded in agarose [17, 29].  
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Figure 1. Focal binding of Polymyxin B to the S. pyogenes surface: The distribution of 
polymyxin B on the surface of S. pyogenes SF370 following sub-lethal challenge was revealed: 
(A) by treatment with biotinylated polymyxin B (1:10,000) and immunogold electron microscopy 
using staining with a streptavidin-gold conjugate (scale bar = 200nm) and (B, C, D, E) by 
fluorescent microscopy following challenge with dansyl-polymyxin B alone (B) at the 
concentration indicated in the Figure (scale bar = 1µm) or in cells counterstained with Nile Red 
(C), fluorescent vancomycin (D) or wheat germ agglutinin Alexa Fluor 488 conjugate (E). 
Staining patterns following challenge with dansyl-polymyxin B were quantitated as described in 
the Experimental Procedures (F). Data represents the mean and standard error of the mean (SEM) 
derived from at least 3 independent experiments and examination of a minimum of 1000 stained 
cells. The number of cells with a single focus was significantly higher than any other staining 
pattern (P < 0.0001). 
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 When a sub-inhibitory concentration of dansyl-polymyxin B (5 µM or 10 µM) was 
included in this assay about 50% of the cells showed staining with both reagents.  
However, when co-stained (Fig. 2), the coincidence of the membrane site recognized by 
dansyl-polymyxin B and the site of SpeB secretion approached 100% (out of at least 200 
co-stained cells observed). 
 
 
 
Figure 2. The site of polymyxin B binding is coincident with the site of SpeB secretion. Cells 
of S. pyogenes SF370 were challenged with dansyl-polymyxin B (10 µM), fluorescent 
vancomycin stained to visualize cell wall and subjected to the red protease assay, which monitors 
cleavage of BODIPY TR-X-casein by the SpeB protease.  Stained cells were then examined by 
fluorescent microscopy. Panels are as follows: (A, E) fluorescent vancomycin, (B, F) BODIPY 
TR-X-casein, (C, G) Dansyl-polymyxin B and (D, H) Merge of Panels A, B and C.  Scale bar = 
1µm. 
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Polymyxin B disrupts ExPortal Lipids.  The data above suggest that at sub-lethal 
concentrations, polymyxin B preferentially targets the ExPortal.  The consequence of this 
interaction was then examined using higher, but still sub-lethal concentrations of the 
CAP.  ExPortal integrity was assessed by staining with 10-nonyl acridine orange (NAO), 
a fluorescent membrane probe that preferentially binds anionic phospholipids [22, 30].  In 
the absence of polymyxin B, NAO stained cells at single foci (Fig. 3A), which were 
previously shown to be co-incident with the ExPortal [22].  Following treatment with 30 
µM polymyxin B, most cells had either multiple foci or a more diffuse staining pattern 
(Fig. 3B), while this latter pattern predominated following treatment with 60 µM 
polymyxin B (Fig. 3C).  This result suggested that the CAP was altering the organization 
of ExPortal-associated anionic phospholipids. Consistent with this, treatment with a 
higher, but still sub-lethal concentration of biotin-labeled polymyxin B resulted in cells 
stained at multiple foci or more diffusely around the membrane when examined by 
electron microscopy, rather than staining at single foci as was observed at lower 
concentrations (compare Fig. 3E with Fig. 1A,).  Similarly, treatment with a higher 
concentration of dansyl-polymxin B resulted in a majority of cells stained at multiple foci 
(compare Fig. 3F, G to Fig. 1B, D, E).  This shift was examined quantitatively (Fig. 3H), 
revealing that the number of cells stained at multiple foci was significantly higher than 
other staining patterns observed. Stressing membranes by subjecting cells to a condition 
known to induce the heat shock response (42oC, 30 mins.; [18]) did not alter the focal 
pattern of NAO staining (Fig. 3; compare panels 3D, 3A).  Similarly, heat shock did not 
alter the focal binding pattern of a low sub-lethal concentration of bodipy-labeled 
polymyxin B (10 µM, Fig. S2C,D), which contrasts with the disruption observed at a  
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Figure 3. Sub-lethal challenge with polymyxin B alters the distribution of anionic membrane 
lipids. Cultures of S. pyogenes SF370 were stained with NAO following challenge with 0 µM 
(A), 30 µM (B) or 60 µM (C) polymyxin B or heat shock at 42˚C (D) and examined by 
fluorescent microscopy (scale bar = 1µm).  The distribution of polymyxin B following higher, but 
still sub-lethal challenge, was revealed by treatment with biotinylated polymyxin B (1:500) and 
immunogold electron microscopy using staining with a streptavidin-gold conjugate (scale bar = 
200nm) (E) and by fluorescent microscopy following challenge with dansyl-polymyxin B alone 
at the concentration indicated in the Figure (scale bar = 1µm) (F) or costained with fluorescent 
vancomycin (G). Staining patterns following challenge were quantitated as described previously 
(H). Data represents the mean and SEM derived from at least 3 independent experiments and 
examination of a minimum of 1000 stained cells. The number of cells with multiple foci was 
significantly higher than any other staining pattern (P < 0.0001) at this polymyxin B 
concentration. 
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higher sub-lethal concentration (45 µM, Fig. S2E,F). Thus, these data suggest that 
disruption of the ExPortal-associated anionic lipid domain is specific to high sub-lethal 
concentrations of polymyxin B and does not result from a general membrane stress 
response.   
 
Polymyxin B disrupts ExPortal Organization.  There is evidence to suggest that the 
asymmetric lipid content of the ExPortal contributes to the retention of some ExPortal-
associated membrane proteins [19]. This suggests that the polymyxin B-mediated 
disruption of ExPortal lipid structure observed above could result in an overall disruption 
of ExPortal organization. To test this, the distribution of several proteins known to be 
enriched at the ExPortal was examined in cells of strain SF370 exposed to a sub-lethal 
concentration of polymyxin B. The concentrations tested (30-60 µM) were those that 
produced a high frequency of cells with multiple NAO- or polymyxin B-stained foci (see 
above). Consistent with prior studies [17, 18], in the absence of polymyxin B, the 
translocon ATPase SecA localized to a single membrane site in a majority of cells when 
examined by immunogold electron microscopy (Fig. 4A).  Similarly, the membrane-
associated HtrA serine protease [18] localized to a single membrane site in a majority of 
cells when examined by immunogold electron microscopy (Fig. 4D) and by 
immunofluoresent microscopy (Fig. 4G, H).  Adding polymyxin B at concentrations <30 
µM did not alter this pattern for either SecA or HtrA. However, polymyxin B 
concentrations of of 30 µM  through 60 µM resulted in redistribution of SecA (Fig. 4B,C) 
and HtrA (Fig. 4E,F, I, J) as demonstrated by a more circumferential staining pattern and 
a significant increase in the number of cells demonstrating multiple stained foci (Fig. 4K;  
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Figure 4. Redistribution of ExPortal proteins following sub-lethal polymyxin B challenge.  
The distribution of SecA (A, B, C) and HtrA (D, E, F) on S. pyogenes SF370 was assessed by 
immunogold electron microscopy following challenge with polymyxin B at the concentrations 
indicated in the Figure (scale bar = 200nm).  The distribution of HtrA was also assessed by 
immunofluorescent microscopy in the absence of (G, H) and following challenge with polymyxin 
B at 47 µM (I, J) and was quantitated as described previously (scale bar = 500nm)  (K). Data 
represents the mean and SEM derived from at least 3 independent experiments and examination 
of a minimum of 1000 stained cells.  In untreated cultures, the number of SF370 or HSC5 cells 
with a single focus was significantly higher than any other staining pattern (P < 0.05), whereas in 
polymyxin B-treated cultures, the number of streptococcal cells with multiple foci was 
significantly higher (P < 0.05). 
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P<0.05). Similar results were observed with the unrelated strain HSC5 (data not shown). 
Analysis of culture fractions indicated that the levels of SecA protein were unchanged in 
peptide-challenged streptococci and that the protein was retained in the same fractions in 
treated and untreated cells (Fig. S3A), suggesting that only localization of SecA at the 
membrane is affected. These data demonstrate that sub-lethal polymyxin B treatment can 
result in a disruption of ExPortal organization. 
 
Polymyxin B inhibits ExPortal-mediated secretion of SpeB. Disruption of ExPortal 
organization could have a deleterious effect on protein secretion.  Particularly vulnerable 
would be those proteins that require the ExPortal to coordinate the activities of multiple 
secretion and biogenesis factors. A prominent example of this class is the SpeB cysteine 
protease, which requires numerous accessory factors, including the ExPortal-localized 
HtrA, for its secretion and conversion of its 43 kDa zymogen into the 28 kDa mature 
form [18, 31-34].  In addition, because the gene encoding SpeB is expressed at the onset 
of the stationary phase of culture [35-37], its expression would provide a sensitive 
assessment of the effect of prior challenge with a CAP at the late logarithmic phase of 
growth.  Treatment of strain SF370 with various sub-lethal concentrations of polymyxin 
B resulted in a dose-dependent reduction in the amount of cysteine protease activity in 
culture supernatant (Fig. 5A), to a level less than 20% of that observed in the absence of 
the CAP (Fig. 5A, 60 µM).  This reduction correlated with a dose-dependent decrease in 
the amount of SpeB polypeptide that was detected in treated culture supernatants (Fig. 
5B). Secretion of SpeB in strain HSC5 was inhibited at lower concentrations of 
polymyxin B (Fig. S3B) and challenge with 60 µM polymyxin B  
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Figure 5. High sub-lethal challenge with polymyxin B inhibits secretion of SpeB and SLO, 
but not SIC. Expression of the SpeB protease in cultures of S. pyogenes SF370 was determined 
following challenge with the indicated concentrations of polymyxin B by quantitation of cysteine 
protease activity in culture supernatant (A), by real-time RT-PCR analysis of speB transcript 
abundance (A, inset) by Western blot analysis of culture supernatant (B) in whole cell lysates (C) 
and following overnight culture on protease indicator plates containing (+) or lacking (-) 150 µM 
polymyxin B (D).  Expression of SpeB results in a zone of clearing around colonies.  Western 
blotting was also used to analyze the amount of SLO (E) and SIC (F) present in culture 
supernatant following challenge with the indicated concentrations of polymyxin B. All samples 
for SpeB analysis were harvested at 3 hrs post-challenge; samples for SLO and SIC were 
harvested 2hrs post-challenge. Open and filled triangles indicate the migration of the zymogen 
and mature form of SpeB, respectively. The migration of the SLO and SIC polypeptides are also 
indicated.  
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resulted in a >95% inhibition of SpeB activity (data not shown). Several lines of evidence 
indicated that inhibition was not caused by an effect on growth, induction of stress or by 
suppression of speB transcription. Firstly, at the time of analysis of SpeB in culture 
supernatants (3 hrs post-challenge, Fig. S3C), the speB transcript was as abundant or 
present at higher levels as compared to untreated cultures (Fig. 5A, inset). Secondly, 
when transcription of speB was de-repressed and partially uncoupled from its growth 
phase-dependent control by mutation of the regulatory gene vfr [34, 38], polymyxin B 
challenge resulted in the same profile of inhibition of SpeB secretion that was observed 
for the wild type strain (Fig. S3D). Thirdly, sublethal polymyxin B did not induce a 
general stress response, as treatment had no effect on levels of the HtrA protease (Fig. 
S3E). Fourthly, while treatment reduced the amount of SpeB present in supernatants, the 
SpeB polypeptide was still produced and could be detected in cell lysates (Fig. 5C).  
Finally, incorporation of polymyxin B into protease indicator plates at concentrations that 
did not reduce numbers of CFU’s, did inhibit expression of protease activity, as indicated 
by an absence of zones of clearance around colonies on treated media following 
overnight culture (Fig. 5D), although some activity was evident upon a prolonged period 
of incubation (not shown).  Taken together, these data indicate that polymyxin B 
challenge inhibits SpeB expression at the level of secretion.   
 
Polymyxin B inhibits secretion of SLO but not SIC. The Sec pathway delivers 
presecretory proteins to the translocons via either the post-translational pathway or the 
co-translational signal peptide recognition (SRP) pathway. While SpeB can be secreted 
via the post-translational pathway, the cytolysin SLO is targeted via the SRP pathway 
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[33].  Given that expression of this cytolysin begins during the early logarithmic phase of 
growth, the challenge assay was slightly modified (see Experimental Procedures) in order 
to detect SLO that was secreted post-challenge. Comparison of supernatant harvested 
from peptide-challenged and untreated cultures of SF370 revealed a dose-dependent 
decrease in the amount of SLO protein detected in treated cultures (Fig. 5E); an effect 
that was more pronounced in HSC5 (data not shown). Similar to speB, slo transcript 
levels in polymyxin B-challenged cultures were as abundant as in untreated cultures at 
the time of analysis (Fig. S3F). A prominent difference between SF370 and HSC5 is that 
the former possesses the Streptococcal Inhibitor of Complement (SIC), which has been 
shown to enhance the resistance of S. pyogenes to CAPs [13, 39].  In contrast to SLO, no 
apparent differences in secreted SIC polypeptide was observed between culture 
supernatants from untreated and challenged cultures of SF370 (Fig. 5F). Thus, inhibition 
of toxin secretion is selective for certain toxins and is not a universal feature of sub-lethal 
polymyxin B treatment.   
 
Human Defensin HNP-1 also disrupts the S. pyogenes ExPortal.  In order to assess if 
human CAPs could also disrupt ExPortal function, cultures were challenged with sub-
lethal concentrations of the α-defensin HNP-1, the ß-defensins hBD-1 and hBD-2, and 
the cathelicidin LL-37.  A Western blot analysis of culture supernatant revealed that of 
these, only HNP-1 noticeably inhibited secretion of SpeB at the CAP concentrations 
tested (<50 µM for all CAPs tested), and did so at concentrations lower than those 
required for similar inhibition by polymyxin B (Fig. 6A). Examination of the staining 
pattern of a fluorescent derivative of HNP-1 (5-FAM-HNP1) revealed that while staining  
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Figure 6. Focal localization and inhibition of SpeB expression by HNP-1. Cultures were 
challenged with HNP-1 or by 5-FAM-HNP-1 at the concentrations indicated. Expression of SpeB 
was evaluated by a Western blot analysis (A) and binding to the S. pyogenes surface was assessed 
using fluorescent microscopy (B, C, D).  Presented are overlays of fluorescent and phase images 
(B, C) or the fluorescent image alone (D) (scale bar = 1µm).  Staining patterns were quantitated 
as described previously (E). Data represents the mean and SEM derived from at least 3 
independent experiments and examination of a minimum of 1000 stained cells.  At minimal 
concentration the number of cells with single foci is significantly higher than all other staining 
patterns, whereas multiple foci and hemisphere staining predominated significantly at higher 
peptide concentrations (P < 0.05).  
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was observed on a small population of cells at low concentration (5 µM, Fig. 6B), that 
these predominantly stained at discrete single or multiple foci (Fig. 6E). Increasing 
concentrations (15 µM) resulted in a higher percentage of cells with multiple foci (Fig. 
6C, 6E), while at even higher concentrations (30 µM) the CAP primarily localizes to one 
hemisphere of the cell (Fig. 6D).  Finally, localization of HtrA by immunofluorescence 
demonstrated that similar to polymyxin B, treatment with HNP-1 at sub-lethal 
concentrations that inhibited SpeB secretion also significantly decreased the number of 
cells exhibiting HtrA at discrete foci (P<0.0001, Fig. 7).  These results suggest that a 
CAP to which S. pyogenes may be exposed to inside a human host can disrupt the 
organization and function of the ExPortal. 
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Figure 7. Challenge with HNP-1 results in redistribution of HtrA. Cultures of S. pyogenes 
HSC5 were challenged with the indicated concentrations of HNP-1 and subjected to 
immunofluorescent microscopy to assess the distribution of HtrA (A, B).  Cell walls were 
visualized by staining with fluorescent vancomycin (scale bar = 1µm).  Staining patterns were 
quantitated as described previously (C). Data represents the mean and SEM derived from at least 
3 independent experiments and examination of a minimum of 1000 stained cells. Challenge with 
the peptide significantly decreased the number of SF370 or HSC5 cells exhibiting HtrA at single 
foci (P<0.0001) and resulted in a significant increase in the number of multiple foci (P<0.0001) 
in the SF370 strain. 
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DISCUSSION 
The ability of S. pyogenes to cause a wide range of diseases has been linked to its 
production of virulence factors that neutralize or subvert innate mechanisms of immunity, 
including the lethal effects of CAPs (for review, see [14, 40, 41]). However, by showing 
that sub-lethal concentrations of CAPs are able to disrupt the secretory ExPortal, the 
results of this study suggest that interaction with CAPs may play a more intimate role in 
S. pyogenes pathogenesis, serving to modulate virulence factor expression at both the 
transcriptional and post-transcriptional levels. Finally, the observation that disruption of 
ExPortal organization is associated with a defect in secretion of certain toxins provides 
additional support for the concept that the ExPortal serves a functional role in facilitating 
protein secretion. 
 A literature is emerging indicating that individual CAPs have a considerable 
diversity in how they interact with and kill bacteria using both lytic and non-lytic 
mechanisms (reviewed in [42-44]).  However, an initial step common to all pathways 
analyzed to date, involves the binding of the CAP to anionic lipids in the membrane.  
While little is currently known about the mechanism(s) by which sub-lethal 
concentrations of CAPs may affect bacterial physiology, the data presented here indicate 
that disruption of ExPortal organization and inhibition of SpeB and SLO secretion were 
also associated with membrane binding by the CAPs.  Most models of CAP action 
postulate that at low sub-lethal concentrations, the peptides bind in a parallel orientation 
relative to the lipid membrane and begin to aggregate as concentrations increase, until a 
lethal concentration is reached and the peptides reorient to attack the membrane 
(reviewed by [4, 43]).  The observation that CAP binding to the ExPortal leads to 
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redistribution of anionic lipids in the absence of pore formation contrasts with CAP 
behavior in model membranes, where they typically cluster anionic lipids (reviewed in 
[45]). Additionally, this redistribution of anionic lipids does not appear to induce or result 
from generalized disruption of the cytoplasmic membrane, as our data show that the 
integrity of the membrane is not compromised. Furthermore, numerous functions that 
depend on membrane integrity are also not compromised, including energy-dependent 
processes such as gene transcription and cell-growth, the latter of which also requires the 
assembly of macromolecular complexes at the membrane. The binding of polymyxin B to 
the membrane appears to only affect the physical location of anionic lipids and SecA 
within the membrane relative to each other and to accessory factors like HtrA. This 
suggests that the initial binding and/or aggregation of the CAPs is sufficient to disrupt the 
factor(s) that maintains ExPortal organization.  If the anionic character of these lipids 
plays a fundamental role in organization, then it is possible that CAP binding serves to 
neutralize their charge to promote disruption. Alternatively, the interaction of CAPs with 
ExPortal lipids may disrupt the insertion or translocation of factors that function to 
maintain ExPortal lipid organization.  The redistribution of ExPortal-associated 
membrane proteins may then occur subsequent to disruption of lipid structure, as analysis 
of a bitopic membrane protein (sortase C) has suggested that interaction between anionic 
lipids and a high density of positive charge in the cytoplasmic tail of its transmembrane 
helix is responsible for its localization at the ExPortal [19]. 
 Many bacterial pathogens segregate charged lipids into microdomains (reviewed 
in [46, 47]) and these support the function of several multi-enzyme complexes required 
for secretion, membrane protein biogenesis and cell division [48-50]. Since some CAPs 
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can kill in the absence of pore formation and can also target charged lipids, it has been 
proposed that they exert their lethal effect by interfering with the dynamic function of 
these lipid-associated complexes, referred to as the “sand in a gearbox” mechanism [51]. 
This concept is supported by the observation that these CAPs can elicit enhanced 
expression of some components of these complexes [51]. By documenting the physical 
disruption of a multi-component organelle in the absence of poration, the results of the 
present study provide strong support for this mechanism. Furthermore, they extend this 
emerging concept to show that disruption can also occur at sub-lethal exposure to CAPs, 
and as a consequence, significantly influence how the bacterium interacts with its 
environment.   
 To date, modulation of signaling via the CovRS (CsrRS) two-component 
transcription regulator has been the most widely studied consequence of sub-lethal S. 
pyogenes-CAP interaction.  Analysis of this mechanism has shown that from among a 
large panel of CAPs that included HNP-1, only human LL-37 functioned to induce 
signaling [12].  Similarly, ExPortal targeting was not a property that was shared by all the 
CAPs tested in the present study, including LL-37.  While the reason for this is not 
known, it was not unexpected, as the considerable diversity of CAP structure is reflected 
in differences in selectivity, binding efficiency, mechanism of killing and the physical 
conditions required for optimum activity (reviewed by [42]).  Furthermore, these 
behaviors have not been extensively investigated at sub-lethal concentrations for any 
CAP.   
 Of the human-derived CAPs tested in the present study, HNP-1 proved more 
potent that polymyxin B in ExPortal disruption. This α-defensin is expressed 
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constitutively in the azurophilic granules of neutrophils [1] and can be detected at 
concentrations of up to 63 µM [52] in secretions from nasopharyngeal tissue, a niche that 
can be colonized by S. pyogenes.  Thus, it is likely that S. pyogenes encounters HNP-1 
during infection.  Also, while HNP-1 targets anionic lipids, it may have additional 
targets, including the lipid II molecule involved in cell wall synthesis [53]. Binding to 
lipid II likely explains why higher concentrations of HNP-1 produced more heterogenous 
patterns of staining, including a tendency for staining one hemisphere of the cell. In 
“ovococci” like S. pyogenes, which divide in successive parallel planes perpendicular to 
their long axis, this pattern is consistent with the pattern of new cell wall synthesis 
(reviewed by [54]).  
The ability of S. pyogenes to secrete numerous toxins likely plays a central role in 
its ability to cause disease [55].  Thus, inhibition of SpeB and SLO may represent a 
physiologically relevant property of sub-lethal CAP concentrations. Since secretion of 
essential proteins will be required to support viability, it is unlikely that sub-lethal CAP 
treatment would produce a global blockade of protein secretion.  It is known that 
biogenesis of SpeB requires secretion factors that are not required for other Sec-secreted 
proteins [31-34]. Similarly, as an SRP substrate [33] SLO’s secretion requires 
coordination between FtsY, the membrane receptor for the SRP, and the Sec translocons 
[56]. In contrast SIC secretion in the SF370 strain was unaffected by CAP treatment, a 
result that suggests that its secretion may not require additional factors in addition to Sec.  
If the ExPortal functions to coordinate interactions between various secretion 
components, then disruption of ExPortal organization could lead to the secretion defect. 
Alternatively, it has been shown that some CAPs can act on internal targets (reviewed by 
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[4]), raising the possibility that sub-lethal CAPs may interfere with secretion factors in 
the cytoplasmic compartment of the streptococcal cell.   
Interestingly, analysis of the recently introduced antibiotic daptomycin has 
suggested that it principally targets regions of membrane enriched in anionic 
phospholipids [57], suggesting that these domains can be exploited for the development 
of even more potent antibiotics.  Thus, further analysis of CAP-ExPortal interaction will 
be valuable for uncovering the fundamental organizing principles of the ExPortal, how 
the ExPortal informs the coordination of protein secretion and maturation and the 
importance of modulation of secretion in response to host factors during infection.  
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EXPERIMENTAL PROCEDURES 
Strains, plasmids, media and growth conditions:  As indicated, experiments utilized S. 
pyogenes HSC5 [58] or SF370 [26]. Localization of HtrA was analyzed in HSC5 
following transformation by pHtrA-HA, which expresses a HA-tagged derivative of HtrA 
[18]. Strain GCP682 contains an in-frame deletion (vfrΔ15-289) in vfr (SPy_0887) (G. Port 
and M. Caparon in preparation). Routine culture was at 37°C in Todd-Hewitt broth 
(BBL) supplemented with 0.2% yeast extract (Difco) (THY medium).  Functional assays 
utilized cultures grown in unmodified C medium as described previously [59]. To 
produce solid media, Bacto Agar (Difco) was added to a final concentration of 1.4%. 
Expression of the secreted SpeB cysteine protease was evaluated on skimmed milk agar 
medium [31]. Liquid cultures were grown without agitation in closed containers and solid 
cultures were incubated under anaerobic conditions using a commercial gas generator 
(GasPak, cat. #260678, BBL) as described [59]. The SpeB protease was inhibited in 
cultures used to analyze the abundance of secreted streptococcal proteins by including the 
cysteine protease inhibitor E64 [31].  In selected experiments, media were supplemented 
with CAPs, including polymyxin B (cat. #P0972-50MU, Sigma), Human Neutrophil 
Peptide-1 (HNP-1, cat. #60743, AnaSpec), Human ß-defensin 1 (hßD-1, cat. #072-53, 
Phoenix Pharmaceuticals), Human ß-defensin 2 (hßD-2, cat.#072-48, Phoenix 
Pharmaceuticals), and Human cathelicidin LL-37 (LL-37, cat. #61302, AnaSpec) at the 
concentrations indicated in the text.   
 
Challenge with CAPs:  Unless otherwise indicated, bacteria were cultured overnight in 
liquid THY medium, diluted 1:100 in fresh C medium and then cultured to the late-
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logarithmic phase of growth (Fig. S3C, 0h).  The CAPs were then added to the various 
final concentrations indicated in the text and incubation continued until cultures reached 
stationary phase (3 hrs post-treatment, Fig. S3C) as determined by monitoring optical 
density (OD600).  Control cultures were grown in parallel, but were not treated with any 
CAPs; control and treated cultures entered stationary phase at approximately the same 
time (Fig. S3C).  For this challenge assay, the minimum concentration of polymyxin B 
and HNP-1 that resulted in a greater than one-log reduction in the number of SF370 
viable cells (determined by enumeration of colony forming units as described below) 
were 145 µM and 67 µM, respectively. This assay differs from a conventional assay for 
determining the minimal inhibitory concentration, which employs an inoculum of 
stationary phase cells from an overnight culture at a low cell density. As expected, SF370 
was more sensitive to polymyxin B in the conventional assay (22 µM). In contrast, SF370 
was more resistant to polymyxin B on protease indicator medium (see Fig. 5), which is 
likely due to its increased lipid content.  For analysis of proteins whose expression begins 
in early logarithmic phase, the challenge assay was modified in order to remove proteins 
secreted into the supernatant prior to challenge as follows: cultures were grown to mid-
logarithmic phase (Fig. S3C), harvested by centrifugation, immediately resuspended in an 
equivalent volume of warm fresh medium and then challenged with CAPs as indicated in 
the text. Samples were collected and processed for assessment of viability, for 
microscopy and for analysis of protein secretion, as described below.  Data presented are 
representative of those obtained over the range of sub-lethal concentrations of CAPs.   
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Analysis of Viability: At selected time points following challenge with CAPs, aliquots 
were removed from cultures and viability assessed by determination of CFUs following 
brief sonication to disrupt streptococcal chains, serial dilution in PBS and plating on C 
medium agar as described previously [60].  Viability was also assessed by staining with a 
fluorescent vital dye (LIVE/DEAD®, BacLighttm) as recommended by the manufacturer 
(Invitrogen). Viability was quantitated by examination using a fluorescent microscope 
(Leica model DM IRE 2) with enumeration of the percentage of live bacteria in randomly 
chosen microscopic fields totaling >1000 cells for each condition examined. Data 
reported represent the mean and standard error of the mean derived from a minimum of 3 
independent experiments. Differences between calculated means were evaluated for 
significance using a one-way Analysis of Variance (ANOVA). 
 
Cellular staining and fluorescent microscopy:  Streptococcal cultures were challenged 
with various CAPs as described above, stained with various fluorescent reagents and then 
analyzed by fluorescent microscopy as follows:  Analysis of the location and integrity of 
a membrane microdomain enriched in anionic phospholipids was assessed by staining 
with 10-nonyl acridine orange (NAO, cat. #A7847 Sigma) as described [22].  
Localization of the discrete membrane site of secretion of the SpeB cysteine protease was 
conducted using the red protease assay [17].  Analysis of CAP binding involved the 
substitution of native CAPs in the challenge assay with sub-lethal concentrations of 
fluorescent derivatives, including dansyl-polymyxin B (5, 10, 15 and 47µM, cat. 
#P13238, Invitrogen), polymyxin B BODIPY®FL conjugate (10 and 45µM, cat. 
#P13235, Invitrogen) or 5-FAM-HNP-1 (5, 15 and 30µM, custom synthesis by 
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AnaSpec). Samples were examined using a Leica model DM IRE 2 fluorescent 
microscope and images captured using a QImaging Retiga 1350 EX charged-coupled 
device camera and Openlab software (Improvision). Where indicated, simultaneous 
treatment with 2 reagents was conducted in order to assess co-localization of staining.  In 
these experiments streptococcal cells walls were visualized by staining with fluorescent 
vancomycin (1 µg ml-1, cat. #V34850, Invitrogen), or wheat germ agglutinin Alexa Fluor 
488 conjugate (5 µg ml-1, cat. #W11261, Invitrogen) and neutral membrane lipids were 
visualized by staining with Nile Red (2.5 ug ml-1, cat. #N1142, Invitrogen).  Focal 
localization in images of cells was quantitated as described in detail elsewhere [19] and 
scored as staining at a unique focus, multiple foci, or non-specifically (staining was of 
homogeneous intensity around the cellular circumference).  Co-localization in the red 
protease assay was quantitated as the percentage of vancomycin-stained cells that 
exhibited focal staining with each individual reagent where the two foci were 
superimposable.  Data presented for each condition represents the mean and standard 
error of the mean derived from at least 3 independent experiments and examination of a 
minimum of 1000 stained cells.  Images were processed for publication using Adobe 
Photoshop CS3. 
 
Immunofluorescent microscopy:  The localization of native and HA-tagged HtrA protein 
(in SF370 and HSC5, respectively) was detected by immunofluorescent microscopy, as 
described [18].  Aliquots from untreated or CAP-treated (47 µM polymyxin B or 29 µM 
HNP-1) challenge assay cultures (see above) were treated with PlyC lysin (prepared as 
described, [61]) and fixed according to the method of Raz and Fischetti [23].  Antisera 
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used included a polyclonal rabbit anti-HtrA antiserum (a gift from Mark Walker, 
University of Wollongong, Australia) used at a dilution of 1:100 that was detected using 
an AlexaFluor 594-lableled goat anti-rabbit IgG (Invitrogen) at 1:500 and an AlexaFluor 
594-conjugated rabbit IgG anti-HA epitope antiserum (Invitrogen) used at 1:500.  Wheat 
germ agglutinin (WGA)-AlexaFluor 488 (Invitrogen) at a final concentration of 5 µg ml-1 
was used to visualize the streptococcal cell walls.  Slides were mounted in an anti-fade 
reagent (Prolong Gold, Invitrogen) and images captured and staining patterns quantitated 
as described above. Differences between means were analyzed for significance using a 
two-tailed Student’s t-test. 
 
Immunogold electron microscopy:  Localization of polymyxin B binding was examined 
by electron microscopy, as follows:  Cultures in the assay described above were 
challenged with biotin-conjugated polymyxin B (HyCult Biotechnologies) at the various 
dilutions indicated in the text.  At 1 hr post-challenge, aliquots were removed and 
prepared for immunoelectron microscopy as described [17, 18].  Sections were stained 
using a streptavidin-gold conjugate (20nm, BBI International) and examined by electron 
microscopy as detailed [17, 18].  Localization of SecA and HtrA following treatment in 
the challenge assay with the concentrations of polymyxin B indicated in the text was 
determined at 2 hr post-challenge by immunogold electron microscopy [17, 18].  Focal 
staining was defined and quantitiated as described in detail elsewhere [19].   
 
Analysis of protein expression and secretion:  Expression of the transcript for the SpeB 
cysteine protease was determined at various time points following challenge with 
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polymyxin B by real time RT-PCR as described [59, 62].  Data represents the mean and 
standard error of the mean derived from 3 independent experiments conducted on 
different days, with each sample analyzed in quadruplicate. Supernantant fractions from 
cultures challenged with polymyxin B were analyzed for SpeB proteolytic activity as 
previously described [18] via the relative increase in fluorescence generated by the 
cleavage of fluorescein isothiocyanate-casein (cat. #C3777, Sigma). Supernatant, cell 
wall and protoplast fractions from cultures challenged with CAPs were prepared and 
analyzed for the presence of SpeB and HtrA by Western blotting as described [33].  Blots 
were developed using a Chemidoc XRS imager (BioRad) and relative protein 
concentrations determined using Quantity One software (BioRad, version 4.6.7).  Data 
are expressed relative to untreated cultures and were derived from a minimum of 3 
independent experiments. Differences between means were evaluated for significance 
using one-way ANOVA. 
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SUPPLEMENTARY FIGURES 
 
 
 
Figure S1. Validation of sub-lethal polymyxin B challenge. Cultures of S. pyogenes SF370 
were treated with the indicated concentrations of polymyxin B in the challenge assay and viability 
assessed by (A) determining the number of colony forming units (CFU) following serial dilution 
and plating on C medium and (B) fluorescent microscopy of cells following staining with 
reagents that distinguish between cells with intact membranes and those whose membranes have 
become porated (LIVE/DEAD BacLighttm, Invitrogen). Samples for both viability assays were 
harvested following 2 hrs of treatment, and numbers of CFU determined following 24 hrs of 
incubation. Numbers of cells with porated membranes were derived from examination of at least 
1000 stained cells.  All data presented represents the mean and standard error of the mean derived 
from at least 3 experiments.  Differences between mean values were evaluated for significance by 
a one-way ANOVA, which revealed no significant differences between any treated vs untreated 
cultures. Identical results were obtained from performing these same analyses on S. pyogenes 
strain HSC5 (data not shown). 
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Figure S2. Focal localization of anionic lipids is unaffected by heat stress.  Cultures of S. 
pyogenes HSC5 (A, C, E) and SF370 (B, D, F) were challenged in the standard assay as follows: 
Cultures were challenged with 10µM bodipy-labeled polymyxin B (Invitrogen) and incubated for 
30 min at 37oC (A, B) or subjected to heat shock (42oC, 30 min.) (C, D) or challenged with an 
ExPortal-disrupting concentration of bodipy-labeled polymyxin B (45µM) (E, F). Samples were 
then analyzed by microscopy and each individual field was examined using fluorescence or phase 
contrast modes  (left and right of each panel, respectively).  Scale bar = 1µm.   
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Figure S3. Validation of secretion-inhibitory effects in streptococci of sub-lethal polymyxin 
B levels. (A). Expression of the secretory translocon ATPase SecA in cultures of S. pyogenes 
SF370 was determined 2 hrs post-challenge with the concentrations of polymyxin B indicated in 
the Fig. A Western blot analysis of cell protoplasts is shown.  (B) Western blot analysis of SpeB 
in culture supernatants of S. pyogenes HSC5 following sub-lethal polymyxin B challenge.  Open 
and filled triangles indicate the migration of the zymogen and mature form of SpeB, respectively. 
(C). Growth of S. pyogenes in the absence or presence of the indicated amounts of polymyxin B.  
Arrows indicate the point at which cultures were challenged (0 h, Mid-log) and the subsequent 
time points where samples were harvested for the various analyses described in the text. (D). A 
Vfr- mutant of HSC5 (GCP682) was cultured to the time of challenge (Mid-log) and then treated 
with the indicated concentrations of polymyxin B. Shown is a Western blot analysis of SpeB in 
culture supernatant.  (E). A Western blot analysis of HtrA in lysates of S. pyogenes SF370 that 
were prepared 3 hrs post-challenge with the indicated concentrations of polymyxin B.  (F).  Real-
time RT-PCR analysis of slo transcript abundance following challenge of S. pyogenes HSC5 with 
the indicated concentrations of polymyxin B. Data shown represent the mean and SEM derived 
from at least three independent experiments conducted on different days and each sample was 
analyzed in triplicate.  
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ABSTRACT 
S. pyogenes and other Gram-positive bacteria circumvent the lack of a specialized 
cellular compartment for folding secreted proteins following their translocation by 
clustering the Sec translocons at a defined microdomain of the cytoplasmic membrane 
that is also enriched in anionic lipids and accessory factors for protein biogenesis, 
referred to as the ExPortal. The function of this secretory organelle appears to be that of 
spatially coupling secretion with protein maturation, but the mechanisms underlying 
ExPortal organization and maintenance are still poorly understood. Emerging literature 
suggests that cell wall biogenesis components interact with cytoplasmic membrane 
structures and the cell division machinery to organize membrane localized processes. In 
the present study we examined the role the streptococcal cell wall and peptidoglycan 
synthesis in the cytoplasmic membrane play in organizing and maintaining the ExPortal 
and report that extracellular peptidoglycan is required for maintaining proper localization 
of both lipid and protein components of the ExPortal. Treatment with a lipid II-targeting 
lantibiotic disrupted localization of anionic lipids and ExPortal proteins, as well as 
secretion of ExPortal substrates in a manner similar to what was observed previously 
with cationic antimicrobial peptides at sub-lethal concentrations. Furthermore, proteins 
responsible for the membrane-associated steps of lipid II synthesis localize to foci in the 
streptococcal membrane that coincide with the anionic lipid microdomain and secretory 
translocons of the ExPortal, suggesting that localization of peptidoglycan synthesis 
coincides with the ExPortal and influences its organization. 
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INTRODUCTION 
Streptococcus pyogenes is the causative agent of numerous diseases in humans that 
range from largely superficial infection of the skin and mucous membranes (impetigo, 
pharyngitis), to highly invasive and life-threatening diseases (necrotizing fasciitis), as 
well as, serious post-infection sequelae (rheumatic fever, glomerulonephritis, reviewed in 
[1]. A gram-positive pathogen, its ability to cause disease is dependent on the secretion of 
an extensive network of virulence proteins [1, 2]. In the absence of other known secretion 
systems, these virulence proteins are exported by the general secretory  [3] pathway (for a 
review see [4]. S. pyogenes and other Gram-postive pathogens circumvent the lack of a 
specialized cellular compartment for folding secreted proteins following their 
translocation, a feature shared by all Gram-positive bacteria, by clustering the Sec 
translocons at a defined microdomain of the cytoplasmic membrane referred to as the 
ExPortal [5-9].  The ExPortal is also highly enriched with accessory factors for protein 
biogenesis at the extracellular leaflet of the membrane, including the sortases involved in 
covalent attachment of proteins to the cell wall, and the multi-function protease and 
chaperone HtrA that aids in the biogenesis of the active form of the SpeB protease [5-7, 
10, 11]. These studies suggest the function of the ExPortal is to spatially couple secretion 
with protein maturation, but the mechanisms underlying the organization and 
maintenance of this secretory organelle are still poorly understood.  
The ExPortal of S. pyogenes has been shown to have an asymmetric lipid content 
enriched in anionic phospholipids [10] that may contribute to the preferential retention of 
certain proteins at the ExPortal vs. the peripheral membrane [7].  Research into the 
interaction between S. pyogenes and cationic antimicrobial peptides (CAPs), which bind 
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to negatively charged membranes, showed that sub-lethal concentrations of certain 
peptides disrupt both localization of anionic lipids and retention of HtrA and the Sec 
translocon ATPase SecA at the ExPortal microdomain, and in doing so inhibit its 
secretory activity [12]. Interestingly, this study also revealed that one of these CAPs, 
human neutrophil peptide 1 (HNP-1), localizes to the bacterial cell surface which 
overlaps to regions of new cell wall synthesis in streptococci at the sub-lethal, ExPortal-
disrupting concentrations tested. It has been previously demonstrated that HNP-1 targets 
the peptidoglycan precursor lipid II in bacterial membranes [13], much like other 
defensins for which a similar affinity for the lipid II molecule has been observed [14, 15]. 
This finding suggests that CAPs can interfere with ExPortal function by disruption of 
lipid II in addition to anionic lipids.  
The best characterized lipid II-targeting molecules known belong to a class of 
small bacterial defense peptides commonly referred to as lantibiotics (for a review, see 
[16]. The best characterized of these, nisin, specifically binds lipid II in a defined 
stoichiometry in order to form pores that efficiently permeabilize bacterial membranes 
[17, 18]. More importantly however, non-porating variants of nisin have been shown to 
efficiently kill bacteria using an alternative mechanism by which lipid II is clustered into 
patches in the cytoplasmic membrane away from the regions where peptidoglycan 
synthesis occurs [19]. Other lantibiotics such as gallidermin, epidermin and mutacin have 
also been observed to act via this alternative mechanism [19-21], thus inhibiting cell wall 
synthesis and causing bacterial cell death without permeabilizing the cytoplasmic 
membrane. The fact that lipid II-targeting molecules can disrupt cell wall synthesis 
without compromising membrane permeability, combined with the observation that a 
  86 
CAP shown to interact with lipid II can similarly target and disrupt the ExPortal hint at a 
possible link between cell wall biogenesis and organization of this secretory organelle. 
The cell wall of Gram-positive pathogens is an extracellular organelle that plays a 
multitude of roles essential to both survival and virulence (for a review see [22]. A rigid 
exoskeleton made up of polymers of alternating N-acetylglucosamine (GlcNAc) and M-
acetylmuramic acid (MurNAc) glycan units crosslinked via peptide bridges, its main 
purpose is to preserve cellular integrity against osmotic forces from without and within 
the bacterial cell [23]. The cell wall is also the attachment site for extracellular factors 
that interact with the host environment, which include surface-associated virulence 
proteins, lipoteichoic and teichoic acids. Since cell wall-anchored proteins are covalently 
attached by sortases to their peptidoglycan acceptor immediately following their 
secretion, most research into the relationship between gram-positive secretion and cell 
wall biogenesis, particularly in the case of streptococci, has focused on the 
characterization of sortase function (reviewed in [24]. In contrast, our present study 
corresponds to an emerging literature on how the organization of cell wall biogenesis 
relates to underlying cytoplasmic membrane structures and cell division machinery [25-
28] by examining the possibility of a more direct relationship between protein secretion 
and cell wall synthesis in streptococci, particularly in terms of the organization of these 
processes. The final steps of cell wall peptidoglycan biogenesis occur at the inner leaflet 
of the cytoplasmic membrane. In gram-postive species including Streptococcus 
pneumoniae, Staphylococcus aureus and Enterococcus faecalis, these involve cytosolic, 
as well as membrane-intrinsic and extrinsic proteins  (for a review see [29]. The cellular 
localization of these proteins relative to the ExPortal microdomain of Streptococcus 
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pyogenes has not been documented and could reveal a great deal as to whether 
peptidoglycan biogenesis influences ExPortal organization. Thus, our current study also 
examined those proteins involved in the first and last of the membrane-associated steps of 
cell wall synthesis. MraY is a membrane intrinsic protein that carries out the first 
membrane-associated step in the synthesis of the lipid II precursor by catalyzing the 
transfer of the phospho-N-acetylmuramoyl(MurNAc)-pentapeptide from the soluble 
cytoplasmic UDP-MurNAc-pentapeptide substrate to the membrane embedded 
undecaprenyl-phosphate (C55-P) acceptor, thus producing undecaprenyl-pyrophosphoryl-
MurNAc-pentapeptide (lipid I), the immediate precursor of lipid II. MurN, on the other 
hand, is a cytosolic polypeptide belonging to the family of FemABX peptidyl transferases 
that attach the amino acids constituting the peptide cross-links between peptidoglycan 
subunits in the cell wall structure of many gram-positive bacteria [30]. This is the final 
synthetic step occurring on the inner leaflet of the cytoplasmic membrane prior to 
translocation of lipid II across the membrane. In S. aureus synthesis of these peptide 
cross-links is required for the sortase-mediated attachment of surface virulence factors to 
the cell wall [31]. Moreover, evidence indicates that sorting of surface virulence factors 
occurs in the immediate vicinity of their site of secretion and coincides with the site of 
de-novo peptidoglycan synthesis [7, 9, 11, 32]. These data further suggest that 
peptidoglycan biogenesis and ExPortal-mediated secretion may be spatially coordinated 
in the streptococcal membrane.  
Thus, in the present study we examined the role the streptococcal cell wall and 
peptidoglycan synthesis in the cytoplasmic membrane play in organizing and maintaining 
the ExPortal and report that cell wall peptidoglycan is required for maintaining proper 
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localization of both lipid and protein components of the ExPortal at their membrane 
microdomain. Treatment with a lipid II-targeting lantibiotic disrupted localization of 
anionic lipids and ExPortal proteins, as well as secretion of ExPortal substrates in a 
manner similar to what was observed previously with other CAPs at sub-lethal 
concentrations [12]. Furthermore, proteins responsible for the membrane-associated steps 
of lipid II synthesis localize to foci in the streptococcal membrane that coincide with the 
anionic lipid microdomain and secretory translocons of the ExPortal, suggesting that 
localization of peptidoglycan synthesis coincides with targeting and organization of the 
ExPortal. 
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RESULTS 
Cell Wall Peptidoglycan is required for maintenance of the ExPortal anionic lipid 
microdomain. In order to characterize the involvement of cell wall biogenesis in 
ExPortal organization we first determined whether the cell wall is necessary to maintain 
ExPortal integrity. To that end we examined the localization of anionic lipids in the 
cytoplasmic membrane in protoplasts devoid of extracellular peptidoglycan. Treatment 
with purified PlyC bacteriophage lysin of logarithmic and stationary phase streptococcal 
cultures resuspended in either raffinose buffer or glycerol-supplemented media removed 
all surface peptidoglycan from the majority of streptococci, as monitored by the 
breakdown of streptococcal chains into individual protoplasts and the absence of either 
FL-Vancomycin or Wheat Germ Agglutinin (WGA) labeling on the protoplast surface 
(Fig. 1). The loss of cell-wall labeling in PlyC-treated streptococci coincided with a 
redistribution of labeled polymyxin B from unique foci to the entirety of the bacterial 
cell’s surface, giving the protplasts a “halo” appearance (Fig. 1A, B, H), distinct from the 
focal localization of the labeled peptide observed in intact streptococci (Fig. 1C and D) 
and PlyC-treated streptococci in which not all of the cell wall peptidoglycan was 
removed, as evidenced by the presence of FL-Vancomycin or WGA label on their surface 
(Fig. 1A, top of panel). The distribution of labeled polymyxin B in protoplasts also 
coincided with the distribution of neutral lipid-binding dye Nile Red (compare Fig. 1H 
and I), suggesting that in the absence of cell wall peptidoglycan, integrity of the anionic 
lipid microdomain of the ExPortal is lost and anionic lipids are uniformly distributed in 
the streptococcal membrane in a manner similar to neutral lipids. Staining streptococcal 
protoplasts with a fluorescent vital dye (LIVE/DEAD BacLightTM) indicated that the  
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Figure 1. Surface peptidoglycan is required for maintenance of the ExPortal anionic lipid 
microdomain. The distribution of anionic lipids on the surface of S. pyogenes SF370 and HSC5 
protoplasts was revealed by fluorescent microscopy. Loss of cell wall labeling by FL-vancomycin 
in SF370 protoplasts coincided with redistribution of anionic lipid labeling by dansyl-polymyxin 
B from focal sites in intact bacteria (A, top) to the entire protoplast membrane surface (A, 
bottom). Similar redistribution of dansyl-polymyxin B to the entire surface was observed in 
HSC5 protoplasts (B), compared to focal localization in intact bacteria (C). Localization of 
dansyl-polymyxin B (D, H) and neutral lipids (E, I) in WGA-stained (F,J) HSC5 intact cells (D-
G) and protoplasts (H-K) further confirmed redistribution of anionic lipids to the entire 
membrane surface. Fluorescent (A, right; D-F, H-J), phase (B, top), and merged images (A, left; 
B,C,G,K) are shown. FL-vancomycin (1µg ml-1, green), Dansyl-polymyxin B (10µM, blue), 
WGA (5µg ml-1, green), Nile red (2.5µg ml-1, red). Scale bar = 1µm. 
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Figure 2. Loss of anionic lipid segregation at a microdomain is not due to membrane 
permeabilization. Membrane permeability of S. pyogenes protoplasts displaying altered anionic 
lipid distribution was assessed by fluorescent microscopy following staining with reagents that 
distinguish between protoplasts with intact membranes (viable) and those with permeabilized 
membranes (LIVE/DEAD BacLighttm, Invitrogen). Fluorescent images of a representative field of 
HSC5 protoplasts displaying uniform membrane-staining with dansyl-polymyxin B (A), viable 
(B) and permeabilized cell staining (C), as well as corresponding merged image (D) are shown. 
Protoplasts generated by PlyC lysin treatment (PlyC+) have non-permeabilized membranes, 
indicated by viable cell staining similar to untreated (PlyC-) HSC5 cells (E). A significant 
number of protoplasts (PlyC+) displaying uniform membrane labeling with dansyl-polymyxin B 
(Halo) had intact membranes (Halo+viable) as opposed to permeabilized membranes 
(Halo+permeabilzed)(F). Few intact cells display uniform membrane labeling by dansyl-
polymyxin B (Halo PlyC-). Numbers of viable, permeabilized protoplasts and intact streptococcal 
cells were derived from examination of 1000 stained cells. Data presented represents the mean 
and standard error of the mean derived from at least 3 experiments.  Differences between mean 
values were evaluated for significance by a one-way ANOVA (P<0.0001). Scale bar = 10µm. 
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cytoplasmic membranes of the protoplasts examined are not permeabilized (Fig. 2A-D). 
Quantitation of protoplasts displaying the uniform membrane distribution of labeled 
polymyxin B described above revealed that a significantly large proportion of them had 
intact membranes (Fig. 2E and F, P<0.0001). This suggests that the observed 
redistribution of anionic lipids resulting from the removal of surface peptidoglycan under 
our experimental conditions is not due to perturbation of membrane permeability. 
 
Cell Wall Peptidoglycan is required for ExPortal protein targeting at the membrane. 
Previous work demonstrated that localization of ExPortal-associated proteins such as 
SecA and HtrA coincided with the anionic lipid microdomain of the ExPortal [6, 10] and 
that disruption of the lipid microdomain by CAPs resulted in redistribution of these 
proteins in the streptococcal membrane [12]. Thus, we examined whether disruption of 
anionic lipid localization in the streptococcal membrane resulting from the absence of 
surface peptidoglycan affected the distribution of ExPortal-associated proteins. 
Immunofluorescence microscopy of streptococcal protoplasts revealed that the 
membrane-associated HtrA protease was distributed uniformly over the entirety of the 
membrane (Fig. 3A). Likewise, the translocon ATPase SecA was observed uniformly in 
the membrane for the most part, as protoplasts in which multiple foci of SecA labeling 
were also observed (Fig. 3B). Removal of cell wall peptidoglycan was confirmed by the 
absence of staining with WGA following PlyC treatment and fixation of streptococci. 
Again, streptococci in which surface peptidoglycan removal was incomplete following 
treatment displayed the unique foci of HtrA (Fig. 3C) and SecA (data not shown) 
localization that are commonly observed in streptococci with intact cell walls, consistent 
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with prior studies [6, 12]. The observed altered localization of HtrA and SecA further 
supports the hypothesis that integrity of an anionic lipid microdomain is central to 
targeting of ExPortal-related proteins in the membrane. Moreover, that localization of 
lipid and proteinacious ExPortal components is altered in the absence of surface 
peptidoglycan suggests that an intact cell wall is necessary for ExPortal organization. 
 
 
 
 
Figure 3. Redistribution of ExPortal proteins following removal of surface peptidoglycan.  
The distribution of HtrA (A) and SecA (B) in S. pyogenes HSC5 cells and protoplasts was 
assessed by immunofluorescence microscopy. Incomplete removal of surface peptidoglycan from 
streptococci following treatment with PlyC lysin does not alter focal localization of HtrA (C). 
Merged fluorescence images of intact streptococci (A, left; B, top) and protoplasts (A, right; B, 
bottom) are shown. WGA (5µg ml-1, green), HtrA and SecA (red). Scale bar = 1µm.  
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The lantibiotic gallidermin disrupts targeting of lipid and proteinaceous ExPortal 
components as well ExPortal-mediated secretion. The experimental results previously 
described suggest that beyond its role of protecting the membrane from damage from 
internal turgor pressure and maintaining cell shape, the streptococcal cell wall might also 
play a role in organizing or maintaining organization of the secretory organelle that is the 
ExPortal. Disruption of the ExPortal resulting from the loss of extracellular 
peptidoglycan does not appear to be due to compromised membrane permeability, 
indicating that the cell wall’s involvement in organizing the ExPortal goes beyond that of 
maintaining membrane integrity. One possibility is that peptidoglycan synthesis and the 
ExPortal are linked, meaning the site of peptidoglycan production at the membrane 
coincides with and influences the localization of protein secretion and processing at the 
ExPortal. To test this hypothesis we first examined whether compounds known to be 
disruptive to cell wall synthesis affect ExPortal organization and function. As mentioned 
previously, lantibiotics such as nisin, gallidermin and mutacin have been demonstrated to 
possess a high affinity for the peptidoglycan precursor lipid II and to interact with it in 
order to porate membranes and disrupt cell wall synthesis. Thus, we monitored the 
localization of the anionic lipid microdomain of the ExPortal in the presence of 
lantibiotics at concentrations that were not lytic to streptococci. We assessed membrane 
permeability using a Live/Dead® stain to quantitate numbers of porated streptococci in 
lantibioitc treated cultures and determined lytic concentrations to be those that resulted 
<50% viable cells in observed microscopy fields. Examination of either HSC5 or SF370 
strain cultures showed that gallidermin and nisin do not compromise streptococcal 
membrane integrity at concentrations lower than 2µM and 0.5µM, respectively (Fig. 4A  
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Figure 4. The lantibiotic gallidermin disrupts localization of anionic lipids at non-lytic 
concentrations. The localization of anionic lipids in S. pyogenes SF370 and HSC5 was assessed 
by fluorescence microscopy following challenge with a non-lytic concentration of gallidermin 
(1µM). Non-lytic concentrations of the lantibiotics gallidermin (A) and nisin (B) were determined 
by fluorescent microscopy of cells following staining with LIVE/DEAD BacLighttm reagents 
(Invitrogen). Distribution of anionic lipids in the membrane was monitored by staining with sub-
lethal levels of polymyxin B BODIPY®FL conjugate (10µM) in gallidermin exposed (C) and 
untreated streptococci (D). Streptococci treated with anionic lipid microdomain-disrupting 
concentrations of polymyxin B BODIPY®FL conjugate (60µM) are shown for comparison (E). 
Fluorescent, phase and merged images are shown. Scale bar = 1µm. Samples for analysis of 
viability were harvested following 1 hr of lantibiotic treatment and numbers of cells with porated 
membranes were derived from examination of at least 1000 stained cells.  All data presented 
represents the mean and standard error of the mean derived from at least 3 experiments. Numbers 
of viable protoplastst (PlyC+) are shown for comparison. Identical results were obtained from 
performing these same analyses on S. pyogenes strain SF370 (data not shown).  
  96 
and B, data not shown). Fluorescent microscopy using bodipy-labeled polymyxin B to 
ascertain the localization of ExPortal-associated anionic lipids revealed that non-lytic 
concentrations of gallidermin disrupt the anionic lipid microdomain of the ExPortal (Fig. 
4C) in a manner similar to high sub-lethal amounts of polymyxin B (compare, Fig. 4C, D 
and E), as observed by the localization of the labeled cationic peptide to multiple foci or 
in a more diffuse staining pattern than in untreated streptococci. Nisin had a disruptive 
effect on the localization of the fluorescent peptide to unique foci at concentrations 
determined to be lytic to streptococci in treated cultures (data not shown), which makes it 
difficult to discern whether this effect of nisin was due to its membrane-porating capacity 
or to its affinity for lipid II. However, given that the disruptive effect of gallidermin on 
anionic lipid localization in the membrane was observed with non-lytic amounts of the 
lantibiotic, we examined whether gallidermin also affected the localization of ExPortal-
related proteins. Immunofluorescence microscopy revealed that gallidermin treatment of 
streptococcal cultures at a non-lytic concentration resulted in redistribution of HtrA to 
either multiple foci or, for the most part, in a diffuse pattern on the streptococcal surface 
(compare Fig. 5A and B). Co-labeling with fluorescent polymyxin B confirmed that the 
observed localization of HtrA corresponded with a re-distribution of ExPortal-associated 
anionic lipids, as identified by the labeled CAP.  
Since gallidermin was observed to interfere with the localization of both lipid and 
proteinaceous components of the ExPortal, we examined whether the lantibiotic could 
inhibit translocation of proteins requiring an intact ExPortal for their secretion, as has 
been previously studied with cationic antimicrobial peptides [12]. Treatment of strain 
SF370 with a non-lytic concentration of gallidermin resulted in a reduction in the amount  
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Figure 5. Redistribution of HtrA following non-lytic gallidermin challenge.  The distribution 
HtrA on S. pyogenes HSC5 was assessed by immunofluorescent microscopy in the absence of (A) 
and following challenge with gallidermin at 1 µM (B). Fluorescent images of cell wall (WGA, 
5µg ml-1, green), HtrA (red), anionic phospholipid (dansyl-polymyxin B, 10µM, blue) labeling 
and merged fluorescent images (bottom panel) are shown.  Scale bar = 1µm. 
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of cysteine protease SpeB in culture supernatants as revealed by Western blot analysis 
(Fig. 6A). This reduction in the amount of secreted SpeB was similar to that observed in 
supernatants from cultures treated with high sub-lethal amounts of polymyxin B and was 
observed in supernatants from the HSC5 strain as well (Fig. 6B). Decreased levels of 
secreted Streptolysin O (SLO) cytolysin were also observed in gallidermin-treated 
cultures of both HSC5 and SF370 strains (Fig. 6 C and D), in the same manner as 
resulted from treatment with high sub-lethal amounts of polymyxin B.  Protein synthesis 
and the capacity to translocate proteins appear to be unaffected as levels of SecA protein 
in gallidermin-exposed streptococci are unaltered relative to untreated bacteria as 
indicated by Western analysis of streptococcal lysates (Fig. 6E), suggesting the effect of 
gallidermin on secretion of ExPortal substrates is due to its disruption of ExPortal 
organization. Altogether, these results indicate that the lipid II-targeting activity of a 
lantibiotic disrupts the streptococcal ExPortal and support the hypothesis that synthesis of 
the peptidoglycan precursor at the membrane influences ExPortal organization.  
 
Synthetic enzymes required for  lipid II peptidoglycan precursor biogenesis co-localize 
with the ExPortal. As mentioned previously, the final steps of cell wall subunit 
biogenesis occur at the cytoplasmic membrane, meaning that lantibiotic interaction with 
lipid II likely occurs in the proximity of the membrane site where precursor synthesis 
takes place. The disruptive effect of gallidermin on ExPortal organization in the absence 
of changes in membrane permeability further supports the possibility that lipid II 
synthesis at the membrane affects maintenance of the ExPortal. If peptidoglycan 
precursor synthesis and the organization of ExPortal-mediated protein biogenesis and  
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Figure 6. Non-lytic challenge with gallidermin inhibits secretion of SpeB and SLO. Secretion 
of the SpeB protease in cultures of S. pyogenes was determined following  challenge with the 
indicated concentrations of gallidermin and polymyxin B by Western blot analysis of culture 
supernatant from SF370 (A) and HSC5 strains (B).  Western blotting was also used to analyze the 
amount of SLO present in culture supernatant following challenge with the indicated 
concentrations of gallidermin and polymyxin B of SF370 (C) and HSC5 (D) cultures. Expression 
of SecA in HSC5 cultures was determined following challenge with the indicated concentrations 
of gallidermin by Western blot analysis of streptococcal lysates (E). All samples for SpeB 
analysis were harvested at 2 hrs post-challenge; samples for SLO and SecA were harvested 1hr 
post-challenge. Open and filled triangles indicate the migration of the zymogen and mature form 
of SpeB, respectively. Migration of the SLO and SecA polypeptides is also indicated. 
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translocation are linked in this manner, then lipid II synthesis and the ExPortal are likely 
to be spatially coordinated in the streptococcal membrane. To further examine this 
hypothesis we monitored the localization of two enzymes involved in the membrane-
associated steps of lipid II synthesis, the membrane spanning MraY, which carries out the 
first membrane-associated step, and the cytosolic MurN transferase that catalyzes the 
final enzymatic step prior to translocation of the peptidoglycan subunits across the 
membrane. Both proteins were C-terminally tagged with superfolder GFP (sfGFP) and 
their expression examined by Western analysis, fluorescence and electron microscopy 
(Fig. 7). Peak expression of MraY and MurN occurred during log phase (Fig. 7A), which 
was not unexpected since most peptidoglycan synthesis occurs during cell division and 
growth. The membrane intrinsic MraY was observed to predominantly localize to unique 
foci in the streptococcal membrane (Fig. 7B-D). Localization of MraY to a membrane 
microdomain occurred under all experimental media conditions used in this study, 
observed most strongly during log-phase in both cultures grown in C media (Fig. 7B) and 
ThyB (Fig. 7C), as determined by fluorescence microscopy. Electron microscopy 
analysis of log-phase streptococci confirmed localization of the tagged protein to unique 
membrane microdomains, as evidenced by the clustering of immunogold particles at 
distinct sites (Fig. 6D). Cytoplasmic MurN was also found at foci in the vicinity of the 
streptococcal membrane (Fig. 7E-G), though some localization throughout the 
streptococcal cytoplasm was also observed (data not shown). Like MraY, MurN localized 
to foci at log phase (Fig. 7E and F) and was ascertained by electron microscopy as well 
(Fig. 7G). 
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Figure 7. Focal localization of MraY and MurN at the S. pyogenes surface. The expression of 
C-terminally sfGFP-tagged MraY and MurN in S. pyogenes HSC5 was confirmed by Western 
blot analysis of the indicated streptococcal culture fractions (A). Arrows indicate the expected 
size of the fluorescent protein-tagged polypeptides (MraY-sfGFP: 63.5kDa; MurN-sfGFP: 
74kDa). Localization of sfGFP-tagged MraY (B-D) and MurN (E-G) in S. pyogenes HSC5 was 
revealed by fluorescent microscopy (scale bar = 1µm) (B,C,E and F) and immunogold electron 
microscopy using staining with a streptavidin-gold conjugate (scale bar = 500nm) (D and G). 
Real color, phase and merged images (B,D; sfGFP, green) are shown, as well as false color 
images (C,F; sfGFP red; WGA, 5µg ml-1, green).  
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To confirm that the observed localization of the tagged proteins corresponded to 
their native localization and not to any effects stemming from expression of the 
fluorescent protein tag, we also monitored the localization of C-terminally tagged YajC 
protein, which is maintained at the membrane by its single transmembrane segment. In 
other bacteria, YajC is considered an auxiliary subunit of the protein translocase by virtue 
of its co-expression and interaction with SecD and SecF proteins, but has been found to 
be non-essential for both viability and secretion [33]. Additionally, S. pyogenes does not 
express SecD and SecF [34] and thus the function of YajC in streptococci remains 
unknown. Unlike MraY and MurN, sfGFP-tagged YajC was observed over the entirety of 
the streptococcal membrane by both fluorescence (Fig. 8A and B) and electron 
microscopy (Fig. 8C) under all conditions tested, suggesting that the observed 
localization of MraY and MurN corresponds to their native cellular site. 
 
 
 
Figure 8. Distribution of YajC on the S. pyogenes surface. Localization of C-terminally sfGFP-
tagged YajC in S. pyogenes HSC5 was revealed by fluorescent microscopy (scale bar = 1µm) (A 
and B) and immunogold electron microscopy using staining with a streptavidin-gold conjugate 
(scale bar = 500nm) (C). Real color, phase and merged images (A; sfGFP, green) are shown, as 
well as false color images (B; sfGFP red; WGA, 5µg ml-1, green). 
 
  103 
Next we determined whether focal localization of MraY and MurN corresponds to 
the site of the ExPortal. We have previously demonstrated that a fluorescently labeled 
cationic animicrobial peptide preferentially targets to the site of the ExPortal lipid 
microdomain at low sub-lethal concetrations [12]. Fluorescence microscopy revealed that 
MraY (Fig. 9A and C) and MurN (Fig. 9B and D) localization predominantly coincides 
with that of labeling by the dansyl-polymyxin B probe, indicating that lipid II synthesis 
occurs at the anionic lipid microdomain of the ExPortal. Finally, we confirmed the 
targeting of lipid II synthetic machinery to the membrane region of the ExPortal by 
determining their localization relative to the Sec machinery translocons. Electron 
microscopy showed that immunogold labeling with antibodies against SecA and sfGFP-
labeled MurN localized to the same focal site on the streptococcal surface (Fig. 9E), 
confirming that peptidoglycan precursor synthesis is spatially coordinated with the 
ExPortal. 
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Figure 9. The sites of MraY and MurN localization are coincident with the site of the 
ExPortal in the streptococcal mmebrane. Localization of sfGFP-tagged MraY (A,C) and MurN 
(B,D) relative to the anionic lipid microdomain of the ExPortal in S. pyogenes HSC5 was 
revealed by fluorescent microscopy following staining by dansyl-polymyxin B (10µM; scale bar 
= 1µm). False color, phase and merged images (A,B: dansyl-polymyxin B, red; sfGFP, green; 
C,D: dansyl-polymyxin B, blue; sfGFP, red; WGA, green) are shown. Co-localization of sfGFP-
tagged MurN and SecA at the ExPortal was revealed by immunogold electron microscopy using 
staining with a streptavidin-gold conjugate (E). SecA was labeled with 12nm beads, MurN-sfGFP 
with 18nm gold-beads. Scale bar = 500nm.  
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DISCUSSION 
 Understanding the mechanisms involved in the biogenesis of secreted virulence 
factors in an organism whose pathogenicity depends highly on secreted effectors is of 
great importance to developing therapeutic strategies against infection by these 
pathogens. A great deal of research has been devoted to elucidating the regulation and 
expression of virulence proteins by S. pyogenes and other related Gram-positive 
pathogens [35]. However, knowledge of how these factors get translocated out of the 
streptococcal cell and processed into their biologically active forms is sparse and 
deserving of further investigation, especially given the emergence of resistance amongst 
gram-positive pathogens against clinically used antibiotics targeted at other cellular 
processes (e.g. macrolides which target protein synthesis; reviewed in [36]).  
 The data presented here indicate that biogenesis of the bacterial cell wall is not 
only necessary for protection from environmental insults and as a scaffold for the display 
of extracellular virulence effectors, but also for the maintenance of the secretory 
organelle that is the ExPortal. Examination of peptidoglycan involvement in the 
distribution of lipids in the underlying cytoplasmic membrane in Bacillus subtilis 
revealed that the cell wall is required for retention of anionic lipids at discrete 
microdomains [25]. In the investigation by Muchova et al. removal of surface 
peptidoglycan by lysozyme treatment produced protoplasts in which 
phosphatidylglycerol failed to localize in the spiral configuration that had been 
previously observed in intact cells using fluorescent lipid dyes [37, 38]. Most 
interestingly, inhibition of peptidoglycan production by depletion of the lipid II-
synthesizing enzyme MurG disrupted localization of both phosphatidylglycerol and 
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cardiolipin in the membrane [25]. This suggests that peptidoglycan synthesis is necessary 
for the establishment of specific lipid domains in B. subtilis or that disruption of lipid II 
production causes disassembly of existing domains [25]. Our experimental data confirms 
that the presence of extracellular peptidoglycan is necessary for maintaining the 
asymmetric distribution of anionic lipids in the cytoplasmic membrane of a gram-positive 
pathogen. Additionally, disruption of anionic lipid localization in the membrane 
following cell wall removal in GAS resulted in mis-localization of ExPortal proteins, 
further supporting the hypothesis that segregation of anionic lipids at a particular 
microdomain constitutes a mechanism underlying ExPortal organization.  
Our data and the results from Muchova et al indicate the gram-positive cell wall is 
involved in restricting lipids and proteins to specific regions of the cytoplasmic 
membrane. The bulk of each of the ExPortal proteins examined is found on opposite 
sides of the membrane, HtrA extracellularly and SecA intracellularly. Both, however, 
were mis-localized to a similar degree in the streptococcal cell membrane in the absence 
of the cell wall, even though SecA is unable to interact directly with extracellular 
peptidoglycan. Like HtrA in S. pyogenes, sortase localization in E. faecalis coordinates 
with that of the secretory translocons in the cytoplasmic membrane [7]. Most importantly, 
the cell wall sorting signal (CWS) of SrtC and SrtA sortases in E. faecalis contains a 
positively charged tail that was hypothesized to determine topology and mediate targeting 
and retention of the sortases within the membrane microdomains at which they were 
observed to localize [7]. Mutagenesis of the C-terminal CWS of SrtC to remove the 
positively charged tail or reduce its cationic character resulted in mis-localization of SrtC 
and reduction of its physiologic activity (pilus assembly), indicating that proper targeting 
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of the sortase to the membrane depended on the interaction of its cationic CWS with 
anionic components in the membrane [7]. Altogether, this data suggests that the retention 
of anionic phospholipids at specific, unique membrane sites constitutes the primary 
mechanism for targeting ExPortal proteins to their destination in the membrane, and that 
peptidoglycan mediates the site restriction of anionic phospholipids. 
The non-membranolytic, lipid II-binding activity of gallidermin also disrupted 
localization of both lipid and proteinaceous elements of the ExPortal. The reported 
mechanism of lantibiotics like gallidermin that are bactericidal despite not permeabilizing 
cytoplasmic membranes is the sequestration of lipid II away from the sites of 
peptidoglycan synthesis [19, 20]. The effect of this can be considered to be two-fold: 
arresting further growth of the cell wall by starving penicillin binding proteins (PBPs) of 
substrate needed for peptidoglycan polymerization at the site of de novo cell wall 
synthesis, and depleting the lipid II content of the cell by preventing recycling of C55-P 
lipid anchors needed for further lipid II production at the inner leaflet of the cytoplasmic 
membrane. The role of the cell wall in organizing the ExPortal may then have more to do 
with peptidoglycan synthesis, rather than with the peptidoglycan polymer itself, though it 
is apparent that integrity of this macromolecule is essential for lipid segregation in the 
membrane. 
Previous research indicates that segregation of anionic lipids in bacterial 
membranes is also a mechanism for targeting the macromolecular complexes involved in 
cell wall synthesis and other essential cellular processes to the sites where their 
physiological activity is required. Lipid microdomains identified in B. subtilis can be 
isolated together with homologues of eukaryotic Flotillin1 and other proteins involved in 
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transport and signaling [39]. In Caulobacter crescentus the dependence of MurG 
localization on helical cables of the cytoskeleton protein MreB [40] and the co-
localization of the division protein MinD with phosphatidylglycerol lipid spirals in the 
cytoplasmic membrane of B. subtilis [28] point to a link between the molecular 
machineries of peptidoglycan synthesis, cell division and membrane lipids. Most 
recently, examination of cell wall synthesis in growing B. subtilis cells found that MreB 
and its isoforms (Mbl, MreBH) assembled with components of the cell wall synthesis 
holoenzyme (MreC, MreD, PbpH, PBP2A and RodA) into discrete patches at the 
cytoplasmic membrane that moved processively along peripheral tracks perpendicular to 
the cell axis [26, 27]. MreC and MreD are transmembrane proteins reported to couple 
cytosolic MreB and its isoforms to the extracellular peptidoglycan synthesis machinery, 
and RodA an integral membrane protein linked to cell wall elongation and to the PBPs 
examined (PbpH and PBP2A; for a review see [41]). Motility of the observed MreB-
associated peptidoglycan biosynthetic complexes was driven by cell wall synthesis and 
MreB polymers restricted localization of patch components in the membrane and directed 
their movement [26, 27]. One possible mechanism then by which peptidoglycan synthesis 
in GAS might affect lipid segregation in the cytoplasmic membrane is by association of 
cytoskeletal components inside the cell with cell wall synthesis outside the cell, placing 
constraints on the distribution of phospholipids in the intervening membrane, thus leading 
to the creation and stabilization of lipid domains. However, S. pyogenes lacks homologs 
to the cytoskeletal MreB proteins [34], and as a morphologically ovococcoid bacterium, 
given its pattern of cell division in successive parallel planes perpendicular to the cell 
axis, S. pyogenes does not express the synthetic machinery required for cell elongation in 
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rod-shaped bacteria like B. subtilis (RodA, MreC, MreD; reviewed in [42]). Rather, the 
macromolecular complex directing cell division and growth in S. pyogenes consists of the 
tubulin homologue FtsZ, its accessory divisome proteins (i.e. FtsA, FtsW, EzrA, DivIB, 
DivIVA) and a set of high- and low-molecular weight PBPs common amongst 
enterococcal and streptococcal species [42]. Thus, although the relevance of 
peptidoglycan to the localization of membrane anionic lipids appears to be similar in S. 
pyogenes and B. subtilis, the mechanism underpinning this function of cell wall 
biogenesis may be different in each species and its elucidation requires characterization 
of the role divisome proteins of GAS play in organization of the ExPortal and cell wall 
synthesis.  
In model membranes, lipids can adopt various fluid and liquid-ordered phases, 
characterized by the different spatial arrangement and motional freedom of each lipid 
molecule with respect to the surrounding molecules, and dependent on the composition, 
structure and environment of the membrane [43]. Different fluid phases can coexist 
within a single membrane plane delimited by a plane boundary, resulting in lateral phase 
segregation and contributing to the formation of lipid microdomains similar to those 
observed in bacterial cytoplasmic membranes. The properties of these lipid phases can 
determine the orientation, mobility and interaction of proteins and lipids contained 
therein and thus directly influence the biological functionality of the domains [44]. An 
alternative, or perhaps contributing mechanism underlying organization of the ExPortal 
by membrane lipid segregation may be localization of the C55-P anchor of lipid II in the 
membrane. The membrane region at which C55-P is localized, thereby determining the 
site at which lipid II synthesis occurs, is different in composition and environment from 
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the rest of the membrane and thus determines where anionic lipids segregate in the 
membrane. The data we present here demonstrate that in GAS, the membrane-associated 
steps of lipid II synthesis are restricted to a unique microdomain of the streptococcal 
membrane, since both an integral membrane transferase (MraY) and a cytoplasmic 
enzyme (MurN) required for the production of lipid II were predominantly localized at 
unique foci in streptococcal cells, as observed by both fluorescent and electron 
microscopy. Moreover, this site coincides with the localization of the anionic lipid 
microdomain and secretory translocons of the S. pyogenes ExPortal. Restriction of lipid II 
synthesis to the site C55-P is found in the membrane could direct localization of 
phosphatidylglycerol, the predominant anionic lipid of GAS membranes. Alternative 
models in which anionic lipids maintain C55-P localization in the membrane or in which 
C55-P and phosphatidylglycerol are equally dependent on each other for localization 
cannot be ruled out. Regardless, both existing research and the data presented here are 
indicative of spatial coordination between molecules like C55-P and anionic lipids. 
Previous work in B. subtilis suggests that the lipids associated with bacterial membrane 
microdomains include polyisoprenoids synthesized via pathways involving squalene 
synthases, as treatement with zaragozic acid, an inhibitor of squalene synthesis, prevented 
the formation of functional lipid microdomains in B. subtilis membranes [39]. Most 
interestingly, further characterization of squalene synthesis inhibition by inactivation of a 
gene involved in the pathway converting farnesyl pyrophosphate into squalene, inhibited 
protein secretion and biofilm formation, but not viability of the bacterium. The C55-P 
membrane anchor of lipid II is also a polyisoprenoid synthesized from the condensation 
of eight isopentenyl pyrophosphate units to farnesyl pyrophosphate, catalyzed by 
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undecaprenyl pyrophosphate synthase (UppS) [45, 46]. Therefore, production of the 
essential C55-P isoprenoid could be the key factor for localization of both cell wall 
synthesis and the ExPortal. This does not however exclude the possibility that targeting 
of C55-P in the cytoplasmic membrane depends on the localization of the UppS 
transferase responsible for its production, which in turn may involve the action of 
divisome proteins, as these are involved in determining the site of cell wall growth and 
septation necessary for the genesis of two daughter cells with their own cell walls from a 
single parent cell.  
Further characterization of the ExPortal organization will require examining the 
involvement of proteins known to coordinate cell division with cell wall synthesis in 
other gram-positive bacteria. It will also be useful to examine the effect of compounds 
that target different aspects of peptidoglycan and lipid II synthesis on organization and 
function of the ExPortal. Recent work revealed that the secretory activity of the 
streptococcal ExPortal and its organization are particularly sensitive to the action of 
CAPs [12]. Since CAPs are a class of antimicrobial molecules against which bacterial 
pathogens have developed limited resistance, it is important to understand how these 
peptides target the ExPortal in order to develop novel and more effective therapeutics 
against GAS. Conversely, characterizing the mechanisms and specific factors supporting 
organization and function of the ExPortal can reveal novel targets to be exploited against 
S. pyogenes and other gram-positive pathogens with similar secretory mechanisms. 
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EXPERIMENTAL PROCEDURES 
Strains, media and growth conditions: As indicated, experiments utilized S. pyogenes 
HSC5 [47] or SF370 [34]. Localization of HtrA was analyzed in HSC5 following 
transformation by pHtrA-HA, which expresses a HA-tagged derivative of HtrA [6]. 
Localization of MraY, MurN, YajC was analyzed in HSC5 strain streptococci expressing 
C-terminal SuperFolder GFP protein fusions generated by chromosomal integration of 
pLAV5912, pLAV51012 and pGCP477. Routine culture was at 37°C in Todd-Hewitt 
broth (BBL) supplemented with 0.2% yeast extract (Difco) (THY medium).  Functional 
assays utilized cultures grown in unmodified C medium as described previously [48], 
supplemented with spectinomycin (100ug ml-1, Sigma #S4014) when indicated. To 
produce solid media, Bacto Agar (Difco) was added to a final concentration of 1.4%. 
Liquid cultures were grown without agitation in closed containers and solid cultures were 
incubated under anaerobic conditions using a commercial gas generator (GasPak, cat. 
#260678, BBL) as described [48]. SpeB protease activity was inhibited in cultures used 
to analyze the abundance of secreted streptococcal proteins by including the cysteine 
protease inhibitor E64 (Sigma #E3132) [49].  In selected experiments, media were 
supplemented with the cationic antimicrobial peptide polymyxin B (cat. #P0972-50MU, 
Sigma), the lantibiotics nisin (Sigma #N5764), or gallidermin (a generous gift from Dr. 
James Smith, Texas A&M University). Protoplasts were generated by treating 
streptococci with PlyC lysin (5U ml-1, 10 minutes) in 30% (wt/vol) raffinose solution 
supplemented with 5mM EDTA. For visualization of lipid and protein localization, 
protoplasts were resuspended in either ThyB or C media supplemented with 5-8% (v/v) 
glycerol, as indicated. 
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DNA techniques: Plasmid DNA was isolated via standard techniques and used to 
transform S. pyogenes as described previously [50]. Restriction endonucleases, ligases 
and polymerases were used according to manufacturer’s recommendations. 
 
Fluorescent protein-tagged constructs: All fluorescent-tagged proteins examined in this 
study were expressed in the HSC5 strain by chromosomal integration of the C-terminal 
tags. Cloning primers are detailed in Table 1. To generate GFP-tagged constructs, the 
coding sequence for SuperFolder GFP (sfGFP) was first amplified from pET28sfGFP  (a 
kind gift from Geoff Waldo at Los Alamos National Laboratory 
http://www.lanl.gov/projects/gfp/index.shtml and 
http://www.theranostech.com/products.htm) using primers GP526 and GP527. The 
amplified sfGFP sequence was then directly cloned by overlap extension PCR cloning 
using Phusion DNA polymerase (Finnzymes) as previously described [51] into pSPC18, 
a derivative of the pUC18 vector with the ampicilin resistance gene bla replaced by the 
spectinomycin resitance gene aad9 [52, 53]. The final product (pGCP458) contains a 
promoter-less sfGFP lacking the start ATG and a 5’ BamHI restriction site for direct 
cloning of the 3’ ends of ORFs to create C-terminal tag protein fusions upon 
chromosomal integration. Amplification of 300 nucleotide C-terminal fragments, absent 
the stop codon, from mraY, murN and yajC using the primer pairs MraY2 Fwd/MraY2-
Rev, MurN Fwd/MurN Rev and GP532/GP533 respectively, followed by double 
restriction digest (BamHI/PstI) and ligation generated pSPC18:MraY-sfGFP 
(pLAV5912) and pSPC18:MurN-sfGFP (pLAV51012) and pSPC18:YajC-sfGFP 
(pGCP477).  
  114 
PlyC expression and purification: Recombinant PlyC, a lysin produced by streptococcal 
phage C1, was expressed and purified as previously described [54, 55], with certain 
modifications. Both subunits of the lysin (PlyCA and PlyCB) were 6-X-His C-terminally 
tagged, and co-purified on Talon® metal affinity resin (Cat#: 635503, Clontech) from 
lysates of separate strains (pPlyCA, pPlyCB). Specific activity of the purified enzyme 
was measured according to established protocols [55]. 
 
Analysis of Viability: Viability was assessed by staining with a fluorescent vital dye 
(LIVE/DEAD®, BacLighttm) as recommended by the manufacturer (Invitrogen). Viability 
was quantitated by examination using a fluorescent microscope (Leica model DM IRE 2) 
with enumeration of the percentage of live bacteria in randomly chosen microscopic 
fields totaling >1000 cells for each condition examined. Data reported represent the mean 
and standard error of the mean derived from a minimum of 3 independent experiments. 
Differences between calculated means were evaluated for significance using a one-way 
Analysis of Variance (ANOVA). 
 
Cellular staining and fluorescent microscopy:  Streptococcal cultures were challenged 
with polymyxin B or lantibiotics as described above, stained with various fluorescent 
reagents and then analyzed by fluorescent microscopy as follows:  Analysis of the 
location and integrity of a membrane microdomain enriched in anionic phospholipids was 
assessed by staining with sub-lethal concentrations of fluorescent polymyxin B 
derivatives including dansyl-polymyxin B (10µM, cat. #P13238, Invitrogen) and 
polymyxin B BODIPY®FL conjugate (10µM and 60µM, cat. #P13235, Invitrogen). 
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Samples were examined using a Leica model DM IRE 2 fluorescent microscope and 
images captured using a QImaging Retiga 1350 EX charged-coupled device camera and 
Openlab software (Improvision). Where indicated, simultaneous treatment with 2 
reagents was conducted in order to assess co-localization of staining.  In these 
experiments streptococcal cells walls were visualized by staining with FL-vancomycin (1 
µg ml-1, cat. #V34850, Invitrogen), or Wheat Germ Agglutinin (WGA) Alexa Fluor 488 
or 350 conjugates (5 µg ml-1, cat. #W11261, #W11263 Invitrogen) and neutral membrane 
lipids were visualized by staining with Nile Red (2.5 ug ml-1, cat. #N1142, Invitrogen). 
Images were processed for publication using Adobe Photoshop CS3. 
 
Immunofluorescent microscopy:  The localization of SecA and HA-tagged HtrA protein 
was detected by immunofluorescent microscopy, as described [6].  Aliquots from cultures 
of intact cells, protoplasts, as well as untreated or lantibiotic-treated (1µM gallidermin) 
challenge assay cultures (see above) were treated and fixed according to the method of 
Raz and Fischetti [11].  Antisera used included a polyclonal rabbit anti-SecA antiserum (a 
generous gift from Donald Oliver) used at a dilution of 1:100 that was detected using an 
AlexaFluor 488-labeled goat anti-rabbit IgG (Invitrogen) at 1:500 and an AlexaFluor 
594-conjugated rabbit IgG anti-HA epitope antiserum (Invitrogen) used at 1:500.  Wheat 
germ agglutinin (WGA)-AlexaFluor 350 (Invitrogen) at a final concentration of 5 µg ml-1 
was used to visualize the streptococcal cell walls, and polymyxin B BODIPY®FL 
conjugate (10µM) was used to visualize anionic lipids.  Slides were mounted in an anti-
fade reagent (Prolong Gold, Invitrogen) and images captured.  
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Immunogold electron microscopy:  Localization of sfGFP-tagged MraY and MurN and 
YajC along with polymyxin B binding was examined by electron microscopy, as follows:  
Cultures were grown as indicated above, aliquots were removed and prepared for 
immunoelectron microscopy as described [5, 6]. Sections were stained using a 
streptavidin-gold conjugate (20nm, BBI International) and examined by electron 
microscopy as detailed [5, 6].  Localization of MraY and MurN and YajC was 
determined at early- and mid-logarithmic phase [5, 6]. Co-localization of MurN and SecA 
was assessed by staining using streptavidin-gold conjugated beads of different sizes 
(12nM and 18nM, BBI International). 
 
Analysis of protein expression and secretion: Supernatant and lysate fractions from 
cultures challenged with gallidermin and polymyxin B were prepared and analyzed for 
the presence of SpeB, SLO and SecA by Western blotting as described [56]. Lysate 
fractions from strains expressing sfGFP-tagged MraY, MurN and YajC were similarly 
examined for the presence of the sfGFP tag. Blots were developed using a Chemidoc 
XRS imager (BioRad) and relative protein concentrations determined using Quantity One 
software (BioRad, version 4.6.7).  
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Table 1. Primers utilized for construction of fluorescent protein tagged constructs. 
Primer Sequence1 
MraY2 Fwd CCCCTGCAGCTTGGAGCTATGTTGGCTGC 
MraY2 Rev CCCGGATCCGAAGACGTATAAGATAGCTAAAACTAGTAAACTAGC 
 
MurN Fwd CCCCTGCAGTTTATCTATACCGAACAAGAGGCC 
MurN Rev CCCGGATCC ATAGCGGTTTAATAGCTTTTTTGC 
GP526 gcaggtcgactctaga ggatcc AGCAAAGGAGAAGAACTTTTCAC 
GP527 cacacaggaaacagctatgacat CCCGGG TTATTTGTAGAGCTCATCCATGC 
GP532 GATACTGCAGTGGTTTATGCAACGTCAAC 
GP533 GATAGGATCCATGGCTTTCAATGGCAC 
1Restriction sites underlined, and for GP526, GP527 lower case denotes pSPC18 
sequence and the uppercase denotes sfGFP sequence.  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Chapter IV 
 
 
 
Work In Progress: Characterizing ExPortal Substrates 
 and Factors Contributing to its Organization 
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ABSTRACT 
 Further characterization of ExPortal organization will entail multiple genetic and 
molecular approaches to isolate the precise factors involved in its establishment and 
maintenance. These approaches include molecular screens to identify substrates in 
addition to SpeB and SLO requiring the spatial coordination of secretory translocons and 
accessory factors for efficient biogenesis and export, as well as targeted mutagenenesis of 
additional cell wall synthesis proteins (i.e. transglycosylases, transpeptidases and cell 
wall hydrolases) to characterize their involvement in ExPortal maintenance. Preliminary 
data resulting from such efforts is presented here. A proteomics screen for polypeptides 
other than SpeB or SLO with altered secretion profiles in response to CAP exposure 
identified the virulence protein EndoS as a potential ExPortal substrate. Identification of 
putative cell wall hydrolases encoded in the Streptococcus pyogenes genome and initial 
characterization of their involvement in ExPortal maintenance by mutagenic approaches 
revealed that though the Isp polypeptide co-localizes on the streptococcal surface with the 
anionic lipid microdomain of the ExPortal, Isp and its homolog Isp2 are not required for 
maintenance of said microdomain. Additionally Isp is unaffected in its expression or 
localization following exposure of streptococci to polymyxin B, indicating further work 
is necessary to determine what role, if any, these putative hydrolases have in ExPortal 
organization. 
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INTRODUCTION 
One approach to elucidating the mechanism(s) by which the ExPortal coordinates 
protein secretion and processing is to identify and characterize its secreted substrates. 
Understanding how these substrates are expressed and what post-translational 
modifications they undergo in order to be processed into their biologically active forms 
can reveal a great deal about ExPortal function. Not all proteins secreted by streptococci 
require the spatial coordination of accessory factors and the secretory translocons, as 
indicated by the effect exposure to sub-lethal levels of CAPs had on ExPortal 
organization and protein secretion. Since sub-lethal polymyxin B concentrations 
selectively inhibited secretion of those proteins requiring an intact ExPortal, I undertook 
a preliminary analysis of what other secreted proteins of streptococci are affected in their 
biogenesis by exposure to sub-lethal levels of a CAP. This analysis identified EndoS, a 
secreted 108kDa protein with specific endoglycosidase activity that cleaves human 
Immunoglobulin G [1], as a potential ExPortal substrate affected by CAP-mediated 
disruption of its secretory activity. 
Data presented in Chapter III demonstrates that cell wall biogenesis is involved in 
organizing the ExPortal and suggests localization of the secretory organelle is 
coordinated with the site of peptidoglycan precursor (lipid II) synthesis. In coccoid 
bacteria like S. pyogenes, cell wall synthesis primarily occurs at the site of cell division 
and involves the action of transglycosylases, transpeptidases and cell wall hydrolases [2]. 
Activity and regulation of these may be important to ExPortal organization as well as cell 
growth and division. Eukaryotic-type Ser/Thr kinases (STK) reported in bacteria, 
including GAS, can regulate cell division, growth, and virulence. Recent research 
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demonstrated that S. pyogenes STK -controlled cell division is mediated under the 
positive regulation of a secreted protein termed CdhA that possesses a cysteine and 
histidine-dependent aminohydrolase/peptidase (CHAP) domain with functional cell wall 
hydrolase activity [3]. Disruption of the CdhA-encoding gene resulted in severe cell 
division and growth defects, while a mutant expressing CdhA absent the CHAP domain 
was solely attenuated for virulence and highly susceptible to cell wall-acting 
antibiotics[3]. CdhA was thus characterized as a multifunctional protein with a N-
terminal region involved in cell division plane-recognition and a C-terminal CHAP 
domain involved in virulence[3]. Characterization of CdhA suggests that localization of 
the macromolecular machineries involved in cell division and cell wall synthesis at their 
site of action in streptococci requires accessory proteins. CdhA and/or related proteins 
then may also act directly or indirectly, through their involvement in regulation of cell 
wall synthesis, on ExPortal organization. Thus, I hypothesize that CdhA or orthologous 
proteins associated with cell wall assembly and involved in determining the plane of cell 
division in GAS, may also play a role in ExPortal organization.  
The work of Pancholi et al indicates the functional CHAP domain of CdhA is not 
involved in the protein’s role of cell division plane-recognition, given that the absence of 
this domain does not produce the same division and growth defects that disrupting 
expression of the whole CdhA polypeptide does. Additional cell wall hydrolases may 
compensate for the absence of CdhA enzymatic activity and the role of recognizing the 
plane of cell division could involve interaction of CdhA with these hydrolases in the cell 
wall or with other factors at the cytoplasmic membrane. Two additional proteins of GAS 
contain a C-terminal CHAP domain closely resembling that of CdhA. Identified as Isp 
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(Immunogenic secreted protein) and Isp2, they are highly homologous to one another, are 
encoded as part of the mga regulon, but have no assigned cellular function [4, 5]. Since 
the CHAP domain of CdhA was shown to still be important for virulence and antibiotic 
resistance, I hypothesize Isp and Isp2 function in conjunction with CdhA to modulate cell 
wall assembly, while targeting to their site of action by CdhA influences localization of 
the cell division plane and the ExPortal. Thus, I proceeded to characterize the function of 
Isp, Isp2 and CdhA in cell division and ExPortal organization. Preliminary data shows 
that lack of isp alone, or in combination with the absence of isp2, does not recapitulate 
the effects on cell division and morphology observed by disruption of CdhA. The absence 
of isp and isp2 also did not affect localization of the ExPortal anionic lipid microdomain 
nor secretion of the SpeB protease. Attempts to generate an in-frame deletion of CdhA or 
its CHAP domain in the strains lacking isp and/or isp2 have thus far proven unsuccessful, 
which hints at a dependence of theses factors on each other for cell viability.  
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RESULTS 
EndoS. Proteins in supernatants harvested from stationary phase streptococcal cultures 
that were treated with a sub-lethal concentration of polymyxin B were compared to those 
from untreated cultures. Proteins found in both samples were isolated by gel 
electrophoresis and subjected to trypsinization and subsequent analysis by mass 
spectrometry at the Siteman Cancer Center Proteomics Core Laboratory (Barnes-Jewish 
Hospital/Washington University School of Medicine, 
http://proteomics.wustl.edu/siteman/Proteomics_page3_new.htm). The results obtained 
were examined using ScaffoldTM 2 Proteome software (ScaffoldTM Version_2.1.03, 
Proteome Software Inc.). Spectrometry analysis confirmed that SpeB was absent from 
supernatants of streptococcal cultures exposed to polymyxin B and identified additional 
proteins absent or in lower relative amounts in treated cultures. Among these, one protein 
of interest for which no trace was detected in peptide treated samples, was the EndoS. 
Further characterization of EndoS as an ExPortal substrate was conducted by examining 
expression of the endoglycosidase in the presence of polymyxin B. Previous research 
indicates that, like SpeB, EndoS expression is growth phase regulated, with peak 
expression occurring in stationary phase [6]. Western analysis of supernatants from CAP-
treated and untreated cultures harvested under the same conditions as indicated for SpeB 
in Chapter I, revealed a dose-dependent reduction in the amount of secreted EndoS 
protein resulting from exposure to polymyxin B (Fig. 1A) and HNP-1 (Fig. 1B). This 
effect on levels of secreted EndoS was observed in both HSC5 and SF370 (Fig. 1C, D) 
strains. Transcriptional analysis however, showed that levels of EndoS transcript were 
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also affected by exposure to polymyxin B (Fig. 1E). These results suggest that disruption 
of the ExPortal can also affect transcription of streptococcal virulence proteins. 
 
Figure 1. High sub-lethal challenge with polymyxin B and HNP-1 inhibits secretion of 
EndoS. Expression of the EndoS endoglycosidase in cultures of S. pyogenes HSC5 (A, B) and 
SF370 (C, D) was determined following challenge with the indicated concentrations of 
polymyxin B and HNP-1 by Western blot analysis of culture supernatant (A-D) and by real-time 
RT-PCR analysis of endoS transcript abundance (E). All samples for EndoS analysis were 
harvested at 2 hrs post-challenge. 
  129 
CdhA, Isp/Isp2. Penicillin binding protein (PBP) transglycosylases, transpeptidases and 
cell wall hydrolases are hypothesized to primarily localize as a multienzyme complex or 
holoenzyme to the sites of peptidoglycan synthesis in bacteria (for a review see [7]). Cell 
wall hydrolase activity serves to remodel peptidoglycan strands as new subunits are 
added to the polymer during growth, cell separation following division and cell wall 
turnover [8-10]. CdhA was demonstrated to have functional hydrolase activity, and given 
that Isp contains a C-terminall CHAP domain similar to that of CdhA, Isp is potentially a 
previously unidentified streptococcal cell wall hydrolase. Thus in order to further 
characterize the role of peptidoglycan biogenesis in ExPortal organization, I examined 
how Isp localizes in the streptococcal cell. Isp localization was monitored by C-
terminally tagging Isp using a hemaglutinin (HA)-mCherry tandem tag. The purpose of 
the tandem tag was to examine localization of the protein by both fluorescent and 
immunofluorescent microscopy as well as expression by Western analysis. Fluorescent 
microscopy revealed that Isp localizes to discrete regions on the streptococcal surface in 
both HSC5 (Fig. 2A) and SF370 strains (Fig. 2B). These regions are observed as either 
unique foci or as hemispherical domains between cells, mirroring the observed 
localization of HNP-1 in GAS (see Fig. 6, Chapter II).  
The disruption of anionic lipid microdomains by CAPs does not appear to disrupt 
cell growth and division, as indicated by data presented in Chapter I. The converse, that 
disruption of the cell wall and of peptidoglycan synthesis affects anionic lipid 
microdomain localization, appears to be the case, as supported by data described in 
Chapter III. I examined then whether exposure to a CAP alters localization of Isp. Neither 
low nor high sub-lethal concentrations of polymyxin B appear to affect localization of Isp 
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(Fig. 2C, D). The lack of an effect on Isp localization as a result of exposure to an 
ExPortal-disrupting CAP was observed in both the HSC5 (Fig. 2C, D) and SF370 strain 
(data not shown). Next I determined whether loss of Isp expression affects localization of 
the ExPortal anionic lipid microdomain. Low sub-lethal amounts of a fluorescently 
labeled polymyxin B derivative (dansyl-polymyxin B) shown to target the ExPortal (see 
Fig., Chapter I) in wild-type streptococci similarly localized to unique foci in a mutant 
strain containing an in-frame deletion of Isp (Fig. 2E). Deletion of both Isp and its 
homolog Isp2 did not alter localization of dansyl-polymyxin B either (Fig. 2F), 
suggesting that individually or together these putative cell wall hydrolases do not 
influence ExPortal localization. Lastly I examined the localization of Isp on the 
streptococcal cell surface relative to the ExPortal. Fluorescence microscopy shows that 
the fluorescently-labled Isp polypeptide and the anionic lipid microdomain of the 
ExPortal labeled with polymyxin B localize adjacent to one another (Fig. 2G, H). This 
could be the result of both targeting to sites of active peptidoglycan synthesis and does 
not imply that localization of one is dependent on the other given the previous data 
described.  
  131 
 
Figure 2. Characterization of Isp and Isp2 putative cell wall hydrolases and their role in 
ExPortal organization. Localization of Isp and Isp2 on the streptococcal surface and their 
involvement in organization of the ExPortal was examined by fluorescence microscopy. 
Localization of C-terminally mCherry-tagged Isp protein was revealed by fluorescence 
microscopy in HSC5 (A) and SF370 (B) strains. Localization of Isp-mCherry was unaltered by 
polymyxin B challenge of streptococci with low (C) and high (D) sub-lethal levels of the cationic 
peptide.  Localization of anionic lipids was examined by fluorescence microscopy using dansyl-
polymyxin B to label membranes of HSC5 mutant strains containing in-frame deletions of isp (E) 
and both isp and isp2 (F). Co-localization of the ExPortal anionic lipid microdomain and Isp 
protein was determined by fluorescence microscopy in dansyl-polymyxin B-stained (blue) HSC5 
strains expressing mCherry-tagged Isp (red) (G) and quantitated (H). Fluorescence, phase and 
merged images are shown. Scale bar = 1µm. Numbers of polymyxin B and mCherry 
fluorescence-labeled streptococci were derived from examination of at least 1000 stained cells. 
All data presented represents the mean and standard error of the mean derived from at least 3 
experiments. 
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DISCUSSION 
The observed effects of polymyxin B on expression of EndoS indicate that 
disruption of ExPortal integrity by the CAP can also alter expression of streptococcal 
virulence factors at the level of gene transcription. This suggests that localization of 
anionic membrane lipids and associated ExPortal proteins also affects gene regulation. 
One possible mechanism by which polymyxin B may be affecting EndoS expression is 
disruption of one of the multiple two-component signal transduction systems identified in 
GAS that regulate virulence gene expression in response to environmental cues [11]. The 
CAP itself could be interacting with such a two component regulator, as is hypothesized 
in the case of cathelicidin induced stimulation of the hasABC operon described in 
Chapter I [12, 13]. Another possibility is that ExPortal disruption inhibits the function of 
an accessory factor required for activation or de-repression of EndoS transcription. 
Function of such a factor could be dependent on lipid-protein or protein-protein 
interactions at the site of protein secretion, similar to how phosphatidylglycerol has been 
shown to be involved in optimal protein translocation via the Sec pathway by influencing 
interaction of SecA with the SecYEG translocon [14, 15]. Whatever the case, the 
identification of EndoS as a virulence factor of streptococci affected by CAP activity on 
the ExPortal opens up an additional avenue of investigation into the role of ExPortal 
function in streptococcal virulence. 
Further characterization of Isp, Isp2 and CdhA localization and activity is 
evidently necessary in order to determine whether these are all indeed functional cell wall 
hydrolases involved in peptidoglycan synthesis and if and how their activity affects 
ExPortal organization. The experimental data published by Pancholi et. al. strongly 
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suggest that CdhA does play a role in proper cell wall assembly during cell division. If 
Isp and Isp2 have functional cell wall hydrolase activity, then the phenotype of the 
∆isp/∆isp2 suggests a functional CHAP domain in CdhA is necessary and sufficient for 
cell division and growth. It will be most interesting to examine whether deletion of the 
CHAP domain of CdhA in an ∆isp/∆isp2 background recapitulates the ∆CdhA 
phenotype, as this would strongly indicate that interaction of all three CHAP-domain 
proteins is required or the division-plane localizing role of CdhA, with the N-terminal 
domain of CdhA acting as the targeting factor for all three proteins and the associated Isp 
and Isp2 activity involved in the role of CdhA in virulence and beta-lactam resistance. 
Other as of yet unidentified factors may also be involved, highlighting the importance 
and novelty of this research. Characterization of the ExPortal in the CdhA-disrupted 
strain is pending collaboration with Pancholi et al, as my attempts to generate a CdhA 
null mutant have been unsuccessful. Further mutagenesis and characterization of CdhA, 
Isp, Isp2 and other components of cell wall synthesis is needed to assess their 
involvement in ExPortal organization.  
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EXPERIMENTAL PROCEDURES 
Strains, media and growth conditions:  As indicated, experiments utilized S. pyogenes 
HSC5 [16] or SF370 [17] and all references to genomic loci are based on the genome of 
SF370 [17]. Localization of Isp was analyzed in HSC5 following transformation by pIsp-
HA-mCherry (pLAV41312), which expresses a Hemagglutinin (HA)-mCherry-tandem-
tag derivative of Isp. Localization and integrity of the ExPortal anionic lipid 
microdomain was assessed in HSC5 following in-frame deletion of isp and isp2 coding 
regions. Routine culture was at 37°C in Todd-Hewitt broth (BBL) supplemented with 
0.2% yeast extract (Difco) (THY medium). Localization and functional assays utilized 
cultures grown in unmodified C medium as described previously [18], supplemented with 
spectinomycin (100ug ml-1, Sigma #S4014) when indicated. To produce solid media, 
Bacto Agar (Difco) was added to a final concentration of 1.4%. Liquid cultures were 
grown without agitation in closed containers and solid cultures were incubated under 
anaerobic conditions using a commercial gas generator (GasPak, cat. #260678, BBL) as 
described [18]. In selected experiments, media were supplemented with the cationic 
antimicrobial peptide polymyxin B (cat. #P0972-50MU, Sigma). 
 
DNA techniques: Plasmid DNA was isolated via standard techniques and used to 
transform S. pyogenes as described previously [19]. Restriction endonucleases, ligases 
and polymerases were used according to manufacturer’s recommendations. 
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Construction of S. pyogenes deletion mutants: All references to genomic loci are based 
on the genome of S. pyogenes SF370 [17]. The construction of mutants containing in-
frame deletions in isp (spy2025) and isp2 (spy1801) was performed by allelic 
replacement [20] using the primers listed in Table 1. The in-frame deletions were 
constructed as follows. Flanking regions of isp and isp2 were amplified from HSC5 
genomic DNA using the corresponding primers indicated in Table 1 to generate 
fragments 500 nucleotides in length with a 5’ XhoI upstream restriction site, an SphI 
restriction site in common at the 3’ end of the upstream flanking region and 5’ end of the 
downstream flanking region and an XbaI downstream restriction site at the 3’ end of the 
downstream flanking region. The amplified flanking regions were ligated following 
restriction digestion of the shared SphI site. The resulting products were amplified using 
the 5’ upstream and 3’ downstream primer pairs (Spy_2026/Isp4 Fwd-Isp/Spy_2023 Rev 
and Spy_1802/Isp2 Fwd- Isp2/Spy_1798 Rev) to generate fragments containing in-frame 
deletions of the regions of isp and isp2 encoding L11-P542 and M11-N493 respectively. 
These deletion fragments were cloned into the pJRS233 shuttle vector using the XhoI and 
XbaI restriction sites to generate pJRS233-∆Isp (pLAV4910) and pJRS233-∆Isp2 
(pLAV11510). HSC5 strain streptococci were transformed as previously described [20] 
with pLAV4910 to generate HSC5:∆isp, which was subsequently transformed using 
pLAV11510 to generate HSC5:∆isp/∆isp2. In frame deletions were confirmed by PCR 
and sequence analysis using the appropriate primers. 
 
Epitope/fluorescent protein-tagged constructs:  Epitope and fluorescent-tagged proteins 
examined in this study were expressed in the HSC5 strain by chromosomal integration of 
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the C-terminal tags. Cloning primers are detailed in Table 1. To generate the HA-
mCherry-tandem-tagged constructs, the coding sequence for mCherry was first amplified 
from pmCHerry-ATG5 (Addgene) using primers IspmCherry2 Fwd/Rev. The amplified 
mCherry sequence was then directly cloned using BamHI/SacI restriction sites into 
pSPC18, a derivative of the pUC18 vector with the ampicilin resistance gene bla replaced 
by the spectinomycin resitance gene aad9 [21, 22]. The final product (pLAV8510) 
contains a promoter-less mCherry lacking the start ATG and a 5’ BamHI restriction site 
for direct cloning of the 3’ ends of ORFs to create C-terminal tag protein fusions upon 
chromosomal integration. Amplification of a 500 nucleotide C-terminal fragment from 
isp, absent the stop codon and including a 3’ HA-tag nucleotide sequence, using the 
primer pair Isp-HA Fwd/Rev followed by double restriction digest (BamHI/PstI) and 
ligation generated pSPC18:Isp-HA-mCherry (pLAV41312).  
 
Cellular staining and fluorescent microscopy: Analysis of the location and integrity of a 
membrane microdomain enriched in anionic phospholipids was assessed by staining with 
sub-lethal concentrations of a fluorescent polymyxin B derivative (dansyl-polymyxin B, 
10µM, cat. #P13238, Invitrogen). Samples were examined using a Leica model DM IRE 
2 fluorescent microscope and images captured using a QImaging Retiga 1350 EX 
charged-coupled device camera and Openlab software (Improvision).  Co-localization of 
Isp with fluorescent polymyxin B derivatives was quantitated as the percentage of 
polymyxin B -stained cells that exhibited focal staining with each individual reagent 
where the two foci were superimposable. Data presented for each condition represents the 
mean and standard error of the mean derived from at least 3 independent experiments and 
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examination of a minimum of 1000 stained cells.  Images were processed for publication 
using Adobe Photoshop CS3. 
 
Analysis of protein expression and secretion: Supernatant fractions from cultures 
challenged with polymyxin B were prepared and analyzed for the presence of EndoS by 
Western blotting as described [23].  Blots were developed using a Chemidoc XRS imager 
(BioRad) and relative protein concentrations determined using Quantity One software 
(BioRad, version 4.6.7). Antibody against EndoS was a generous gift from Mattias Collin 
(Lund University, Sweeden). 
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Table 1. Primers utilized for construction of epitope/fluorescent-tagged constructs and in-frame 
deletions. 
Primer Sequence1 Description 
IspmCherry2 Fwd CCCGGATCCGTGAGCAAGGGCG
AGGAG 
5’ amplification primer for 
mCherry 
IspmCherry2 Rev CCCGAGCTCCTACTTGTACAGCT
CGTCCATGC 
3’ amplification primer for 
mCherry 
Isp-HA Fwd CCCCTGCAGATATCATGACCAAA
CTAGACCAAT 
5’ primer for insertion of HA 
epitope tag 
Isp-HA Rev CCCGCATGCTTAAGCATAATCTGG
AACATCATATGGATATGGTCTTGG
GAGTTTGTCCCC 
3’ primer for insertion of HA 
epitope tag 
Spy_2026/Isp4 Fwd CCCCTCGAGTATCAATCTCGAAG
AACAATTCGTCAA 
 5’ primer for amplifying the 
upstream flanking region of 
isp 
Spy_2026/Isp Rev CCCGCATGC 
TGTTACTGCTAACAATTTCCTTTT
CTTCAT 
3’ primer for amplifying the 
upstream flanking region of 
isp 
Isp/Spy_2023 Fwd CCCGCATGCGTCGTAGGGGACAA
ACTCCCAAGACCATAA 
5’ primer for amplifying the 
downstream flanking region 
of isp 
Isp/Spy_2023 Rev CCCTCTAGATGAGAAAACAGGGC
TTTGGGTTCTATTTTG 
3’ primer for amplifying the 
downstream flanking region 
of isp 
Spy_1802/Isp2 Fwd CCCCTCGAGGGTTCTGATCTAAG
CTTACCATTTC 
5’ primer for amplifying the 
upstream flanking region of 
isp2 
Spy_1802/Isp2 Rev CCCGCATGCGGCAACTCTTAATA
GTTTGTTTTTATT 
3’ primer for amplifying the 
upstream flanking region of 
isp2 
Isp2/Spy_1798 Fwd CCCGCATGCAACATATGTTAT 
TGGCAAGAGTAAAAA 
5’ primer for amplifying the 
downstream flanking region 
of isp2 
Isp2/Spy_1798 Rev CCCTCTAGATCTATCACTTTG 
TGATTATTTTGTCAA 
 
3’ primer for amplifying the 
downstream flanking region 
of isp2 
1Restriction sites underlined, Hemagglutinin (HA) tag italicized. 
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Chapter V 
 
 
 
An Emerging Model for Spatial Coordination of Protein Biogenesis and Secretion: 
the Role of Lipid Segregation and Cell Wall Synthesis in ExPortal Organization 
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INTRODUCTION 
Previous work discovered the co-localization of secretory translocons with an 
accessory factor for protein biogenesis at an anionic lipid microdomain, which defined 
the ExPortal as a secretory organelle dedicated to coordinating protein processing with 
secretion. My thesis research sought to further understanding of how such spatial 
coordination in the membrane is achieved and maintained, and what its relevance is to 
streptococcal pathogenensis. The experimental data resulting from this research 
constitutes a meaningful and exciting contribution to both of these aims.  
Investigation of cationic antimicrobial peptide (CAP) interaction with the 
ExPortal increased knowledge of an aspect of streptococcal pathogenesis that is not often 
examined. As effectors of innate immunity, CAPs have traditionally been considered to 
primarily act as membrane permeabilizing factors against which bacteria have little 
resistance. However, the work presented here demonstrates in a physiological model 
what has, for the most part, been investigated in model lipid membranes. That is, CAPs 
interact with the cytoplasmic membranes of bacteria via mechanisms that do not result in 
membrane permeabilization, but can have substantial effects on cell viability nonetheless. 
In Streptococcus pyogenes, CAPs influenced the secretion of virulence factors that have 
been demonstrated to be of great importance to pathogenicity, opening up a new area for 
investigation into how CAPs may participate in colonization of a human host by GAS.  
The results presented also support a tentative model for ExPortal organization. 
According to this model, anionic lipids in the streptococcal membrane play a central role 
in the localization of secretory translocons and accessory factors in the membrane. 
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Segregation of these charged lipids to a microdomain in the membrane appears to be 
mediated by, or at least involve, interaction with the cell wall and with peptidoglycan 
production. Further testing of this model will include characterization of the involvement 
in ExPortal organization and function of cell division proteins required for directing cell 
wall synthesis and growth. This makes S. pyogenes an emerging model organism for 
examining the intersection of multiple cellular processes in the membrane of Gram-
positive pathogens. 
 
Figure. 1 An emerging model of ExPortal organization. Spatial coordination of anionic lipids, 
peptidoglycan biogenesis proteins and secretory translocons in the ExPortal to effect efficient 
secretion and processing of streptococcal virulence factors. 
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CONCLUSIONS 
The model of ExPortal organization and maintenance supported by the 
experimental results presented can be described as follows and is schematically 
represented (Fig. 1). Interaction of anionic lipids with the Sec translocons, accessory 
factors (HtrA), and secreted substrates requiring post-translational processing (SpeB, 
SLO) appears to target and maintain these polypetides at the ExPortal. I have shown that 
without segregation of anionic lipids to unique microdomains in the streptococcal 
membrane, targeting and maintenance of these ExPortal proteins at their cellular site is 
lost, meaning lipid segregation in the membrane is central to ExPortal organization. Thus 
segregation of anionic lipids, mainly phosphatidylglycerol, constitutes the primary 
mechanism for targeting protein components to the site of the ExPortal. Identification of 
the peptide sequences involved in the lipid-protein interactions localizing these proteins 
is therefore an area of interest for further research. The establishment and maintenance of 
anionic lipid microdomains is in turn dependent on the presence of extracellular 
peptidoglycan and its biogenesis. Production of the peptidoglycan precursor lipid II is 
localized to the same membrane site as the ExPortal, and loss of peptidoglycan disrupts 
anionic lipid and ExPortal protein localization in the membrane. Lipid II production at 
the site of the ExPortal may also be dependent on the presence of an anionic lipid 
microdomain to which membrane-associated lipid II-synthetic proteins are targeted. 
However, the observation that a lipid II-binding lantibiotic (gallidermin) disrupts 
ExPortal lipid and protein localization favors a mechanism whereby targeting of the 
peptidoglycan precursor influences lipid segregation in the membrane, rather than the 
converse. The experimental results presented support a model in which cell wall outside 
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the membrane restricts localization of anionic lipids by determining the site of lipid II 
synthesis. Without an intact cell wall in which PBPs assemble peptidoglycan, lipid II in 
the outer leaflet of the cytoplasmic membrane is deprived of acceptors for its 
glycopeptide cargo. This can prevent recycling of its prenyl-phosphate anchor and inhibit 
further lipid II production, thus disrupting ExPortal organization and inducing 
morphological defects if peptidoglycan synthesis is completely arrested (see Fig. 3 
Chapter I). There is experimental precedent that supports such a model in the substrate 
recognition mechanism of PBP recruitment to division septa. A D-Ala-D-Ala 
carboxypeptidase (PBP3) of S. pneumoniae, encoded by the dacA gene also present in 
GAS, degrades the substrate of PBP transpeptidases by trimming the lipid II peptapeptide 
[1-3]. S.pneumoniae mutants disrupted in PBP3 display defects in division [4] and in co-
localization of PBPs with the FtsZ ring [2]. PBP3 appears distributed over the whole cell 
surface except the mid-cell region before division starts [2], meaning pentapeptides are 
only available at equatorial peptidoglycan, where PBPs would be recruited to by affinity 
for their substrate. This cooperation between PBP substrate affinity and availability lends 
support to the hypothesis that the cell wall restricts localization of peptidoglycan 
synthesis through the activity of PBPs and the availability of sites for peptidoglycan 
polymerization in intact cell wall. According to this model then, the site at which cell 
wall synthesis primarily occurs determines where lipid II is produced and in so doing 
affects ExPortal localization. In summary, my thesis work has expanded our model of 
ExPortal organization, by demonstrating that anionic lipid segregation is central to 
targeting ExPortal proteins to their membrane site and that this lipid microdomain is 
maintained by the cell wall and depends on lipid II biogenesis localized at the ExPortal. 
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This model of ExPortal organization proposes that spatial coordination of protein 
secretion and processing results from cooperation of multiple cellular mechanisms in a 
highly interdependent manner. The individual contributions cell wall biogenesis, lipid 
segregation and protein interaction make are each necessary but not sufficient by 
themselves to either establish or maintain the spatial coordination of secretory 
translocons and accessory factors. This suggests further dissection of the specific roles 
each plays in ExPortal organization may prove difficult. However, it is that much more 
important for the discovery of highly effective antimicrobials, as it makes the ExPortal a 
useful target for the development of novel antibiotics that can disrupt multiple cellular 
processes. 
 
Mechanism of CAP activity on the ExPortal. One aim of my thesis research was to 
investigate involvement of the ExPortal in streptococcal pathogenesis. Previous research 
suggested that CAP activity is an aspect of host immunity that would interact directly 
with the ExPortal. As described in Chapter I, the principal mechanism of CAP activity is 
the permeabilization of the cytoplasmic lipid membrane. Interaction of membrane lipids 
with multimeric protein complexes is central to the biological processes of membrane 
biogenesis, cell wall synthesis, and responding to environmental challenges (i.e. cell 
signaling, secretion of virulence factors). Integrity of the cytoplasmic membrane is 
therefore crucial to bacterial survival. Hence the prominence and effectiveness of CAPs 
as antimicrobials against which bacterial pathogens have limited resistance. The 
experimental data presented here indicate that CAPs affect their bacterial target in a 
manner other than by altering membrane permeability. A readily available CAP 
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(polymyxin B) and a physiologically important one (HNP-1) were shown to interact 
directly with the ExPortal and disrupt its organization and function in the absence of 
membranolytic activity. These findings contribute novel observations in a physiological 
model to emerging research that is elucidating the mechanisms of non-membranolytic 
interaction by which CAPs influence pathogens. 
Several factors modulate how CAPs partition into membranes, the most important 
of which are membrane electrical potential, curvature strain of the membrane and 
hydrophobic interactions with the lipid acyl chains [5]. Electrical potential is dictated by 
the electrostatic interactions between the lipid headgroups and the peptides’ charged 
residues. Cell membranes rich in lipids with a net negative charge at physiological pH, 
like phosphatidylglycerol (PG), cardiolipin (CL) or phosphatidylserine [6], tend to be 
highly electronegative, making them preferentially targeted for interaction with CAPs. 
Unlike unsaturated lipids that promote negative curvature strain in monolayers, PG 
generates no such strain given its cylindrical geometry. Interaction of CAPs with the acyl 
chains of lipid molecules occurs via van der Waals and hydrophobic interactions that can 
frustrate lipid packing in the membrane, inducing membrane thinning and/or lipid phase 
segregation. These properties of PG/CAP interaction explain the preferential localization 
of CAPs like polymyxin B and HNP-1 at the ExPortal. The electronegativity of an 
anionic lipid microdomain such as that of the ExPortal promotes interaction with the 
CAPs, and the reduced membrane strain in a region enriched for the cylindrical topology 
of PG facilitates insertion of the peptides into the bilayer and interaction with the 
hydrocarbon acyl chains.  
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Hydrophobicity and a net cationic nature are common to all CAPs however, but 
not all CAPs tested showed a propensity to affect ExPortal secretory function. One 
explanation is that varying degrees of hydrophobicity and net charge have great influence 
on the affinity of CAPs for membranes of varying composition. A study of 
diastereomeric peptides composed of varying ratios of lysine and leucine revealed that 
highly hydrophobic peptides had lytic activity against anionic and zwitterioinic 
phsopholipid vesicles alongside hemolytic and antibacterial activities, whereas highly 
cationic peptides only permeabilized acidic phoshpolipid vesicles and  lysed bacteria [7]. 
Though composed of the same two amino acids in different proportions, these 
proportions had a marked effect on the activity of the synthetic CAPs. Given the 
enormous diversity in the amino acid sequences of CAPs, not all will target the ExPortal 
as effectively.  
Binding to the streptococcal membrane was not directly examined in all the CAPs 
studied, thus it is possible that those CAPs that did not affect ExPortal secretory function 
do bind anionic lipids at the ExPortal, but their initial interaction with the membrane 
surface did not have any appreciable disruptive effects on its organization. This could be 
because these peptides do not exert any effects beyond a membranolytic activity on their 
bacterial targets or that the sub-lethal concentrations tested don’t reflect the threshold 
concentration of the peptides under the experimental conditions used.  Below this so-
called threshold concentration CAPs fold and remain adsorbed parallel to the bilayer [8-
11]. As the ratio of peptides to lipid increases, peptides orient perpendicular to the 
membrane [12], insert and partition into the hydrophobic core of the bilayer. Aspects 
influencing partitioning are peptide concentration, the propensity of a CAP to 
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oligomerize, composition of the membrane, fluidity, chemistry and size of the 
phospholipid headgroups, transmembrane electrical potential and pH [8, 11, 13-15]. 
Thus, CAPs that did not have disruptive effects on the ExPortal might not have achieved 
the threshold concentrations necessary to influence its organization or they had a 
propensity to only adsorb at the surface unless they achieved the threshold concentration 
that induces permeabilization of the membrane by one of the mechanisms described in 
Chapter I.  
As described in chapter III, different lipid phases can coexist within a single 
membrane plane, delimited by a plane boundary, giving rise to lateral phase segregation 
and formation of the lipid microdomains observed in bacterial cytoplasmic membranes. 
The properties of these lipid phases determine the orientation, mobility and interaction of 
proteins and lipids contained therein and thus directly influence the biological 
functionality of the domains. Research using synthetic amphipathic α-helical peptides 
showed that formation of lipid phases can be influenced by peptides of this kind, which 
also exhibited antimicrobial activity [16]. Peptides affecting lipid phases have been 
observed to perturb the membrane by forming specific lipid-peptide domains, by lateral 
phase segregation of zwitterionic from anionic phospholipids and by inducing non-
lamellar phases at physiologically relevant concentrations [5]. One demonstration of such 
modes of action was the observation of anionic phospholipids de-mixing in Gram-
positive model membranes exposed to peptides with this kind of activity [17]. Peptide 
induced lipid segregation then appears to be the mechanism employed by those CAPs 
that have disruptive effects on the ExPortal. The activity of CAPs like polymyxin B and 
HNP-1, which target PG and/or lipid II localized in an anionic lipid microdomain of the 
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streptococcal membrane, most likely disrupts the physiological role of the ExPortal by 
causing lipid phase boundary defects through peptide-induced reorganization of 
membrane lipids. The possibility that polymyxin B and HNP-1 act on other or additional 
polypeptide targets to influence ExPortal organization and biogenesis of secreted factors 
requires further investigation as previously described in Chapter I and therefore cannot be 
entirely ruled out. However, the data presented here as well as investigation conducted in 
other bacterial organisms strongly suggests that lipid segregation by CAPs promotes 
dissolution of lipid-protein complexes in the membrane and abrogates their functionality. 
 
Challenges to the ExPortal model of coordinated protein secretion and processing. A 
great deal of data, published and unpublished, has been presented here to support a 
mechanism of localized protein secretion and maturation in S. pyogenes. However, 
experimental data has been published that disputes the spatial coordination of secretory 
translocons and accessory factors at a unique site in the streptococcal membrane. One 
study indicated that M protein and Protein F (SfbI) localized at the cell surface of GAS at 
distinct and separate sub-cellular regions: M protein directed at septa and SfbI at polar 
domains [18]. Swapping of N-terminal signal sequence domains between the two proteins 
switched their localization patterns, with SfbI observed at septa and M protein at polar 
domains [18], suggesting that differences in signal sequences is determinant in targeting 
of streptococcal factors to their extracellular site. Analysis of sortase-mediated anchoring 
of M protein and SfbI to their respective cellular surface locations revealed that the two 
proteins are anchored simultaneously throughout the cell cycle, with M protein rapidly 
anchored at the septum and SfbI accumulating gradually on peripheral peptidoglycan, 
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culminating in mainly polar localization at the old cell poles [19]. However, disruption of 
sortase function did not impede the appearance of M protein and SfbI at their respective 
cellular sites, suggesting that these secreted factors were not translocated at a shared, 
unique microdomain and then sorted to their extracellular site, but directly translocated at 
their site of localization [19]. Though these data appear to call into question the existence 
of an ExPortal for coordinated protein secretion and biogenesis, alternative mechanisms 
for this differential targeting of secreted proteins in GAS should be considered and 
investigated. For example, the data indicates that these proteins target differently on the 
streptococcal surface, whether by sortase-mediated anchoring or immediately following 
translocation. It is possible that the signal sequences, which as demonstrated by Carlsson 
et. al. are the determinants of localization, serve to segregate the secreted proteins in the 
membrane immediately following translocation and prior to the action of sortase-
mediated anchoring to the cell wall, in order to efficiently distribute M protein and SfbI 
to their final surface destination. One experimental approach to determine if this is the 
case would be to swap signal sequence domains of M protein and SfbI with those of 
known ExPortal substrates (SpeB and SLO) to assess localization upon translocation.  
Efforts to directly tag the SecYEG translocon in the streptococcal membrane have thus 
far proven unsuccessful, but if accomplished, direct labeling of SecYEG in the 
cytoplasmic membrane will greatly help resolve these conflicting results.  
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FUTURE DIRECTIONS 
Further characterization of ExPortal organization and refinement of this model 
will include examination of the role cytoskeletal and cell wall synthesis proteins play in 
ExPortal maintenance. Due to their ellipsoid shape and pattern of division in successive 
parallel planes perpendicular to the long cell axis, GAS are morphologically described as 
ovococci along with other streptococci and enterococci [20]. Ovococci synthesize the cell 
wall primarily at the division site, with new hemispheres of the daughter cells synthesized 
between the old hemispheres of the parent cell, as demonstrated by labeling of S. 
pnemoniae cells mostly at mid-cell with fluorescent-vancomycin [21]. Ultrastructural, 
mutational and drug treatment studies in streptococci indicate that PBPs are arranged into 
two synthetic machineries co-localized at a single cellular site [22, 23]. One machinery 
synthesizes peptidoglycan at mid-cell on the inner face of the cell wall concomitant with 
splitting of the new wall, resulting in the observed initial phase of longitudinal growth. 
[20]. This is followed by activity of the second PBP machinery which builds the septal 
cross-wall ahead of septal splitting of the wall in order to produce the cross-wall observed 
in ovococci. High molecular weight (HMW) PBPs localize mid-cell at the site of FtsZ 
ring formation at the onset of cell division, suggesting a mechanism of FtsZ triggered cell 
wall synthesis [20]. Thus, most activity of PBPs in ovococci involves polymerization of 
peptidoglycan during cell division-associated growth.  
One hypothesis of interest for future work to test then, is that the multimeric cell 
division machinery (divisome) of streptococci is involved in localizing the ExPortal, most 
likely by determining the site of peptidoglycan synthesis. As mentioned in Chapter III, 
GAS lack cell wall elongation-associated divisome proteins (RodA, MinCD), but express 
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other peptidoglycan synthesis-related divisome factors: DivIB, DivIC, DivIVA, and 
EzrA. DivIB and DivIC are bitopic membrane proteins with major extracellular domains 
that in other ovococci are often encoded in operons along with genes involved in lipid II 
synthesis [20]. In S. pyogenes DivIB is encoded directly downstream of a lipid II 
synthase gene (murG) and immediately upstream of a Z-ring accessory factor gene (ftsA), 
while DivIVA is encoded a not very far downstream of the latter [24]. In S. pneumoniae 
and E. faecalis, loss of DivIVA expression produces aberrant cell shapes, incomplete 
septa and cells devoid of nucleoid [25, 26] and in S. aureus DivIVA has been shown to 
primarily localize at division septa [27]. The integral membrane protein EzrA regulates 
timing and positioning of FtsZ rings in B. subtilis [28] and can directly bind to and 
regulate assembly of FtsZ polymers in vitro [29]. EzrA is also required for recruitment of 
PBP1 to the cell division site in B. subtilis as part of the septal wall synthesis machinery 
[30]. While not essential in S. aureus, EzrA is important for regulation of cell size and is 
likewise required for localization of PBP1 [31]. 
 Given all this experimental evidence of the close relationship between divisome 
proteins and cell wall synthesis in ovococci like GAS, one approach to examine the role 
of said proteins in ExPortal organization would be to generate in S. pyogenes mutants 
disrupted in DivIB, DivIVA and EzrA. Attempts to generate in-frame deletion mutants as 
well as targeted disruptions of DivIB, EzrA and its associated PBP (PBP1) have thus far 
been unsuccessful. A method of targeted gene disruption using synthetic inducible 
riboswitches, developed by Topp et al. [32] and applied in GAS by Bugrysheva et al. in 
controlling expression of an essential gene [33], is an alternative approach to consider for 
generating the desired disruption of EzrA, DivIB and PBP1. Examining localization of 
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these proteins and the effect of their disruption on the distribution of lipid and 
proteinaceous ExPortal components constitutes an important next step in understanding 
organization of this secretory organelle. 
Given the diversity and ubiquity of CAPs throughout all realms of life, it should 
come as no surprise that bacterial pathogens have developed resistance mechanisms 
against them. As described in Chapter I, a great deal of research has gone into identifying 
and characterizing these mechanisms in order to develop therapeutic strategies that 
enhance the inherent ability and efficiency of CAPs at killing pathogens. One avenue of 
research that resulted from the investigation of CAP interaction with the ExPortal 
undertaken in this thesis work was the development of a screen to isolate spontaneous 
mutations rendering S. pyogenes impervious to the inhibitory effect of CAPs on ExPortal-
mediated protein secretion. The aims of such a screen are to further understanding of 
host-pathogen interactions by dissecting how GAS coordinate the protein secretion and 
processing that is central to their pathogenesis and to gain insight into how streptococci 
might overcome the action of host antimicrobials. Initial characterization of mutants 
isolated in this screen has validated the experimental approach by identifying mutants 
encoding between 1 and 4 single nucleotide polymorphisms that map to molecular 
pathways involved in secretion, lipid biosynthesis and protein processing. Efforts to 
recreate the identified mutations by directed mutagenesis and characterize their 
phenotypes are currently underway and show great promise. 
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ABSTRACT 
 
 The signal recognition particle (SRP) pathway is a universally conserved pathway 
for targeting polypeptides for secretion via the co-translational pathway.  In particular, 
the SRP pathway is thought to be the main mechanism for targeting polypeptides in 
Gram-positive bacteria, including a number of important human pathogens.  Though 
widely considered to be an essential cellular component, recent advances have indicated 
this pathway may be dispensable in Gram-positive bacteria of the genus Streptococcus 
under in vitro conditions.  However, its importance for the pathogenesis of streptococcal 
disease is unknown.  In this study, we investigated the importance of the SRP pathway 
for virulence factor secretion in the human pathogen Streptococcus pyogenes.  While not 
essential for viability in vitro, SRP mutants demonstrated a carbohydrate-specific growth 
defect.  We also observed that a distinct subset of virulence factors were dependent upon 
the SRP pathway for secretion, whereas others were completely independent of this 
pathway.  Significantly, deletion of the SRP pathway resulted in mutants that were highly 
attenuated in both a zebrafish model of necrotic myositis and a murine subcutaneous 
ulcer model, highlighting the importance of this pathway in vivo. These studies 
emphasize the importance of the SRP pathway for the in vivo survival and pathogenesis 
of S. pyogenes.  
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INTRODUCTION 
 
 The important human pathogen Streptococcus pyogenes is able to establish 
infection and cause disease in a wide variety of tissues in the host including the pharynx 
(eg. “strep throat”) and the epidermis (eg. impetigo, erysipelas), as well as deeper tissues 
like the dermis, fascia and muscle (eg. cellulits, necrotizing faciitis, myositis).  Crucial to 
the establishment of infection is the production of a multitude of virulence factors that are 
secreted across the single cellular membrane of this Gram-positive pathogen (14).  
Understanding how these various factors are trafficked to their appropriate destinations, 
including the streptococcal cell membrane, its cell surface, the extracellular spaces and 
host cells, will be important for elucidating the role of protein secretion in streptococcal 
virulence.  An unexplored question is how intracellular routing of a nascent polypeptide 
contributes to its trafficking fate. 
 Protein secretion by Gram-positive bacteria has recently been revealed to be a 
complex, organized process with specific domains dedicated to protein secretion and 
folding (11, 42, 43).  However, the pathways used to route presecretory proteins to the 
sites of translocation across the membrane are not well understood.  As Gram-positive 
bacteria lack a discernable homolog of SecB, a chaperone involved in the post-translation 
targeting pathway, most polypeptides are presumably targeted co-translationally via the 
signal recognition particle (SRP) pathway (45).  This is supported by the fact that most 
Gram-positive signal sequences tend to be longer and more hydrophobic than their Gram-
negative counterparts, which are features thought to be important for efficient routing of 
the presecretory protein to the SRP pathway (12).  Many studies in model bacterial 
species, including Escherichia coli and Bacillus subtilis, have highlighted the essential 
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nature of the SRP pathway for bacterial viability (25, 41).  However, more recent studies 
of bacteria in the genus Streptococcus have indicated that SRP essentiality may not be a 
universal characteristic of all bacteria (23).  
 The SRP itself is a ribonucleotide-protein complex composed of a protein, the 
fifty-four homolog (Ffh) and an RNA known as the small cytoplasmic RNA 
(scRNA)(45).  The SRP binds to signal sequences as they exit the ribosome and targets 
them to the bacterial membrane by binding the membrane-associated receptor, FtsY, 
which then releases the signal peptide to the Sec translocon (30).  Recent cyro-electron 
micrographs revealed the details behind this process whereby the interaction between 
FtsY with the ribosome and Ffh results in a conformational change in the ribosome to 
promote binding to the translocation machinery (21).  Crucial for proper function of SRP 
is the GTPase activity of both Ffh and FtsY, which is shared in a common catalytic 
chamber of this heterodimeric complex (17).  The SRP receptor interacts directly with the 
SecYEG translocon, highlighting the close association between these two protein 
complexes (3).   
 Interestingly, deletion of the genes encoding Ffh, FtsY and scRNA singly or in 
combination in Streptococcus mutans is not a lethal event for growth on complex media 
(23).  Under non-stress conditions, the SRP- mutants have growth yields similar to wild 
type, although with somewhat longer doubling times during logarithmic growth (23).  
The SRP mutants do have a reduced capacity to resist certain stresses, most prominently 
osmotic and acid shock (20) and fail to form biofilm (24).  However, a decreased 
resistance to stress is not a global phenotype as the mutants do retain an ability to adapt to 
acidic environments under conditions that more gradually expose them to decreased pH 
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(13).  Also, their growth patterns are not altered in response to many other stresses 
including high and low temperature (23).  The importance of the SRP for the 
pathogenesis of S. mutans disease remains to be determined.   
 Studies in E. coli have suggested that the SRP pathway is the major pathway for 
targeting secretion of integral membrane proteins, which typically lack cleavable signal 
sequences (44).  Similarly, analysis of membranes of S. mutans SRP- mutants 
demonstrated that approximately 17 proteins were either absent or were present at 
significantly reduced levels (24).  This latter class included the β-subunit of the F1F0 
ATPase, which is known to be a SRP substrate in other bacterial species (47).  Since this 
proton pump plays a central role in the ability to adapt to acidic conditions (5), this defect 
may explain the enhanced sensitivity of these mutants to acid stress.  Other proteins with 
altered membrane abundance included several glycolytic enzymes and LuxS, which is 
responsible for synthesis of an autoinducer known to be important for formation of 
streptococcal biofilm (46, 48).  However, most of these proteins lack clearly identifiable 
signal sequences, so the global importance of the SRP for the trafficking of polypeptides 
with both cleavable and non-cleavable signal sequences in the streptococci is unknown.   
 The objectives of the present study were to examine whether the non-essentiality 
of the SRP can be generalized to other pathogenic streptococcal species, and if so, what 
role the SRP pathway may play in the secretion of virulence factors and whether the SRP 
is required for virulence.  Our analysis of an Ffh-deficient mutant of S. pyogenes revealed 
that a distinct subset of virulence factors with cleavable signal sequences was dependent 
upon the SRP pathway for secretion.  Furthermore, SRP- mutants were highly attenuated 
in animal models of necrotic myositis and subcutaneous infection.  These data provide 
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insight into the conservation of the SRP pathway function in the streptococci, and suggest 
that while it is not essential for growth, it is essential for virulence.   
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MATERIALS AND METHODS 
Strains, media, culture conditions. Strains used included, Escherishia coli DH5α and S. 
pyogenes HSC5 (22). Routine culture of S. pyogenes was at 37oC and employed Todd-
Hewitt medium (BBL) supplemented with 0.2% yeast extract (Difco).  Culture of E. coli 
utilized Luria-Bertanini (LB) broth at 37oC with shaking.  Proteolytic assays employed 
strains grown in C-medium that were cultured under the conditions previously described 
(32).  When required, antibiotics were used at the following concentrations:  
erythromycin, 750 µg/ml for E. coli and 1 µg/ml for S. pyogenes. 
DNA and computational techniques. Plasmid DNA was isolated via standard 
techniques and used to transform S. pyogenes as described previously (10). Restriction 
endonucleases, ligases, and polymerases were used according to manufacturer’s 
recommendations.  The fidelity of all constructs derived by PCR were confirmed by 
DNA sequencing analyses.  All references to genomic loci are based on the genome of S. 
pyogenes strain SF370 (15).  Gene assignments were based on the information available 
in the Kyoto Encyclopedia of Genes and Genomes (www.genome.jp), and were 
supported by subsequent interrogation of the SF370 genome using BLAST (2) and query 
sequences derived from Bacillus subtilis gene products with experimentally confirmed 
activities, as noted in the text. 
Construction of Mutants. An in-frame deletion was constructed by an inverse PCR 
technique (31) to delete an internal fragment encompassing 500bp of the central portion 
of ffh (Spy1200). Allelic replacement proceeded as described previously (31), with 
confirmation of mutant genome structure by PCR using primers of the appropriate 
sequences. Primers for the deletion included Ffhdeletion1 AAC CTA GGG GGC CTA 
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TGG AAG ACC TCT TGA AAA TGA TTC CAG G and Ffh deletion 2 AAC CTA GGC 
AAA CCT TTT CTG ACA ATA TCG ACT GC. The resulting fragment of ffh has a 
deletion from amino acids spanning positions 180 to 340.  
Cellular fractionation and preparation of membranes.  Protoplasts were prepared as 
previously described (40) and then lysed by multiple freeze-thaw cycles (-80oC/37oC) 
followed by agitation with glass beads (106 µm, Sigma) using a reciprocating shaking 
device (FastPrep®, Q.biogene) at a speed setting of 4.5 for 45 seconds, repeated 4-5 
times.  Membranes were collected by centrifugation (120,000xg, 4˚C, 60 minutes) and 
resuspended in distilled water. SDS sample buffer was added to the membranes followed 
by a 10 minute boil. Membrane fractions were then separated by SDS-PAGE, transferred 
to Immobilon-PSQ membrane, and stained with Coomasie Brilliant blue R. Protein 
identification was performed by N-terminal sequencing of Coomasie-stained bands 
(Midwest Analytical, St. Louis, MO). 
Analysis and identification of proteins. Cell wall fraction, membrane, and cytosolic 
fractions were prepared from cultures as previously described (43). Cell free supernatants 
were subjected to TCA precipitation for protein concentration. Cell wall fractions from 
protoplast preparations were utilized for M protein analysis while culture supernatants 
were utilized for SpeB, SLO, and SPN.  Other fractions were consistently negative for the 
presence of these proteins. Protein samples were separated by SDS-PAGE and transferred 
to PVDF membranes. Blocking and antibody binding was done in PBS-T with 5% non-
fat dry milk. Antisera against SLO and SpeB have been described previously (31, 35).  
An anti-peptide antiserum that recognizes multiple serotypes of M protein was generated 
as described (16). An antiserum that specifically reacts against SPN was generated using 
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purified SPN (C. Smith, M. Caparon, S. Hultgren; unpublished).  Analyses of culture 
supernatant fluids for SpeB proteolytic activity and SLO hemolytic activity were 
conducted as described (32, 35).   
Analysis of transcription.  RNA from various streptococcal strains was isolated and 
analyzed as described previously (7, 29). Briefly, overnight growth in THY medium was 
diluted 1:100 in fresh THY medium followed by growth at 37°C to mid-logarithmic 
phase (OD600 = 0.500). RNA was then isolated by using glass beads (Lysing Matrix A, 
Q/BioGene) and a high-speed reciprocating shaking device (FP-120, Savant Instruments). 
RNA was further purified (RNeasy Mini Kit, Qiagen) and contaminating DNA was 
removed by DNase treatments according to the manufacturers instructions (RNase free 
DNase set, QIAGEN and DNase I, amplification grade, Invitrogen). The A260/A280 ratio 
was used to determine the RNA concentration and purity. For cDNA synthesis, 5 µg total 
RNA was treated with 200 U Superscript II Reverse transcriptase (Invitrogen) using 250 
ng of oligonucleotide random primers (Invitrogen). Real time RT-PCR was performed 
employed an iCycler thermocycler (Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad) 
and the methods and primers described previously (29). Transcript abundance was 
normalized to recA as previously described (29) and data presented represent the mean 
and standard deviation derived from at least two independent experiments that were 
performed on different days, with each individual sample analyzed in triplicate.   
Zebrafish infections. Bacterial strains were back-diluted 1:100 from overnight culture 
and grown in THY broth until OD600=0.30. Bacteria were then subjected to brief 
sonication to disrupt bacterial chains and used for intramuscular injection of zebrafish, as 
described previously (39). Experimental groups consisted of 10 zebrafish, each of which 
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was injected with 105 CFU in a volume of 10 µl or with an equivalent volume of sterile 
medium alone in the case of Mock infection.  Survival was monitored for 5 days and any 
differences in survival between groups infected with wild type or mutant strains tested for 
significance as described (7).  Data presented are pooled from 3 independent 
experiments, each of which was conducted on a different days.   
Mouse subcutaneous infections. Bacterial strains were grown and prepared as outlined 
above, then used to infect mice subcutaneously as previously described (8). Experimental 
groups consisted of 5 mice, each of which received a subcutaneous injection into the right 
flank of 108 CFU in a volume of 100μl. Lesion development was monitored over a period 
of 96 hours and recorded as described elsewhere (8).  Differences between groups in 
lesion area and in the number of mice developing an ulcer were tested for significance by 
the Mann-Whitney U test and the Chi-square test with Yates’ correction, respectively (8).  
For all test statistics, the null hypothesis was rejected when P < 0.05.  Data presented are 
pooled from two independent experiments that were conducted on different days. 
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RESULTS 
 
Ffh is not essential in Streptococcus pyogenes.  Disruption of the SRP pathway leads to 
a variety of phenotypes in the various bacterial species examined.  In E. coli and B. 
subtilis deletion of Ffh is lethal (41).  Furthermore, conditional depletion of Ffh and FtsY 
in B. subtilis results in a marked impairment of protein secretion (25), although the effect 
on the secretome may be more modest when the bacteria are cultured in rich media (49).  
In Streptococcus mutans, disruption of Ffh was first revealed in a screen for acid-
sensitive mutants (19).  It was subsequently shown that all components of the SRP 
pathway could be extensively disrupted in S. mutans with few phenotypic consequences 
apart from sensitivity to certain stresses (13).  Interestingly, disruption of both the SRP 
and one of its two homologs of YidC (YidC2) resulted in S. mutans cells which were 
severely impaired in growth (23).  We sought to ascertain whether SRP was also 
dispensable for the growth of S. pyogenes and the effect of SRP disruption on the 
secretion of several important virulence factors.  An in-frame deletion allele of the gene 
encoding Ffh was constructed to remove 500 bp from the central portion of the Ffh open 
reading frame, which includes the region encoding conserved residues necessary for 
GTPase activity that are crucial for function (17).  The resulting allele (ffhΔ180-340) was 
successfully used to replace the wild type gene in S. pyogenes HSC5 (Fig. 1A) and the 
resulting mutants grew normally and produced colonies on THY agar plates that were 
indistinguishable from wild-type.  Thus, similar to S. mutans, the SRP pathway is 
dispensable for viability of S. pyogenes.   
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A medium-specific growth defect.  The method for allelic replacement generates a 
tandem duplication of wild type and mutant alleles that resolves by homologous 
recombination to produce strains carrying either the wild type or mutant allele (9).  One 
Ffh- mutant (FFH1) was chosen for further analysis and its ability to grow in liquid media 
under various nutrient conditions was examined when compared with a matched wild 
type revertant (WTrev).  When grown in standard THY broth, a complex medium rich in 
glucose (18) the mutant showed a modest defect in its growth rate, but obtained an 
equivalent growth yield as compared to wild type on the basis of culture densities (Fig. 
1B).  When grown in C-medium, a more minimal medium rich in peptides but low in 
glucose, the Ffh- mutant presented a pronounced defect in both growth rate and yield, 
with cultures reaching a final density that was less that 50% of that obtained with a strain 
with the wild type gene (Fig. 1C).  However, this defect could be rescued by the addition 
of additional glucose to C-medium, which produced a growth profile that was 
indistinguishable from that of THY medium (Fig. 1, compare 1D to 1B).  Addition of 
NaCl (up to 150 mM) did not restore growth; however, buffering the pH of the medium 
to between pH 6.0 to pH 6.5 had the same effect as the addition of glucose, and restored 
growth of the mutant to levels identical to THY medium (data not shown). 
 
Stress Response Activated.  Membrane protein profiles of the wild type revertant and 
Ffh- mutant were compared.  Consistent with the relatively normal growth characteristics 
of the mutant in THY broth medium, these profiles were remarkably similar (Fig. 2).  An 
exception was the presence of two bands that were consistently more intense in 
membranes of the mutant when compared with the wild type revertant.  Subjecting these 
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bands to N-terminal sequencing revealed them to be DnaK and GroEL (Fig. 2).  These 
proteins play prominent roles in several stress responses, particularly under conditions 
where misfolded proteins accumulate (38, 49).  This observation suggests that despite 
near normal growth characteristics in this medium, that the mutant is accumulating some 
mis-folded proteins.   
 
Selective defects in secretion of proteins with cleavable signal sequences.  A 
prominent characteristic of S. pyogenes is its ability to secrete a large number of proteins 
during growth in culture and in tissue that have cleavable signal sequences.   The fate of a 
subset of these proteins, including the M protein, is to become covalently associated with 
the cell wall (34).  Others have well-characterized toxic activities and are known to have 
distinctly different trafficking fates when the bacterium is growing while attached to 
surface of host cells.  For example, many secreted proteins, such as the SpeB cysteine 
protease, are trafficked into the extracellular spaces.  At least one, the S. pyogenes NAD-
glycohydrolase (known as Nga or SPN), is translocated across the host cell membrane 
into its cytosol by a process that involves a second secreted translocator protein, 
streptolysin O (known as SLO), that is itself delivered to the host cell membrane (33, 35, 
37).  Since M protein, SpeB, SPN and SLO have different trafficking fates, the 
consequence of the loss of Ffh on their secretion was assessed.  Following its secretion 
via the Sec pathway, the signal sequence of the M protein is cleaved and then it is 
subsequently processed at a site towards it carboxy-terminal end and covalently cross-
linked to peptidoglycan by the enzyme sortase (4).  Examination of cell walls revealed 
that the amount of M protein in the mutant was as similar or lower than the amount of M 
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protein in the wild type parental strain (Fig. 3) indicating that Ffh is not essential, for the 
secretion of M protein and its delivery to the sortase pathway.  In contrast, the loss of Ffh 
had marked effects on the secretion of SPN and SLO.  Analysis of culture supernatants 
revealed that SPN and SLO were undetectable even after the proteins in these 
supernatants were concentrated by TCA precipitation (Fig 3). Additionally, culture 
superntants from Ffh- mutants lacked detectable SLO hemolytic activity and SPN NAD 
glycohydrolase activity (Table 1), confirming a defect for secretion of these proteins.  
The genes encoding SPN and SLO are co-transcribed from a common promoter (36) and 
the failure to observe the secreted forms of either protein was not due to a defect in 
transcription from this promoter as analysis of the slo and spn transcript by real time RT-
PCR at the time of maximal expression in logarithmically-growing cultures indicated that 
it was as abundant in the mutant as it was in the wild type revertant (Table 1). A similar 
analysis of the transcript levels of the gene encoding M protein at a time point 
corresponding to the period of its maximal expression also showed no differences 
between the Ffh- mutant strain in comparison with the wild type revertant (Table 1).  No 
intracellular pool of SLO was detected when the mutant was subjected to lysis at this 
time point (data not shown), suggesting that the polypeptide was rapidly degraded in the 
absence of secretion. ).  Taken together, these data show that the SRP pathway does make 
a critical contribution to secretion of at least a subset of the exported virulence factors of 
S. pyogenes that possess cleavable signal sequences. 
 
Medium-dependent effect on secretion of SpeB.  The absence of Ffh had a different 
effect on secretion of SpeB, as it was observed that the Ffh- mutant secreted the SpeB 
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polypeptide at levels higher than those observed for the wild type revertant during growth 
in THY medium (Fig. 3).  However, this increased level of SpeB protein did not result in 
greater expression of protease activity in the Ffh- mutant, as SpeB-dependent cysteine 
protease activity in culture supernatant from the mutant was somewhat reduced from 
levels observed for the wild type revertant (Table 1).  This phenotype was medium-
dependent, as the supernatant fluids from the Ffh- mutant lacked both detectable cysteine 
protease activity (data not shown) and detectable levels of the SpeB polypeptide 
following culture in the glucose-deficient C medium, which is a medium that supports 
robust expression of SpeB by the wild type reveratant (Fig. 4).  This defect was not due 
to a failure of the mutant to express SpeB, as the intracellular fraction of the mutant 
contained detectable levels of the SpeB polypeptide (cytoplasmic, Fig. 4).  Glucose has a 
repressive effect on expression of SpeB (28, 29) and as expected, supplementing C media 
with glucose resulted in repression of SpeB expression in the wild type revertant 
(compare WTrev supernatant, C medium + Glc to C medium, Fig. 4).  However, the 
addition of glucose resulted in increased SpeB expression in the Ffh- mutant, as levels in 
the supernatant fraction for both the SpeB polypeptide (C medium + Glc, Fig. 4) and 
cysteine protease activity (data not shown) were elevated to the levels observed in the 
wild type revertant in unsupplemented C medium.  Similar to their effects on growth in C 
medium (see above), buffering to pH 6.5, but not the addition of NaCl, resulted in 
enhanced levels of SpeB in the supernatant fluids of the mutant (data not shown).    
 
The SRP pathway is required for pathogenesis in a zebrafish model of necrotic 
myositis.  Since the Ffh- mutant had a both a medium-specific growth defect and a 
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selective deficiency in its ability to export several toxins, it was of interest to determine if 
the mutant was also altered in its ability to cause disease.  The virulence of the Ffh- 
mutant was evaluated in a zebrafish model of necrotic myositis that reproduces several 
features commonly observed in streptococcal infection of human muscle, including local 
growth in muscle tissue, extensive necrosis of the infected tissue and diminished 
inflammation (39).  Infection of zebrafish with the wild type revertant at approximately 
10-fold the LD50 produced characteristic survival curves in which greater than 90% of 
infected zebrafish did not survive past day 3 post-infection (Fig. 5).  Also, all fish 
infected with the wild type revertant demonstrated a characteristic discolored lesion at the 
site of infection apparent 24 hrs post-infection that reflects the extent of the underlying 
necrosis in muscle (39) and all zebrafish that developed a lesion did not survive.  In 
contrast, greater than 95% of zebrafish infected with the Ffh- mutant were still viable at 
Day 3 (Fig. 5) demonstrating that the loss of the SRP rendered S. pyogenes significantly 
less virulent (p < 0.0001).  Although not as intense or of equivalent area as in zebrafish 
infected with the wild type revertant, approximately 25% of the zebrafish infected with 
the mutant did develop lesions by Day 2, and these animals typically survived and their 
lesions resolved.  Lesion development had not been associated with any of the attenuated 
mutants analyzed previously (8, 39).   
 
The SRP pathway is required for pathogenesis in a murine model of subcutaneous 
infection.  Virulence of the Ffh- mutant was also examined in a murine model of 
subcutaneous infection, in which challenge with S. pyogenes HSC5 has been observed to 
cause visible ulcer-like lesions following injection into subcutaneous tissue (8).  
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Consistent with previous reports, all mice injected with the wild type revertant had visible 
lesions by 48 hrs post-infection, while most mice infected with the Ffh- mutant failed to 
develop any evidence of a visible ulcer even following 72 (Fig. 6) and 96 hours of 
examination (data not shown), demonstrating that the mutant was significantly less 
virulent (P < 0.02).  A subset of mice infected with the mutant did develop ulcers (Fig. 
6).  However, the wild type reverant caused lesions that were significantly larger in size 
compared with the mutant when compared at a time when lesion formation by the wild 
type revertant had reached a maximum (72 hrs, P < 0.005, Fig. 6) and at subsequent time 
points over the duration of the experiment (96 hrs).  These data provide additional 
evidence to suggest that Ffh play an important role in S. pyogenes virulence.   
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DISCUSSSION 
 
 These data suggest that the non-essentiality of the SRP pathway may be a general 
feature of the streptococci.  However, the SRP does contribute to a number of important 
functions of S. pyogenes, including the ability to efficiently utilize carbohydrates for 
growth, to secrete several proteins involved in host cell-pathogen interactions, and to 
cause disease in multiple animal models of streptococcal infection.  The fact that the SRP 
is not required for growth should allow more refined molecular studies of this important 
pathway for targeting presecretory proteins that should provide insight into the pathway 
in other bacterial species where the SRP is essential.  Further analyses of the SRP 
pathway in S. pyogenes should also be useful for understanding how targeting pathways 
may influence the trafficking fate of secreted proteins during infection.   
 While it is clear that the signal sequence is important for recognition by the SRP, 
the specific features of the signal sequence that dictate whether the nascent presecretory 
protein will be routed to the SRP pathway or to another pathway are not clear.  Signal 
sequences themselves canonically have 3 regions, including an amino-terminal region 
enriched in positively charged residues (N region), a central region consisting of 
hydrophobic residues (H region) and moderately polar carboxy-terminal domain (C 
region) (Fig. 5).  Studies in E. coli have suggested that while it is not an exclusive signal, 
that the probability of SRP recognition of any one signal peptide does correlate with its 
degree of hydrophobicity (26, 27).  Preliminary results from our analysis using the 
computational method of Huber et al (26) failed to identify any correspondence between 
hydropobicity and whether the signal sequences of the 4 protein analyzed in this study 
were routed to the SRP pathway.  A complication is that the longer hydrophobic regions 
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typical of Gram-positive signal sequence generally renders them quite hydrophobic 
overall.  The signal sequences of SLO, SPN, M protein and SpeB are unremarkable in 
this regard and have H regions encompassing 17-18 residues (Fig. 5).  It has also been 
suggested that the presence of glycine residues in the H region can destabilize formation 
of an alpha-helix that results in an inability to interact with the SRP (1).  An examination 
of the four streptococcal signal sequences shows their H regions all contain multiple 
glycine residues (Fig. 5).  Thus, there are no obvious characteristics of these signal 
sequences that distinguish between their routing pathway.    
 Evidence suggests that an important function for the SRP pathway is in the 
insertion of integral membrane proteins (44). Since nutrient transporters typically include 
an integral membrane component, the loss of a transporter could explain the medium-
specific growth defect of the S. pyogenes Ffh- mutant. As the growth and SpeB secretion 
defect could be reversed by the addition of glucose, it is possible that an important 
peptide transporter requires the SRP for its insertion into the membrane, making the 
mutant more dependent on carbohydrates for growth and the secretion of virulence 
factors.  A differential dependence of nutrient transporters on the SRP pathway may also 
explain recent studies that shown that depletion of the SRP in B. subtilis results in a 
pronounced secretion defect when cells were grown in minimal media that was much less 
severe when cell were grown under rich media conditions (49).  Likewise, the viable SRP 
null mutants of S. mutans are typically grown in complex rich media (23).  An increased 
requirement for glucose could help to explain the S. pyogenes Ffh- mutant’s attenuated 
ability to cause disease.  Analysis of the transcriptome during infection has shown that S. 
pyogenes experiences a significant starvation for carbohydrates in well-developed 
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necrotic lesions (29).  This idea is supported by evidence that suggests that the nutritional 
environment experienced by S. pyogenes in a necrotic lesion is similar to the nutritional 
landscape presented by unsupplemented C medium during growth in culture (29) and this 
medium had the most restrictive effect on the Ffh- mutant’s growth and secretion of the 
several media evaluated.   
 Alternatively, the Ffh- mutant’s requirement for glucose for growth and for 
secretion of SpeB in C medium may reflect the complex transcriptional regulatory 
networks that control expression of SpeB.  It is known that transcription of the gene that 
encodes this protease is highly regulated and sensitive to several different regulatory 
pathways, including those that respond to nutritional cues (29).  For example, 
transcription of speB is repressed by a culture pH higher than pH 6.5, and glucose and 
NaCl concentratins of 100 mM and 140 mM or greater, respectively (29).  Interestingly, 
the Ffh- mutant expressed higher levels of SpeB, and hyperexpression was not sensitive 
to repression by glucose or pH.  Also, while the mutant grew poorly in unsupplemented C 
medium, it did express SpeB, although failed to secrete the protease.  A failure to secrete 
the protease could be a factor that contributes to poor growth in unsupplemented medium 
as SpeB proteolytic activity in the cytoplasmic compartment of the cell would likely be 
deleterious.  In addition, since the effect of supplementation does not appear to be a 
repression of speB expression, but rather, a rescue of the secretion defect, it is possible 
that there is an accessory secretion factor required for high level secretion that is 
regulated by pH and glucose.  Accessory factors secretion factors that promote high 
levels of secretion have been described for other Gram-positive bacterial species (for 
review, see Ref # 45).   
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 Analysis of the trafficking of thioredoxin in E. coli has suggested that proteins 
exported by SRP-dependent signal sequences are those that have the ability to fold 
rapidly in the cytoplasm (26).  If allowed to accumulate in the cytoplasm for any length 
of time, it is likely that these proteins would jam the translocons if an attempt was made 
to secrete them in a partially-folded state, a situation that can be by-passed by co-
translational secretion (26).  Support for this function for the SRP pathway comes from 
the observation that SPN depends on the SRP for secretion.  As an NAD glycohydrolase, 
SPN is indiscriminate in its source of substrate and is toxic to both streptococcal and host 
cells.  In fact, the ability of S. pyogenes to produce SPN is absolutely dependent on co-
expression of an immunity factor known as IFS (36).  This immunity factor acts as a 
competitive inhibitor of SPN’s NAD substrate to ameliorate its toxicity (36).  
Interestingly, IFS resides exclusively in the streptococcal cytoplasm, suggesting that even 
if a few molecules of SPN go off-pathway and fold rapidly in the cytoplasm, the result is 
an inability to sustain viability.  Secretory stress induced by partially folded proteins 
could also explain the fact that even under conditions where it is growing robustly, that 
the mutant appeared to be experiencing a stress response as evidenced by the enhanced 
association of DnaK and GroEL with membranes.  A similar stress response has been 
observed in Ffh-depleted B. subtilis (49) and in S. mutans mutants (24).   
 Our analysis has contributed to the emerging picture that protein secretion by S. 
pyogenes and other Gram-positive bacteria is a complex and organized process.  For 
example, S. pyogenes has been shown to have a distinct membrane microdomain 
dedicated to protein secretion known as the ExPortal (42), which may serve as a protein 
folding organelle by promoting the interaction of unfolded nascent secretory proteins 
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with accessory maturation factors (43).  Secreted proteins that are substrates of the 
sortase pathway are not distributed randomly in the cell wall.  Rather, the M protein first 
appears linked to the cell wall predominantly along septum, while Protein F first appears 
at higher concentrations at the cell poles (11).  These events imply that there is 
considerable cooperation between the protein export and cell wall synthesis machineries 
and imply that intracellular routing signals play an important role in dictating trafficking 
fate.  This notion is supported by the observation that exchange of signal sequences 
between M protein and Protein F alters how the proteins appear in the wall (11).  Thus, 
while the SRP appears dispensable for growth of various species of streptococci, 
understanding how the SRP pathway contributes to the secretion process will be essential 
for understanding how protein secretion contributes to the pathogenic mechanisms by 
which this group of bacteria cause disease.   
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FIGURES 
 
 
 
 
 
 
Figure 1. Deletion of ffh results in specific nutritional requirements. Successful replacement 
of ffh (spy1200) in the wild type strain with a deletion allele (ffhΔ180-340) produced Ffh- strain 
FFH1.  (A) Analysis of PCR products generated using ffh-specific primers by agarose gel 
electrophoresis revealed bands of the expected sizes for the wild type (WT) and mutant (Ffh-) 
strains as shown.  Open and closed arrows at the left of the DNA size standards (Std.) (TrackIttm 
DNA ladder, Invitrogen) indicate the 1650 and 1000 bp bands, respectively.  The growth of the 
mutant (Ffh-) in liquid media was compared to a matched wild type revertant (WTrev) using THY 
medium (B), C-medium (C) and C-medium supplemented with glucose (D).  Data shown are 
from a single experiment representative of a minimum of three independent experiments, each of 
which was conducted on different days.   
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Figure 2.  The majority of membrane proteins are correctly targeted in the absence of the 
SRP.  Membranes purified from mutant (Ffh-) and a matched wild type revertant (WTrev) were 
analyzed by SDS-PAGE and staining with Coomasie blue as shown.  The identities of the bands 
labeled on the left of the Figure were determined by N-terminal amino-acid sequencing.  The 
migration of several size standards is indicated to the right of the Figure.   
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Figure 3. The SRP is required for the secretion of a distinct subset of virulence factors.  
Analysis of the secretion of a selection of virulence factors that have both cleavable signal 
sequences and distinct trafficking fates during infection is shown.  Included are the sortase 
pathway substrate the M protein, the SpeB cysteine protease that is released into the extracellular 
compartment, SLO that is trafficked to the host cell membrane, and SPN that is translocated into 
the host cell cytosol.  Compared by Western blot analyses are the mutant (Ffh-) and a matched 
wild type revertant (WTrev) using antisera specific for each indicated protein.  Samples analyzed 
for M protein were cell walls from protoplast preparations, cell-free overnight culture supernatant 
fluids for SpeB, and cell-free overnight supernatant fluids that were concentrated by TCA 
precipitation for SLO and SPN.  The migration of the zymogen (proSpeB) and mature (SpeB) 
forms of SpeB are indicated to the right of the SpeB panel.   
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Figure 4.  A medium-dependent secretion defect.  A Western blot analysis of SpeB expression 
from mutant (Ffh-) and wild type revertant (WTrev) following culture in C medium or C medium 
supplemented with glucose (C medium + Glc) is shown.  As indicated in the Figure, both 
supernatant and cytoplasmic fractions were analyzed.   
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Figure 5. The SRP is required for virulence in an animal model of necrotic myositis.  Groups 
of zebrafish were challenged intramuscularly with 1 x 105 CFU of mutant (Ffh-), a matched wild 
type revertant (WTrev) or were injected with sterile media alone (Mock).  Survival was monitored 
for 72 hours and the data presented as a Kaplan-Meier plot.  Data are pooled from three 
independent experiments, each of which was conducted using 10 zebrafish per group.  These data 
indicate that the mutant was significantly less lethal than the wild type revertant (P < 0.0001).   
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Figure 6.  The SRP is required for virulence in the murine subcutaneous ulcer model.  
Groups of female SKH1 hairless mice received a subcutaneous injection of 107 CFU of mutant 
(Ffh-) or a matched wild type revertant (WTrev) into the hind flank.  Following 72 hrs, the area of 
any visible ucler that formed at the site of injection was determined as described (8).  Data shown 
are pooled from two independent experiments.  Each symbol represents the area of the ulcer 
observed in an individual mouse, and the horizontal bar indicates the mean value obtained for the 
pooled set of 10 mice.  As indicated in the Figure, lesions caused by the WTrev were significantly 
larger than those caused by the Ffh- mutant.   
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Figure 7. Comparison of virulence factor signal sequences.  The N, H and C regions of the 
signal peptides of SPN (Spy0165), SLO (Spy0167), Emm1 (Spy2018) and SpeB (Spy2038) are 
shown.  Positively-charged residues in the N region and the residues of the hydrophobic H region 
are indicated in bold type and by grey highlighting, respectively.  Helix disrupting glycine 
residues in the H regions are indicated in white type.  The signal peptidase cleavage site 
(indicated by the arrow) predicted computationally by SignalP, version 3.0 (6) agreed with the 
mature N-termini that have been experimentally determined and reported for each protein. 
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